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inbrief
When results become available from a new
Census, it is possible to assess the accuracy of
the population estimates that are produced by
rolling forward from the previous Census. The
assessment provides quantitative evidence of
the accuracy of the population estimates by the
end of the intercensal period. It is carried out
by comparing a mid-2001 population estimate
rolled forward from the 1991 Census with the
mid-2001 estimate based on the 2001 Census.
The results of the assessment of accuracy are
planned to be published in December 2002.
The comparison also provides the information
needed to revise the intercensal series of mid-
1992 to mid-2000. The revised series is
required so as to ensure historic estimates are
not affected by moving from one Census base
to another. The revised series are also planned
to be published in December 2002.
The mid-2001 population estimates are being
published as soon as they are available. An
inevitable consequence is that there will be a
short gap between publication of the mid-2001
population estimates and provision of an
Rebasing the Registrar
General’s Mid-Year
Population Estimates
for England and Wales
The Registrar General’s mid-2001 estimates of the resident population of England
and Wales are planned to be published at the end of August 2002. They will be the
first set of annual mid-year population estimates based on the results of the 2001
Census and will take account of population change from Census day 2001 to the
mid-year.
historic series that is consistent for all areas
with the new 2001 base. However, in planning
this work the time that users have to wait to
receive a consistent past series has been kept
to a minimum. There is a lot to do between
August and December and in order to achieve
the timetable we would be grateful to users if,
during this time, they would direct their
enquiries and requests for population estimates
through pop.info@ons.gov.uk
Availability
It is planned that national level estimates for
the UK and constituent countries will be
available, by age and sex.
Subnational population estimates for
government office regions, counties, unitary
authorities, local government districts in
England and Wales and health authority areas
as constituted in 2001 will be available on
publication day by broad age group. There will
also, for the first time on the website, be local
and health authority tables by five-year age
groups and sex soon after publication day.
An electronic volume will be made available
during September.
All of these data, together with commentary
where appropriate, will be published on the
National Statistics website at
www.statistics.gov.uk
A short guide to population estimates is
available in the ‘What’s New’ section of the
Population and Migration theme on the
National Statistics website at
www.statistics.gov.uk
Cause of death
coding in ICD-10:
changes to
Table 6.3
Coding to the Tenth revision of the
International Classification of Diseases (ICD-
10) was introduced for cause of death
information for all deaths registered in
England and Wales from 1 January 2001.
This edition of Health Statistics Quarterly
presents annual cause of death data for 2001
registrations (see Report on page 67).
Quarterly data appear in Table 6.3. Figures for
2001 coded to ICD-10 were previously
presented separately from those for earlier
quarters coded to ICD-9 (Tables 6.3a and
6.3b). In this edition, however, a single table
has been reintroduced, in which the causes of
death reflect the ICD-10 groupings. For some
data prior to 2001, the range of ICD-9 codes
used differs from those published in earlier
editions in order to achieve greater
comparability with the ICD-10 groupings. The
causes affected are Leukaemia, Diseases of the
Liver, Land transport accidents and male
breast cancer, for which there was previously a
separate code.
Health Stat ist ics Quarterly 14 Summer 2002
3   Nat ional  Stat ist ics
There remain some discontinuities in the data
due to applying new rules for assigning
underlying cause. The most notable
discontinuity is in the number of deaths due to
Pneumonia. This is explained in a footnote to
the table. Further details can be found in
articles in Health Statistics Quarterly 08 and
13 and in the Report on the bridge-coding
study in this edition (see page 75).
It should be noted that the quarterly figures for
2001 for ‘Land transport accidents’ (V01-V89)
in Table 6.3 differ from those included in Table
6.3b in the previous three editions, when they
related to ‘Land transport accidents involving
Recent Publications
Cancer Statistics, Registrations 1998 (February, available on the
National Statistics website at: www.statistics.gov.uk/products/p8843.asp)
Population Trends 107 (The Stationery Office, £37.50, March, ISBN 0-
11-621535-6)
Non-fatal Suicidal Behaviour Among Adults aged 16 to 74 in
Great Britain (The Stationery Office, £37.50, March, ISBN 0-11-
621548-8)
Mortality statistics: Childhood, infant and perinatal, 2000,
England and Wales. Series DH3 no. 33 (March, available on the
National Statistics website at www.statistics.gov.uk/products/p6305.asp)
pedestrians, pedal cyclists motor cyclists and
occupants of motor vehicles’ (V01-V79).
Experience suggests that there is no group in
ICD-10 precisely comparable with ‘Motor
vehicle traffic accidents’ in ICD-9.
The category ‘Intentional self harm; and
events of undetermined intent’ has been
extended to include most of code Y33 ‘Other
specified events with undetermined intent’.
Data for the first three quarters of 2001 have
been revised as necessary. Code Y33.9 has not
been included in this category as it is used for
deaths where the results of legal proceedings
are pending.
Key Population and Vital Statistics 2000. Local and health
authority areas. Series VS no.27, PP1 no.23 (TSO, £35, April, ISBN
0-11-621549-6)
International migration: Migrants entering or leaving the
United Kingdom and England and Wales, 2000. Series MN
no.27 (April, available on the National Statistics website at
www.statistics.gov.uk/products/p507.asp)
All of the above publications from The Stationery Office can be
ordered on 0870 600 5522 or online at www.click.tso.com. They can
also be downloaded free of charge from the National Statistics
website.
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Figure B Age-standardised mortality rate
Figure A Population change (mid-year to mid-year)
Figure C Infant mortality (under 1 year)
Figure D Age-standardised quarterly abortion rates – residents
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Prevalence of diagnosed
diabetes mellitus in general
practice in England and
Wales, 1994 to 1998
National  Stat ist ics
Angela Newnham and Ronan
Ryan,
Office for National Statistics
Kamlesh Khunti,
Department of General
Practice and Primary Health
Care, University of Leicester
Azeem Majeed,
School of Public Policy,
University College London
INTRODUCTION
Diabetes mellitus is a common chronic disease associated with
considerably increased morbidity and mortality (Box 1). The
standardised mortality ratio of people with diabetes is significantly
higher than for those without diabetes,1 and diabetes accounts for
around 9 per cent of annual hospital inpatient expenditure.2 Smaller
studies have shown that the overall prevalence of diabetes is around
1.9 per cent,3 and that the crude and age-standardised prevalence of
type 1 and type 2 diabetes have been increasing during the past few
decades.4 World-wide, it has been projected that the number of people
with diabetes will increase by 78 per cent, from 124 million in 1997
to 221 million in 2010.5
The aim of this study was to describe trends in the prevalence of
diagnosed diabetes in England and Wales from 1994 to 1998 using
data from the General Practice Research Database (GPRD). We
describe changes over time and by socio-economic status in its overall
prevalence and in the prevalence of diet controlled, oral
hypoglycaemic treated and insulin treated diabetes. We have also
estimated the numbers of people that may have this diagnosis in the
future. The aim of the new National Service Framework for Diabetes
is to improve the health of people with diabetes by raising the quality
of the services they receive and by reducing inappropriate variations
in care.6 This study provides baseline data for those who will be
responsible for implementing the National Service Framework.
This study describes the
prevalence of diagnosed
diabetes mellitus in England and
Wales using data from the
General Practice Research
Database from 1994 to 1998.
The age-standardised
prevalence of diagnosed
diabetes increased from 1.89 to
2.23 per 100 males and from
1.37 to 1.64 per 100 females.
Overall, 29, 48 and 24 per cent
of males with diabetes, and 26,
48 and 26 per cent of females
respectively were diet
controlled, treated with oral
hypoglycaemic drugs only, or
insulin. Prevalence generally
increased with increasing
deprivation in men and women
aged 35 to 74 years. It is
estimated that there were 1.15
million people with a diagnosis
of diabetes mellitus in 1998.
Even with a conservative
increase in prevalence of 10 per
cent, this is projected to rise by
44 per cent to 1.66 million by
2023.
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similar to the population of England and Wales in 1998.7 Based on the
Townsend score of the practice ward, 1.7 per cent of the national
population in the least deprived quintile and 3.0 per cent in the most
deprived quintile were represented in 1998.
Pilot study
We reviewed the Read and OXMIS codes used in the GPRD that
contained the words ‘diabetic’ or ‘diabetes’. We included codes that
denoted type 1, type 2 or otherwise unspecified diabetes mellitus and
excluded those for diabetes insipidus, gestational or drug induced
diabetes and diabetes due to haemochromatosis, in line with the World
Health Organisation classification.9
To improve the case selection criteria, we reviewed the full GPRD
records of a sample of people assigned one of these codes during 1996
or in a previous year. We also wanted to assess the proportion of people
that we initially classified as having diabetes who did not actually have
type 1 or type 2 diabetes. This is the false positive rate. Samples were
selected so that all age groups and both sexes were represented. As
women may have gestational diabetes and because diabetes in the
young is usually insulin treated rather than diet controlled, women of
childbearing age and young people without an antidiabetic prescription
might be more likely to be false positives. Hence, we selected greater
proportions of people from these groups. We defined a person as false
positive if there was a code or comment at any point in their record for
diabetes other than type 1 or type 2 diabetes. We also defined a person
as false positive if there was a comment after the last relevant code
querying the diagnosis or stating that the code or diagnosis referred to
screening only, to someone else, or to a risk of diabetes.
The results indicated that it was feasible to use this list of codes to
identify people with diabetes if additional steps were taken to minimise
the false positive rate, as described below. Furthermore, antidiabetic
treatments are rarely used for conditions other than diabetes and over
99 per cent of people with an antidiabetic prescription in 1996 had been
assigned one of the codes during 1996 or in a previous year. Therefore,
the proportion of people that we classified as not having diabetes but
who did actually have the disease, the false negative rate, was likely to
be low.
Definition of cases and rates used in the full study
Patients were included in the analysis if they were alive and
permanently registered at a practice for the last six months of the
analysis year. Cases of diabetes in a given year were those who had
been assigned a code for diabetes from the list at any time during that
year or in a previous year. Women for whom the only instance of a
relevant code was within a year of pregnancy were excluded. This was
necessary as 15 per cent of women aged 25 to 44 years without an
antidiabetic prescription in the pilot study had gestational diabetes.
People who had a diagnostic code for cystic fibrosis at any time were
also excluded, in line with the World Health Organisation
classification.9
Because many people with diabetes did not have a code specific to type
1 or type 2 diabetes in their record, it was not possible to categorise
them in this way. Instead, we categorised people by their treatment. For
each analysis year, we defined: people with diet controlled diabetes as
people with diabetes who had no antidiabetic prescriptions in that year;
people with oral hypoglycaemic treated diabetes as people with
diabetes who had prescriptions for oral hypoglycaemic drugs (British
National Formulary section 6.1.2) but not insulin in that year; and
people with insulin treated diabetes as people with diabetes who had a
prescription for insulin (British National Formulary section 6.1.1
METHODS
Data source
The GPRD was set up in 1987 and operated by the Office for National
Statistics from 1994 to 1999. Participating practices followed
guidelines for recording all significant morbidity events, prescriptions
and reasons for prescribing and referrals. Contacts were coded using the
Read and OXMIS systems. The age and sex of all registered people
were collected and the practices regularly submitted anonymised,
patient-based electronic records.7 Data from each practice were
reviewed every six weeks to ensure that quality criteria were being met,
and practices were advised about problem areas. The
comprehensiveness and accuracy of the data recorded has been
previously documented.8
The data for this study are from 210 general practices with a combined
list size of around 1.2 million people. These practices contributed data
to the GPRD from 1994 to 1998 that passed quality checks. Although
they were voluntarily recruited, their age and sex distribution was
Box one
DIABETES MELLITUS
People with diabetes mellitus have an abnormally high
blood glucose level due to a lack of, or insensitivity to,
the hormone insulin which metabolises glucose. There
are two main types of diabetes. Type 1 is more common
in children and is caused by destruction of the cells in
the pancreas that make insulin by the body’s own
immune system. Type 2 diabetes is more common in
older adults and in adults of Asian and African-
Caribbean origin and is usually caused by insensitivity to
insulin. Diabetes also occurs more rarely when insulin
production is disrupted by certain drugs or other
diseases. Diabetes can occur only in pregnancy, known
as gestational diabetes.
The symptoms of diabetes include excessive thirst and
urination. If left untreated, the metabolic disturbances
caused by a high blood glucose level can be life
threatening. In the long term, nerves and small blood
vessels can be damaged leading to ulcers, visual and
renal complications and other problems. Damage to
larger blood vessels can lead to heart disease, strokes,
disruption of the blood supply to the legs and other
problems. As a result, people with diabetes have higher
death rates than people of the same age and sex
without diabetes.
People with type 1 diabetes usually need regular insulin
injections. Although type 2 diabetes can sometimes be
controlled by restricting the dietary intake of glucose,
drugs that stimulate production of, or increase
sensitivity to insulin and insulin injections are also often
used. Recent evidence suggests that the outcomes for
people with type 1 and type 2 diabetes are improved by
tightly controlling the glucose level. People with
diabetes also need regular check-ups to look for signs
of complications so that they can be detected and
treated early.
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excluding 6.1.1.3, hypodermic equipment) in that year. The three
categories are mutually exclusive.
As the false positive rate in the pilot study in children and young adults
aged 0 to 24 years without an antidiabetic prescription was 38 per cent,
we validated the diagnosis and the treatment category in this group by
reviewing their full GPRD record. We excluded patients if there was a
code or comment at any point in their record for diabetes other than
type 1 or type 2 diabetes, or if there was a comment after the last
relevant code querying the diagnosis or stating that the code or
diagnosis referred to screening only, to someone else, or to a risk of
diabetes. In a given analysis year, we recategorised the diabetes as
insulin treated if the diagnosis was made at the end of that year and
there was evidence of insulin use early in the next year. We also
recategorised the diabetes as insulin treated if there was evidence of
insulin use before the analysis year because we considered it more
likely that a patient would be receiving treatment elsewhere, such as a
hospital clinic, than that they had stopped needing insulin.
Using the combined populations of the general practices as the
denominator, we calculated the crude and age-specific prevalence of all
diabetes and each category of diabetes in men and women for each year
of the study. To facilitate comparisons over time and externally with
other European countries, age-standardised prevalences were calculated
by applying the age-specific rates for each five-year age group to the
European standard population.
Variation by socio-economic status
The Townsend Material Deprivation Score is calculated using
information on unemployment, overcrowding, car availability and home
ownership from the Census.10 Using this score, wards in England and
Wales were arranged in order and divided into five quintiles, each
containing 20 per cent of the population. The wards in which patients’
general practices were located were used to allocate them to a
deprivation quintile. The data were then grouped by quintile.
Future numbers of patients with diabetes
We estimated the number of people that had diagnosed diabetes in
England and Wales in 1998 by applying the prevalence in broad age
groups of males and females (0 to 24 years, 25 to 49 years, 50 to 74
years, 75 years and over) to the estimated population in those age
groups. By applying each prevalence to the population projected for
England and Wales in 2023 in those age groups, we estimated the
number of males and females that would have this diagnosis in that year
if prevalence remained constant. We also calculated what each age-
specific prevalence would be in 2023 if they increased by 10, 20 and 30
per cent. We applied these to the population projected for 2023 in each
age group to estimate the number of males and females that would have
diagnosed diabetes in that year if prevalence increased by 10, 20 or 30
per cent.
RESULTS
From 1994 to 1998, the age-standardised prevalence of diagnosed
diabetes increased by 18 per cent from 1.89 to 2.23 per 100 males, and
by 20 per cent from 1.37 to 1.64 per 100 females (Table 1). The age-
standardised prevalence was higher in males than females throughout
the period. The age-specific prevalence was also consistently higher in
men than women aged 25 years and over (Figure 1). Prevalence
increased in males and females of most ages each year from 1994 to
1998, and peaked in those aged 75 to 84 years in each year. One in 11
men and one in 15 women in this age group had diagnosed diabetes in
1998.
From 1994 to 1998, the age-standardised prevalence of diet controlled
diabetes increased by 8 per cent from 0.56 to 0.60 per 100 males, and
by 18 per cent from 0.33 to 0.39 per 100 females (Table 1). The age-
standardised prevalence of oral hypoglycaemic treated diabetes
increased by 21 per cent from 0.88 to 1.07 per 100 males, and by 18 per
cent from 0.64 to 0.76 per 100 females. The age-standardised
prevalence of insulin treated diabetes increased by 23 per cent in males
and females, from 0.46 to 0.57 per 100 males and from 0.40 to 0.49 per
100 females. The age-standardised prevalence of each category of
diabetes was lower in females than males each year from 1994 to 1998.
About half of the males and females with diabetes in the period 1994 to
1998 were treated with oral hypoglycaemic drugs alone (Table 2).
Around one quarter of the remaining males and females had diabetes
that was diet controlled, and one quarter had insulin treated diabetes.
The proportion of males and females with diet controlled diabetes
increased with age to a maximum in those aged 85 years and over. The
proportion of males and females with oral hypoglycaemic treated
diabetes also increased with age to a maximum in men aged 65 to 74
years and women aged 75 to 84 years. In contrast, the proportion of
people whose diabetes was insulin treated peaked in those aged 0 to 15
years and declined to 8 and 9 per cent respectively in men and women
aged 85 years and over.
The prevalence of diet controlled and oral hypoglycaemic treated
diabetes increased in most age groups from 1994 to 1998, and was
consistently higher in men than women aged 35 years and over and 25
years and over respectively. This is similar to all diabetes and reflects
the contribution made by these categories of diabetes to the overall
estimates. Prevalence also increased with age, as with all diabetes. In
each year, the prevalence of diet controlled diabetes was highest in men
aged 75 years and over (2.93 per 100 men aged 75 to 84 years in 1998),
and in women aged 85 years and over (2.27 per 100 women in 1998). In
Crude (CP) and age-standardised prevalence (ASP)
with 95% confidence interval (CI) of diagnosed
diabetes per 100 males and females, by calendar
year, 1994 to 1998
Table 1
Males Females
CP ASP* (95% CI) CP ASP* (95% CI)
All diabetes
1994 1.99 1.89 (1.86-1.93) 1.69 1.37 (1.34-1.40)
1995 2.09 1.97 (1.93-2.00) 1.77 1.43 (1.40-1.46)
1996 2.22 2.07 (2.03-2.11) 1.86 1.50 (1.47-1.53)
1997 2.32 2.14 (2.11-2.18) 1.96 1.57 (1.54-1.60)
1998 2.43 2.23 (2.20-2.27) 2.04 1.64 (1.61-1.67)
Diet controlled diabetes
1994 0.59 0.56 (0.54-0.58) 0.44 0.33 (0.32-0.35)
1995 0.61 0.57 (0.55-0.59) 0.46 0.34 (0.33-0.36)
1996 0.64 0.59 (0.57-0.61) 0.49 0.37 (0.36-0.39)
1997 0.65 0.59 (0.57-0.61) 0.51 0.39 (0.38-0.41)
1998 0.66 0.60 (0.58-0.62) 0.52 0.39 (0.38-0.41)
Oral hypoglycaemic treated diabetes
1994 0.93 0.88 (0.85-0.90) 0.82 0.64 (0.62-0.66)
1995 0.98 0.92 (0.89-0.94) 0.86 0.67 (0.65-0.69)
1996 1.05 0.98 (0.95-1.00) 0.90 0.70 (0.68-0.72)
1997 1.11 1.02 (1.00-1.05) 0.93 0.72 (0.70-0.74)
1998 1.17 1.07 (1.04-1.09) 0.98 0.76 (0.74-0.78)
Insulin treated diabetes
1994 0.48 0.46 (0.44-0.48) 0.43 0.40 (0.38-0.42)
1995 0.50 0.48 (0.46-0.49) 0.45 0.42 (0.40-0.44)
1996 0.52 0.50 (0.48-0.52) 0.47 0.43 (0.42-0.45)
1997 0.56 0.53 (0.51-0.55) 0.51 0.46 (0.45-0.48)
1998 0.60 0.57 (0.55-0.58) 0.54 0.49 (0.47-0.51)
* Direct standardisation using the European standard population.
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each year, the prevalence of oral hypoglycaemic treated diabetes was
highest in men aged 65 to 84 years (4.70 per 100 men aged 65 to 74
years in 1998), and in women aged 75 to 84 years (3.63 per 100 women
in 1998).
Similar to all diabetes and the other categories of diabetes, the
prevalence of insulin treated diabetes increased in most age groups each
year from 1994 to 1998, and was usually higher in men than women
aged 25 years and over. However, the prevalence of insulin treated
diabetes was higher than that of diet controlled and oral hypoglycaemic
treated diabetes in males and females aged 0 to 44 years. Furthermore,
the increase in prevalence with age thereafter was less marked than for
the other categories of diabetes, although prevalence was still highest in
older men and women aged 65 to 74 years (1.33 per 100 men and 1.21
per 100 women in 1998).
Socio-economic differences
The age-standardised prevalence of diagnosed diabetes was higher in
males and females from the most deprived quintile than in those from
the least deprived quintile (Table 3). This difference was greater in
females, in whom the age-standardised prevalence was 50 per cent
higher in those from the most deprived quintile (1.80 per 100 females)
than in those from the least deprived quintile (1.20 per 100 females).
Prevalence generally increased with increasing deprivation in men and
women aged 35 to 74 years (Figure 2).
The age-standardised prevalence of diet controlled and oral
hypoglycaemic treated diabetes were also higher in males and females
from the most deprived quintile than in those from the least deprived
quintile (Table 3). In contrast, there was no obvious association
Males Females
Oral Oral
Diet controlled diabetes hypoglycaemic Insulin treated diabetes Diet controlled diabetes hypoglycaemic Insulin treated diabetes
treated diabetes treated diabetes
Age in years % % % % % %
0–15 2.9 0.0 97.1 2.9 0.5 96.5
16–24 3.7 1.6 94.7 5.2 2.4 92.5
25–34 9.5 9.2 81.3 11.3 10.0 78.8
35–44 22.0 27.6 50.4 19.6 25.7 54.7
45–54 27.5 45.3 27.2 24.8 43.8 31.4
55–64 29.4 53.8 16.9 24.3 53.1 22.6
65–74 31.0 54.9 14.1 27.1 55.0 17.9
75–84 34.1 53.7 12.2 30.3 55.6 14.1
85 and over 39.0 52.9 8.1 37.2 53.9 8.9
All ages 28.5 47.5 24.0 26.0 48.3 25.7
Proportions of the age-specific prevalence of diagnosed diabetes that are accounted for by diet controlled, oral
hypoglycaemic treated and insulin treated diabetes, males and females, 1994 to 1998
Table 2
Age-specific prevalence of diagnosed diabetes per 100 males and females, by calendar year, 1994 to 1998Figure 1
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between the age-standardised prevalence of insulin treated diabetes and
deprivation.
The prevalence of diet controlled diabetes generally increased with
increasing deprivation in females aged up to 74 years. However, there
was no clear relationship between deprivation and age-specific
prevalence for diet controlled diabetes in males, although prevalence
was markedly higher in those aged 85 years and over from the least
deprived quintile. The prevalence of oral hypoglycaemic treated
diabetes usually increased with increasing deprivation in men and
women aged 35 to 64 years, and was highest in men aged 75 years and
over and women aged 85 years and over from the least deprived
quintile. This is similar to all diabetes and reflects the contribution
made by this category of diabetes to the overall estimates. The
prevalence of insulin treated diabetes was highest in males and females
aged 0 to 24 years from the least deprived quintile, but was generally
lower in older men and women from the less deprived quintiles, except
for men aged 75 years and over.
National estimates and future projections
We estimate that there were 0.61 million males and 0.54 million
females with diagnosed diabetes in England and Wales in 1998 and
over half (60 and 53 per cent respectively) were aged 50 to 74 years
(Table 4). Because the population is ageing, the number of males and
females with diagnosed diabetes is projected to rise to 0.84 million (37
per cent increase) and 0.67 million (24 per cent increase) respectively
in 2023, even if there is no further increase in age-specific prevalence.
From 1994 to 1998, the increase in prevalence was 24 per cent in 0- to
24-year-old males, 18 per cent in 25- to 49-year-old men, 15 per cent in
50- to 74-year-old men and 14 per cent in men aged 75 years and over.
In females, the increases were 17, 20, 18 and 12 per cent respectively. If
Crude (CP) and age-standardised prevalence (ASP)
with 95% confidence interval (CI) of diagnosed
diabetes per 100 males and females by deprivation
quintile, 1994 to 1998
Table 3
Males Females
Quintile CP ASP* (95% CI) CP ASP* (95% CI)
All diabetes
Q1 (least deprived) 2.22 1.92 (1.88-1.97) 1.57 1.20 (1.17-1.24)
Q2 2.20 1.93 (1.90-1.97) 1.83 1.36 (1.33-1.39)
Q3 2.12 1.99 (1.96-2.03) 1.87 1.51 (1.49-1.54)
Q4 2.35 2.15 (2.11-2.18) 2.01 1.58 (1.55-1.61)
Q5 (most deprived) 2.21 2.33 (2.29-2.37) 1.93 1.80 (1.77-1.83)
Diet controlled diabetes
Q1 (least deprived) 0.67 0.57 (0.55-0.59) 0.40 0.28 (0.26-0.30)
Q2 0.63 0.54 (0.53-0.56) 0.47 0.33 (0.32-0.35)
Q3 0.59 0.55 (0.53-0.57) 0.48 0.37 (0.35-0.38)
Q4 0.65 0.58 (0.56-0.60) 0.53 0.39 (0.37-0.40)
Q5 (most deprived) 0.64 0.68 (0.66-0.70) 0.50 0.45 (0.43-0.47)
Oral hypoglycaemic treated diabetes
Q1 (least deprived) 1.02 0.86 (0.83-0.89) 0.71 0.49 (0.47-0.52)
Q2 1.04 0.89 (0.86-0.91) 0.92 0.64 (0.62-0.66)
Q3 1.00 0.94 (0.92-0.97) 0.89 0.69 (0.67-0.71)
Q4 1.12 1.01 (0.99-1.04) 0.96 0.72 (0.70-0.74)
Q5 (most deprived) 1.08 1.15 (1.12-1.18) 0.96 0.89 (0.86-0.91)
Insulin treated diabetes
Q1 (least deprived) 0.53 0.49 (0.47-0.52) 0.47 0.43 (0.41-0.45)
Q2 0.53 0.50 (0.48-0.52) 0.44 0.39 (0.37-0.40)
Q3 0.52 0.50 (0.48-0.52) 0.50 0.46 (0.44-0.47)
Q4 0.58 0.55 (0.53-0.57) 0.52 0.47 (0.46-0.49)
Q5 (most deprived) 0.49 0.50 (0.49-0.52) 0.47 0.46 (0.44-0.48)
* Direct standardisation using the European standard population.
Age-specific prevalence of diagnosed diabetes per 100 males and females by deprivation quintile, 1994 to 1998Figure 2
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prevalence increases by 10 per cent from 1998 to 2023, the number of
males with the diagnosis is projected to rise by 51 per cent to 0.92
million in 2023, and the number of females with the diagnosis is
projected to rise by 36 per cent to 0.74 million (Table 4). Given a 20 per
cent increase in prevalence, the number of males is projected to rise to
1.01 million (65 per cent increase) in 2023, and the number of females
is projected to rise to 0.80 million (48 per cent increase). If prevalence
increases by 30 per cent from 1998 to 2023, the number of males and
females is projected to rise to 1.09 million (78 per cent increase) and
0.87 million (61 per cent increase) respectively in 2023.
DISCUSSION
Main findings
We estimated the prevalence of diagnosed diabetes in England and
Wales from 1994 to 1998 using data from the GPRD. The age-
standardised prevalence increased each year in males and females.
Prevalence increased in most age groups, was higher in males than
females in most age groups and peaked in those aged 75 to 84 years in
each year. It usually increased with increasing deprivation in men and
women aged 35 to 74 years. The number of people with diagnosed
diabetes is projected to rise even if there is no further increase in age-
specific prevalence because the population is ageing. With a
conservative increase in prevalence of 10 per cent from 1998 to 2023,
the number of people with diagnosed diabetes is projected to rise from
1.15 to 1.66 million.
Strengths and weaknesses of study
The practices included in this study had a combined list size of 1.2
million in 1998. We were able to describe trends over time and
variation in prevalence by socio-economic status by mapping practices
to a deprivation quintile, although it would have been more precise to
map patients to quintiles. Although practices contributing to the
database are self-selected, their age and sex distribution is comparable
to the general population.7 The prevalence of diabetes is higher in
certain ethnic groups.11 However, as general practices do not routinely
collect information relating to ethnicity, we were unable to examine its
association with diabetes. As with many other studies, we were only
able to identify people whose diabetes was diagnosed. Several studies
have suggested that this will be an underestimate of the true prevalence
of diabetes.11, 12
We categorised diabetes by treatment modality rather than as type 1 or
type 2 diabetes. Although this is not ideal, it does give some idea of the
resource implications of changes in the prevalence of diabetes treated
with oral hypoglycaemic drugs or insulin. A previous study defined
type 1 diabetes as treatment with insulin within one month of
diagnosis.13 However, this type of definition may now be unreliable, as
more patients with type 2 diabetes are likely to be treated with insulin,
following publication of evidence that tighter glycaemic control in
these patients improves outcomes.14, 15
Antidiabetic treatments are rarely used for other conditions. As almost
all patients who were prescribed oral hypoglycaemic drugs or insulin in
1996 had also been assigned one of the codes used to identify patients
with diabetes, it seems likely that most people with drug treated
diabetes were identified in this study. The false negative rate in patients
with diet controlled diabetes would have also been low if there had
been no systematic difference in the way that diet controlled and drug
treated diabetes were recorded by primary care professionals. This
seems likely as the proportion of patients who were diet controlled in
this study is similar to estimates from other studies.13, 16 For chronic
conditions, such as diabetes, GPRD age-specific consulting rates were
found to be 10 to 20 per cent lower than rates from the Fourth National
Study of Morbidity Statistics from General Practice.8 However, this was
based on face to face consultations during the analysis year only and
ignored referrals, letters and hospitalisations. This is in contrast to the
present study which has a more complete method of capturing people
with diabetes.
The pilot study suggested that false positive rates for diet controlled
and medication treated diabetes were low in older people. The higher
false positive rate in patients aged 0 to 24 years with no antidiabetic
prescription was minimised by reviewing their records, as detailed in
the methods section. Even so, three per cent of males and females aged
0 to 15 years with diabetes were categorised as having diet controlled
diabetes. These children may not have diabetes but we could find no
evidence to exclude them. Alternatively, we may have miscategorised
their diabetes and they may actually be treated with insulin. Although
patients with diabetes would be known to their primary care team, they
Projected numbers of males and females with diagnosed diabetes in England and Wales in 2023, from the baseline of 1998,
given different percentage increases in age-specific prevalence
Table 4
Age in years
0–24 25–49 50–74 75 and over Total
Prevalence per 100 males in 1998 0.21 1.13 5.74 8.52
Thousands of males with diabetes in 1998* 18 110 365 118 610
Thousands of males with diabetes in 2023† – if prevalence has remained constant 17 107 512 202 838
– if prevalence has increased by 10% 19 118 563 222 921
– if prevalence has increased by 20% 21 129 614 242 1,005
– if prevalence has increased by 30% 22 139 665 262 1,089
Prevalence per 100 females in 1998 0.22 0.82 4.24 6.41
Thousands of females with diabetes in 1998* 18 77 286 160 541
Thousands of females with diabetes in 2023† – if prevalence has remained constant 17 75 379 199 669
– if prevalence has increased by 10% 19 82 417 218 736
– if prevalence has increased by 20% 21 90 455 238 803
– if prevalence has increased by 30% 22 97 493 258 870
* Estimated numbers calculated using the estimated resident population of England and Wales at mid-1998 from the Office for National Statistics.
† Projected numbers calculated using population projections from the Government Actuary’s Department.
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Estimates of the crude prevalence per 100 people of diagnosed diabetes in the United Kingdom from 1994 to 1998Table 5
may be treated at a hospital clinic, or have moved but not have been
removed from the practice list. In such cases, the patient would have a
relevant code but prescriptions would not be recorded.
Another alternative explanation is that these patients do actually have
this category of diabetes. Over the period of this study, the prevalence
of diet controlled and oral hypoglycaemic treated diabetes in children
aged 0 to 15 years was 0.041 per 1000 children and this is similar to an
estimate of 0.038 in under 18 year olds cared for in Birmingham in
2000.17 In America, type 2 diabetes represents eight to 45 per cent of
diabetic diagnoses in large paediatric centres.18
Around 12 per cent of people with diabetes are cared for in hospital
clinics only,19 and hence it may be necessary to use data from primary
and secondary care to get an accurate estimate of the number of patients
known to have diabetes.20 However, although there may be some
potential for treatment miscategorisation in this study, all cases of
diabetes known to secondary care should also be known to their
primary care team. Furthermore, specific information related to hospital
care should be present in patients’ GPRD record, increasing the chances
of ascertainment.
Comparisons with previous studies
Several studies have estimated the crude prevalence of diagnosed
diabetes in the United Kingdom during our study period (Table 5).3, 13, 16,
20, 21, 22
 Although our estimate for 1996 (2.04 per 100 people) was similar
to estimates from other studies for this year, our estimates for 1994 and
1997 (1.84 and 2.13 per 100 people respectively) were higher than
those from other studies for these years. However, sex and age-
standardised estimates were often absent from other studies and the
discrepancies could be due to the different age and sex structures of the
populations.
Age- and sex-specific prevalence estimates were available for the study
in Poole,13 and applying these to the European standard population
gives age-standardised prevalences of 1.72 per 100 males and 1.22 per
100 females. These were lower than those calculated using our data and
the same age groups (2.07 per 100 males and 1.51 per 100 females),
although the ratios of the age-standardised prevalence in males to that
in females were both 1.4:1. Excluding children where the numbers are
smaller, the greatest differences in age-specific prevalence were in
older adults. The estimates from our study for adults in 10 year age
groups from 40 to 80 years were 17 to 42 per cent greater than those
from Poole. Although we may have overestimated prevalence, it is also
possible that other studies have underestimated prevalence or that the
populations sampled may not be directly comparable with the
population from the GPRD for reasons other than a different age and
sex structure.
The Health Survey for England is a population-based survey of people
living in private households.23 We age-standardised the prevalence of
self-reported diabetes in the 16,000 men and women aged 16 years and
over who were surveyed in 1998. Although the resulting prevalences
(2.9 per 100 men and 2.1 per 100 women) were very similar to those
calculated using our data for men and women over 16 years of age (2.9
per 100 men and 2.1 per 100 women), the age-specific prevalences
varied widely. The prevalence estimates from the Health Survey in men
and women aged over 24 years in 10 year age groups ranged from 21
per cent lower to 40 per cent greater than those from our study. Any
comparison is also limited by the fact that the Health Survey is based
on self-reported information. Although only diagnoses that are reported
as having been confirmed by a doctor are recorded, it is possible that
this method may overestimate the prevalence of a condition when
compared with prevalence based on a documented diagnosis.
Overall, we found that 48 per cent of patients with diabetes were treated
with oral hypoglycaemic drugs, 25 per cent were treated with insulin
and 27 per cent were diet controlled. This is broadly in keeping with
results from other studies.13, 16
Socio-economic differences
The prevalence of diagnosed diabetes increased with increasing
deprivation in men and women aged 35 to 74 years. Ascertainment or
recording bias is unlikely to account for this relationship, as patients in
affluent areas would probably be more likely to be diagnosed and have
their diabetes recorded. Researchers from Middlesborough and East
Cleveland used a community based diabetes register to identify known
cases of diabetes in a population of 300,000 people in 1994.21 They
described the relationship with socio-economic status based on the
ward of residence of the patient and found that there was a similar trend
of increasing prevalence of diet controlled and oral hypoglycaemic
treated diabetes with deprivation in men and women. In keeping with
our study, they found that the steepest gradient was in those aged 40 to
69 years. Researchers in Tayside found that the prevalence of type 2,
but not type 1, diabetes varied with deprivation category, and that there
were more obese, diabetic patients in deprived areas.24 They suggested
that these patients require more targeted resources and primary
prevention.
We also observed that the prevalence of oral hypoglycaemic treated
diabetes was highest in the oldest adults from the least deprived
quintile, and that the prevalence of diet controlled and insulin treated
diabetes was highest in the oldest men from the least deprived quintile.
Although there are potentially many reasons for this, this may reflect
increased testing and diagnosis of diabetes in the oldest men in the less
deprived quintiles. Additionally, mortality is higher in people with
diabetes in the lower socio-economic groups than in those from the
higher socio-economic groups,25 indicating that differential survival of
affluent people may also be important. This may be particularly relevant
to this study because we excluded patients who died during the analysis
year.
Males Females Both
England and Wales16 1993–1995 Primary care audit groups 1,474,512 - - 1.46
South Tees21 1994 Community based register 287,157 1.75 1.39 1.50
Poole13 1996 Primary and secondary care registers 184,801 2.17 1.77 1.96
Tayside3 1996 Primary and secondary based sources 391,274 - - 1.94
South Glamorgan20 1996 Primary care audit database and other sources 434,398 - - 2.30
Manchester22 1997 Evaluation of primary care based audit project 418,000 - - 1.46
PrevalencePlace Date Data source Denominator
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National Service Framework for Diabetes recommends that strategies to
identify people who do not know they have diabetes should be
implemented.6 Changes in the prevalence of diabetes in people from
ethnic minorities and changes in the size and age structure of the ethnic
minority population will also affect the future number of people with
diabetes. To adequately plan future preventive, diagnostic and treatment
services, it will be necessary to continue to describe the change in the
prevalence of diabetes over time, and more fully explore inequalities in
diabetes prevalence and the relationship with ethnicity.
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Key findings
• From 1994 to 1998, the age-standardised prevalence
of diagnosed diabetes increased by 18 per cent from
1.89 to 2.23 per 100 males, and by 20 per cent from
1.37 to 1.64 per 100 females. Prevalence increased
in most age groups, was higher in males than females
in most age groups and peaked in those aged 75 to
84 years in each year.
• About half of the males and females with diabetes
from 1994 to 1998 were treated with oral
hypoglycaemic drugs alone. Around one quarter of
the remaining males and females had diabetes that
was diet controlled and one quarter had insulin
treated diabetes.
• The prevalence of diagnosed diabetes usually
increased with increasing deprivation in men and
women aged 35 to 74 years.
• Because the population is ageing, the number of
males and females with diagnosed diabetes is
projected to rise even if there is no fur ther increase
in age-specific prevalence. Even with a conservative
increase in prevalence of 10 per cent from 1998 to
2023, the number of people with diagnosed diabetes
is projected to rise by 44 per cent, from 1.15
million in 1998 to 1.66 million in 2023.
Meaning of the study
The increase in the prevalence of diagnosed diabetes over time
demonstrated in this study is unlikely to be due to increased recording.
The GPRD was in place for several years before 1994 and there were
no major changes in the way that data were recorded during the period
of the study. Other studies have demonstrated increases in the
prevalence of diabetes. Researchers in Poole used primary and
secondary care data sources to describe the prevalence of diagnosed
diabetes in 90,000 people.4 From 1989/9 to 1996, the age-standardised
prevalence increased by 53 per cent in men and 43 per cent in women.
The age-specific prevalence of self-reported diabetes also increased in
most 10 year age groups of adults aged 16 years and over who were
surveyed from 1994 to 1998.23 Therefore, it seems likely that the results
from this study do support an increase in the overall prevalence of
diagnosed diabetes. Improved survival and increased ascertainment
may have contributed to the increase in prevalence due to increased
awareness of diabetes and, towards the end of the study period, the
benefits of tight glycaemic control in patients with type 2 diabetes.14, 15
Given the increasing prevalence of diabetes, it may be appropriate to
target prevention activities at those at higher risk. Body mass index has
been identified as a dominant risk factor for diabetes, and the risk of
diabetes was reduced among men who took regular exercise.26 In
Finland, type 2 diabetes was prevented by lifestyle changes, including
weight loss, in overweight middle aged patients.27
Future research
The age-standardised prevalence of diagnosed diabetes increased from
1994 to 1998, and this was probably due to increased survival, case
ascertainment and incidence. Because the population is ageing, the
number of people with diagnosed diabetes is projected to rise even if
there is no further increase in age-specific prevalence. However, it is
likely that the prevalence of diagnosed diabetes will continue to
increase for several reasons. For example, better treatments should lead
to longer survival in patients with type 1 and type 2 diabetes, and the
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Age- and sex-specific
antibiotic prescribing
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1994 to 1998
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In recent years, there have been
several initiatives to encourage
more prudent prescribing of
antibiotics, particularly in
primary care. Using information
from 210 general practices in
the General Practice Research
Database with a total list size of
1.4 million patients, we
examined trends in antibiotic
prescribing in general practice in
England and Wales between
1994 and 1998. The age-
standardised antibiotic
prescribing rate in 1998 was 575
per 1,000 in males and 800 per
1,000 in females. Antibiotics
were prescribed most frequently
to children and the elderly.
There was a decline in the use of
all antibiotics between 1994 and
1998, particularly among the
more commonly used antibiotics
and among children. Age-
standardised prescribing rates
were higher in the most
deprived electoral wards and the
rate of fall in prescribing was
also lowest in these areas. There
was a more than five-fold
variation in prescribing rates
among the 210 practices in this
study, from 289 to 1,597 per
1,000 patients.
INTRODUCTION
The increase in antibiotic resistance is one of the most worrying trends
facing 21st century medicine. Doctors worldwide have noted the ever-
increasing prevalence of resistant organisms and the problems this is
leading to. For example, there have been recent reports of deaths among
children in the community in the USA attributed to antimicrobial
resistance.1 In the United Kingdom (UK), antibiotic resistance within
hospitals is becoming an increasingly important problem. Much
antibiotic prescribing is likely to be of limited therapeutic value and
there is some evidence that lower rates of antibiotic prescribing may
also lead to lower rates of antibiotic resistance.2
To help reduce antibiotic prescribing rates, doctors have been
encouraged to prescribe more rationally and to follow evidence based
guidelines when prescribing antibiotics.3 There is some evidence that
national programs can have an effect on prescribing rates.4,5 In 1998,
the Department of Health’s Standing Medical Advisory Committee
published a major report on antibiotic resistance.6 More recently, the
Department of Health has established a Specialist Advisory Committee
on Antimicrobial Resistance to take forwards work in this area. In the
UK, general practitioners prescribe the majority of antibiotics and some
of the key components of the strategy to reduce antibiotic prescribing
are aimed at this group. However, there has been very little research
examining recent trends in antibiotic prescribing in primary care.7
We analysed data from the General Practice Research Database
(GPRD) to examine trends in antibiotic prescribing by general
practitioners for the period 1994 to 1998. Our main objective was to
examine whether guidelines on antibiotic prescribing, publication of
research studies, and evidence from advisory bodies published from the
mid 1990s onwards influenced the antibiotic prescribing practice of
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general practitioners in England and Wales.3, 5, 8, 9 Because a reduction in
the prescribing of antibiotics could lead to a lower prevalence of
bacterial resistance,10 our findings may have important implications for
both the NHS and for other health care systems.
We used recent data from the GPRD to examine the age- and sex-
specific prescribing rates for the main antibiotic groups between 1994
and 1998; the trends in overall antibiotic prescribing; to assess the
percentage of each age group prescribed an antibiotic in each year; and
to examine the variation in antibiotic prescribing rates between general
practices, NHS regions, and between deprived and affluent areas. We
also looked in more detail at the use of the quinolones, a group of
antibiotics that are felt to be less appropriate as first line treatment in
primary care.
METHODS
The antibiotic prescription data used in this study came from 210
general practices in England and Wales contributing data to the General
Practice Research Database (GPRD). The total list size was 1.4 million
patients in 1998, representing 2.6 per cent of the population of England
and Wales. There is some variation in coverage between regions from
1.4 per cent in North Thames to 3.4 per cent in West Midlands. The
GPRD was originally set up in 1987 by the VAMP software company
and was acquired by Reuters Health Information Ltd. who in 1994
donated it to the Department of Health. The Office for National
Statistics (formerly OPCS) operated the database from 1994 to 1999.
The Medicines Control Agency has been responsible for the overall
management and financial control of GPRD since April 1999, and its
operation since October 1999.
Participating practices follow agreed guidelines for the recording of
clinical and prescribing data and submit anonymised, patient-based
clinical records on a regular basis to the database. All of the 210
practices included in this analysis contributed data throughout the five-
year period 1994 to 1998 that passed regular quality checks. The
accuracy and comprehensiveness of the data recorded in the GPRD has
been documented previously.11, 12, 13, 14 The combined population of the
practices in 1998 had a very similar age-sex composition to the mid-
1998 population of England and Wales.15 Prescribing information is
recorded using either VAMP or Multilex drug codes. These codes are
mapped to the classification used by the British National Formulary
(BNF). Prescribing information can be extracted using these mappings.
Antibiotic prescriptions
All prescription items for antibacterial drugs (BNF section 5.1) issued
during the year were included in the analysis and were classified by
type of antibiotic. Only prescriptions issued while patients were
registered and therefore ‘at risk’ were included. The data relate to
prescriptions issued and recorded by GPs and not to prescriptions
dispensed.
For the most recent years for which prescribing data were available
(1994 to 1998), we calculated age- and sex-specific prescribing rates for
selected antibiotic categories, based on British National Formulary
definitions. To allow direct comparison of the rates over time, between
the sexes, and across regions and deprivation categories, directly age-
standardised rates were calculated (based on the European Standard
Population). The percentage of patients in each age-sex group receiving
at least one prescription for an antibiotic was also calculated. Finally,
we examined the overall variation in antibiotic prescribing rates among
the 210 practices. Prescribing rates for 1998 are presented along with
some trend data for 1994 to 1998.
As not all patients were registered with the practices for the entire
duration of the study, prescribing rates were calculated as the number of
prescriptions per 1,000 patient years at risk. Patient years at risk were
calculated as the sum of the number of days that patients were
registered during the year, divided by the number of days in the year.
Geographic and area deprivation classifications
In the GPRD, no information is available on where the practice patients
live so all geographic and socio-economic analyses are based on
practice location. Practice postcode is used to ascertain which electoral
ward the practice is located in. Data were aggregated for all
participating practices in each region and deprivation category.
The analysis of regional variation in antibiotic prescribing patterns used
NHS Regional Office areas for England, which dated from April 1996
(when they replaced Regional Health Authorities) and comprised eight
areas.
The deprivation categories used in the study are derived using the
Townsend Material Deprivation Score.16 This is a composite score
calculated using information on unemployment, overcrowding, car
availability and home ownership derived from 1991 Census data; the
percentage of: i) economically active residents aged 16–59/64 who are
unemployed, ii) private households with more than one person per
room, iii) private households with no car and iv) private households not
owner occupied. The higher the score the greater was the level of
relative deprivation in 1991.
The Townsend Scores for all wards in England and Wales were
arranged in ascending order of Townsend Score along with the total
population of each ward in 1991. The wards were divided into five
groups each of which contained 20 per cent of the total population of
England and Wales. A range of Townsend Scores describes each of
these population quintiles. Each general practice was allocated to a
quintile on the basis of the Townsend Score of the ward in which it is
located. There was one practice for which it was not possible to obtain
ward information. Consequently data for this practice are not included
in the deprivation analysis.
RESULTS
Age- and sex-specific prescribing rates of antibiotics
The age-standardised antibiotic prescribing rate in 1998 was 575 per
1,000 in males and 800 per 1,000 in females (Table 1). Broad-spectrum
penicillins were by far the most commonly prescribed antibiotics in
both sexes, and accounted for 40 per cent of all antibiotic prescriptions.
In children aged under five years, broad-spectrum penicillins accounted
for about 60 per cent of antibiotics prescribed.
In males and females there was a U-shaped relationship between
antibiotic prescribing rates and age, although this association was less
marked in women. Rates of metronidazole and tinidazole prescribing
were higher in women aged 16 to 44 years, probably representing
treatment of gynaecological infections. Sulphonamides and
trimethoprim were more frequently prescribed to women, with rates
highest in elderly women. This is probably due to treatment of urinary
tract infections. Tetracyclines were most commonly prescribed to men
aged 16 to 24, probably reflecting their use in the treatment of acne.
Prescribing rates between 1994 and 1998
Prescribing rates of most antibiotic groups peaked in 1995 and then
decreased (Table 2). Overall, antibiotic prescribing rates decreased by
nine per cent in males and eight per cent in females between 1994 and
1998. The decrease between 1995 and 1998 is even more striking (18
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per cent in males and 16 per cent in females). There were some
exceptions to this; for example, the use of penicillinase-resistant
penicillins appears to be increasing. The reduction in prescribing rate is
most marked in the antibiotic classes prescribed most frequently. The
rate of quinolone prescribing has remained fairly constant, as have the
rates of prescribing of metronidazole and tinidazoles.
Total antibiotic prescription items by age, sex and
calendar year
There has been a marked reduction in antibiotic prescribing in both
sexes and in most age groups between 1994 and 1998 (Table 3). The
decrease is greatest in young children, with a reduction of 17 per cent in
children under five years. During the period 1995 to 1998, there were
even more striking reductions in antibiotic prescribing rates, again most
marked among children. In women aged over 74 years, however,
antibiotic prescribing rates increased between 1994 and 1998.
Variation by NHS region and area deprivation
During the period 1994 to 1998, the age-standardised antibiotic
prescribing rate was constantly around one third higher in Wales and in
the northern regions (Northern & Yorkshire and North West NHS
regions), compared to the southern regions (South Thames, and South
and West) (Table 4). During the same period, there were also large
differences in age-standardised antibiotic prescribing rates by area
deprivation (Table 5). The rates were consistently highest among
patients registered with practices located in the most deprived fifth of
                   Age
BNF+ 0–4 5–15 16–24 25–34 35–44 45–54 55–64 65–74 75–84 85 and Crude standardised Number of
Section Antibiotic over rate rate prescriptions
Males
5.1.1.1. Benzylpenicillin & phenoxymethylpenicillin 92 86 73 42 31 21 20 20 17 15 45 47 27,400
5.1.1.2. Penicillinase–resistant penicillins 61 49 46 35 37 34 40 48 60 87 43 44 26,525
5.1.1.3. Broad–spectrum penicillins 850 298 138 130 147 159 211 286 345 398 236 249 144,921
5.1.2. Cephalosporins, cephamycins etc. 122 43 23 21 24 30 46 73 101 133 43 44 26,663
5.1.3. Tetracyclines 0 20 154 51 44 49 60 77 69 48 57 57 34,978
5.1.5. Macrolides 216 89 80 48 49 47 63 80 89 88 73 77 45,078
5.1.8. Sulphonamides & trimethoprim 69 17 13 13 16 19 33 53 82 131 28 28 16,922
5.1.11. Metronidazole & tinidazole 1 1 4 6 7 8 11 14 12 12 7 6 4,180
5.1.12. Quinolones 0 1 7 11 14 18 26 43 59 73 17 15 10,287
5.1.13. Treatments for urinary–tract infections 1 0 1 1 1 2 2 6 7 14 2 2 1,144
Other antibiotics in 5.1 3 3 4 3 4 5 9 12 12 8
5.1. Total antibiotic prescriptions 1,418 609 541 361 374 393 521 712 854 1,007 556 575 341,504
Females
5.1.1.1. Benzylpenicillin & phenoxymethylpenicillin 81 121 126 84 53 34 30 25 20 19 66 71 41,359
5.1.1.2. Penicillinase–resistant penicillins 49 52 52 48 43 42 41 51 66 96 50 48 31,268
5.1.1.3. Broad–spectrum penicillins 764 323 236 259 243 243 290 303 309 351 300 310 188,841
5.1.2. Cephalosporins, cephamycins etc. 116 60 68 75 70 75 94 117 140 160 86 82 53,919
5.1.3. Tetracyclines 0 19 101 69 76 78 70 61 46 28 61 60 38,192
5.1.5. Macrolides 176 100 103 92 88 81 91 95 88 86 96 99 60,560
5.1.8. Sulphonamides & trimethoprim 76 43 73 66 69 74 89 108 146 190 80 75 50,532
5.1.11. Metronidazole & tinidazole 2 3 33 41 29 19 17 18 15 21 22 21 13,560
5.1.12. Quinolones 1 2 12 18 23 30 37 48 53 58 24 21 15,310
5.1.13. Treatments for urinary–tract infections 1 2 6 7 7 7 12 16 23 29 9 7 5,540
Other antibiotics in 5.1 4 3 4 3 4 5 7 11 8 4
5.1. Total antibiotic prescriptions 1,270 729 814 761 706 689 778 852 914 1,042 798 800 502,263
Table 1 Age- specific prescribing rates of antibiotics per 1,000 patients, 1998
Age-
Crude
rate
(all
ages)
Age-
standardised
r te
(all g s)*
* Direct age-standardisation using the European standard population.
+ British National Formulary.
BNF*   Males  Females
Section Antibiotic 1994 1995 1996 1997 1998 1994 1995 1996 1997 1998
5.1.1.1. Benzylpenicillin & phenoxymethylpenicillin 62 63 59 54 47 94 94 88 82 71
5.1.1.2. Penicillinase-resistant penicillins 33 36 38 42 44 37 39 42 48 48
5.1.1.3. Broad-spectrum penicillins 277 316 294 291 249 343 390 361 361 310
5.1.2. Cephalosporins, cephamycins etc. 50 54 53 52 44 83 92 90 91 82
5.1.3. Tetracyclines 68 69 62 60 57 73 75 69 66 60
5.1.5. Macrolides 80 98 87 87 77 100 120 110 111 99
5.1.8. Sulphonamides & trimethoprim 38 33 30 29 28 89 83 78 78 75
5.1.11. Metronidazole & tinidazole 5 6 7 6 6 22 21 21 21 21
5.1.12. Quinolones 14 15 16 16 15 21 21 22 22 21
5.1.13. Treatments for urinary-tract infections 2 2 2 2 2 7 8 8 8 7
5.1. Total antibiotic prescriptions 633 697 653 646 575 869 948 892 894 800
Table 2 Age-standardised prescribing rates per 1,000 patients for antibiotic groups*,  1994 to 1998
* Direct age-standardisation using the European standard population.
+ British National Formulary.
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Table 5 Total antibiotic prescriptions per 1,000 patients, by area deprivation,  age-standardised rates,* 1994 to 1998
Deprivation Quintile
Q1 (least deprived) 623 664 622 611 565 837 868 814 814 745
Q2 632 683 633 624 549 849 918 870 860 766
Q3 612 677 626 629 565 844 919 856 875 792
Q4 615 684 644 630 542 847 932 881 873 760
Q5 (most deprived) 682 767 732 722 650 967 1,080 1,018 1,021 921
      Males Females
1994 1995 1996 1997 1998 1994 1995 1996 1997 1998
Table 4 Total antibiotic prescriptions per 1,000 patients, by NHS region (April 1996 boundaries) age-standardised rates,* 1994 to
1998
NHS Region
Wales 751 848 776 765 650 1,012 1,140 1,044 1,038 896
Northern & Yorkshire 694 773 715 727 653 963 1,062 1,000 1,020 921
Trent 607 666 623 634 561 835 906 863 901 793
Anglia & Oxford 617 657 603 599 570 845 903 835 860 806
North Thames 571 635 604 599 532 755 836 796 787 727
South Thames 556 612 581 554 481 762 841 805 757 671
South and West 566 604 569 562 493 776 835 778 775 683
West Midlands 657 721 679 653 581 899 974 928 917 805
North West 679 775 737 726 649 953 1050 991 990 897
      Males Females
1994 1995 1996 1997 1998 1994 1995 1996 1997 1998
*Direct age-standardisation using the European standard population.
*Direct age-standardisation using the European standard population.
Table 3 Total antibiotic prescriptions per 1,000 patients, by age, sex and calendar year, 1994 to 1998
Age
85 Crude  standardised
0–4 5–15 16–24 25–34 35–44 45–54 55–64 65–74 75–84  and over rate   rate
Males
1994 1,700 715 552 387 405 408 536 739 915 1,053 614 633
1995 1,812 824 637 438 444 452 576 786 942 1,124 675 697
1996 1,734 703 598 404 413 428 582 769 929 1,083 631 653
1997 1,671 715 574 406 419 433 572 767 940 1,017 624 646
1998 1,418 609 541 361 374 393 521 712 854 1,007 556 575
% change 1994–98 -16.6 -14.8 -1.9 -6.9 -7.5 -3.7 -2.7 -3.6 -6.7 -4.4 -9.5 -9.2
% change 1995–98 -21.8 -26.1 -15.1 -17.7 -15.8 -13.1 -9.5 -9.4 -9.3 -10.4 -17.6 -17.5
Females
1994 1,538 835 856 815 772 735 800 855 882 1,014 861 869
1995 1,639 949 966 900 831 782 867 905 911 1,058 933 948
1996 1,549 831 899 843 781 754 844 893 934 1,069 882 892
1997 1,507 836 902 846 794 756 855 904 956 1,073 886 894
1998 1,270 729 814 761 706 689 778 852 914 1,042 798 800
% change 1994–98 -17.4 -12.8 -4.9 -6.5 -8.5 -6.3 -2.7 -0.3 3.6 2.8 -7.3 -8.0
% change 1995–98 -22.5 -23.2 -15.8 -15.4 -15.0 -11.9 -10.3 -5.9 0.3 -1.5 -14.5 -15.6
Age-
Crude
rate
(all
ages)
Age-
standardised
r te
(all ag s)*
*Direct age-standardisation using the European standard population.
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electoral wards. In 1998, the rate in quintile five (most deprived) was
650 prescriptions per 1,000 patient years at risk among males and 921
among females, 15 and 24 per cent higher respectively compared to the
rate in quintile one (least deprived). Between 1994 and 1998, the rate
declined in all quintiles, but the decline was smallest for practices
located in the most deprived areas.
Percentage of patients receiving an antibiotic in
1998
About half of all children under 5 years (52 per cent for boys and 49
per cent for girls) received an antibiotic prescription in 1998 (Figure
1). Except in children less than 5 years, more females received an
antibiotic prescription in 1998 and overall, females were about 35 per
cent more likely to be prescribed an antibiotic than men. In both sexes
but more marked in males, there was a U-shaped relationship between
age and the probability of receiving an antibiotic prescription.
Inter-practice variation in antibiotic prescribing
rates
The prescribing rates for the 210 practices in this study varied nearly
six-fold in 1998, from 289 to 1,597 per 1,000 patients, with a median
rate of 660 per 1,000 and an inter-quartile range of 549 to 823 (Figure
2). There also appeared to be no correlation between total prescribing
rates and prescribing of quinolones (Figure 3).
DISCUSSION
The most striking finding from this study is that antibiotic prescribing
rates have fallen substantially since 1995. The decline in antibiotic
prescribing rates began before the start of the Department of Health’s
drive in 1998 to reduce antibiotic prescribing. This suggests that
general practitioners were already aware of the need to reduce antibiotic
prescribing and the limited effectiveness of antibiotics for many
common community infections, and had begun to change their
prescribing practice to reflect this. Whether this decline in antibiotic
prescribing rates will translate into lower levels of antibiotic resistance
in the community is unclear.17, 18 However, the decline will have a
number of other public health benefits, including lower NHS
expenditure on antibiotics and a reduction in the rate of adverse
reactions to antibiotics in the population. The study also shows that the
likelihood of receiving an antibiotic prescription increases at the
extremes of age. Except among young children, females are more likely
to be prescribed an antibiotic at all ages.
Antibiotic prescribing rates were consistently higher in Wales and in
northern England. Prescribing rates were also higher in practices
located in the most deprived areas. There was also a marked variation
in prescribing rates among the general practices in the study, with some
practices prescribing less than 300 scripts per 1,000 patients compared
to nearly 1,600 scripts per 1,000 at the other extreme. This variation is
probably too large to be accounted for by differences in rates of
infectious diseases and probably reflects differences in doctors’
prescribing practices.
Antibiotic prescribing rates have fallen by about 17 per cent among 0-
to 4-year-olds since 1994. From 1995 onwards (when antibiotic
prescribing rates peaked), rates have fallen by about 22 per cent in this
group. Hence, studies showing the limited value of antibiotics for
conditions such as otitis media and upper respiratory tract infections,
both of which are common in children, appear to be beginning to
influence clinical practice. In line with recommended practice, most
prescriptions in young children were for broad-spectrum penicillins and
macrolides.19 The prescribing rate for boys under five years was higher
than that in girls of the same age. The explanations for this difference
are unclear.
Figure 2 Total antibiotic prescribing rates per 1,000
patients in 210 general practices in 1998
Figure 1 Percentage of patients who received a prescription
for an antibiotic in 1998
0–4 5–15 16–24 25–34 35–44 45–54 55–64 65–74 75–84 85 and
over
0
10
20
30
40
50
60
Percentage
Age group
Males Females
30
0–
39
9
40
0–
49
9
50
0–
59
9
60
0–
69
9
70
0–
79
9
80
0–
89
9
90
0–
99
9
10
00
–1
09
9
11
00
–1
19
9
12
00
–1
29
9
13
00
–1
39
9
14
00
–1
49
9
15
00
–1
59
9
0
10
20
30
40
50
60
Number of practices
Prescribing rate per 1,000 patients
19   Nat ional  Stat ist ics
Health Stat ist ics Quarterly 14 Summer 2002
Among 16- to 74-year-olds, women were much more likely to be
prescribed an antibiotic than men. Much of this variation is in the use of
broad-spectrum penicillins, cephalosporins, sulphonamides and
trimethoprim. This difference is probably due to the use of antibiotics in
the treatment of urinary tract and gynaecological infections. Because
we were not able to examine the length of treatment, we were unable to
assess the impact of guidelines for the treatment of uncomplicated
urinary tract infections. These guidelines suggest limiting treatment of
these infections to three days.4, 20 Additional guidelines for health
professionals on the treatment of gynaecological and genito-urinary
infections may further help to rationalise antibiotic prescribing for
women.
Antibiotic prescribing rates decreased less among the elderly than in
other age groups, and among women aged over 74 years, prescribing
rates increased between 1994 and 1998. Much of the research on the
limited effectiveness of antibiotics has been for disorders such as otitis
media and sore throat, which are commonest in children. Hence, most
current guidelines are aimed at the treatment of children and there are
few guidelines available for antibiotic prescribing in the elderly. If
prescribing rates are to be reduced among the elderly, then evidence-
based guidelines also need to be produced for this group. Because
bacterial infections are often more serious in the elderly, general
practitioners may be reluctant to change their prescribing practice in
this group until better evidence is available.
There remain marked differences in prescribing rates between different
regions, different practices located in areas of different socio-economic
status, and between practices. All primary care trusts and general
practices have access to Prescribing Analysis and Cost (PACT) data that
can be used to provide detailed information on their prescribing rates
and help influence prescribing. Questions that prescribing advisers and
general practitioners can then ask include: What are the reasons for
prescribing differences at a local level? Are the higher prescribing
doctors less aware of prescribing guidelines? Would educational
Table 6 Number of antibiotic prescriptions dispensed in the
community in England, 1991 to 2000
Year Prescription Net ingredient
items (millions) cost (£ millions)
1991 43.7 167.1
1992 43.4 170.4
1993 47.7 179.1
1994 45.8 177.5
1995 49.4 192.4
1996 46.6 174.4
1997 46.4 172.0
1998 42.6 163.0
1999 38.6 177.1
2000 36.9 172.2
Source: Department of Health’s Prescription Cost Analysis for England.
interventions or prescribing incentive schemes help to reduce these
differences? There is also evidence suggesting that parent and patient
education can influence antibiotic use.21 This is also an area that
primary care trusts and general practitioners may need to examine.
The rate of prescribing of quinolones remained fairly constant over the
period of the study, but there remains a large variation in their use
between practices. There was little association between the rates of
quinolone prescribing and the overall antibiotic prescription rate. This
suggests that the factors influencing antibiotic prescribing are complex
and that those prescribing large amounts of antibiotics may be
favouring certain antibiotic groups. Therefore guidelines aimed at
reducing overall prescribing rates may by themselves not lead to better
prescribing practice in the choice of antibiotic used.
STRENGTHS AND WEAKNESSES OF STUDY
The use of a delayed or reserve prescription, suggested as a method of
reducing antibiotic use,19 would not be identified by this study. This
may result in the prescribing rates in this study slightly over-estimating
the number of prescriptions that patients actually have dispensed.
However, Prescription Cost Analysis data for England (based on
prescriptions dispensed) for the period 1991 to 2000 also show a large
decrease (25 per cent) in the number of antibiotic prescriptions
dispensed in the community since 1995 (Table 6).
We were unable to examine the average or median length of the
prescriptions issued. If changes in antibiotic prescribing rates were due
to prescribing guidelines, then it would be interesting to see if
prescriptions are also for recommended strengths and lengths. A link
between diagnosis and the antibiotic prescribed would also be useful, as
this would allow analysis of trends in antibiotic prescribing for specific
disorders.
CONCLUSIONS
General practitioners have reduced their antibiotic prescribing rates
substantially since 1995. However, there remain marked differences in
prescribing rates between general practices and in different parts of the
country. There are also wide variations in antibiotic prescribing rates
between different countries.22 There are a number of possible
explanations for these variations. General practitioners’ workload has
increased in recent years and may be higher in some practices than in
others. Many patients may still expect an antibiotic prescription when
they present with an infection to their doctor. There may be differences
in patient education levels. Some patients and doctors may still not
perceive antibiotic resistance to be a problem that they can influence.23
There is evidence that educational initiatives and feedback of data can
Figure 3 Association between total antibiotic prescribing
rates per 1,000 patients and prescribing of
quinolones in 210 general practices in 1998
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influence prescribing rates. Hence, it is important that information and
advice on the importance of reducing antibiotic prescribing continues
to be disseminated.3, 24
A similar analysis to that carried out in this paper is not currently
possible for hospital prescribing because there is no readily available
source of data to do this. This is paradoxical, as the problem of
antibiotic resistance is greatest in hospitals. This deficiency needs to be
addressed to give a better overall picture of antibiotic prescribing and
also to determine the effects of educational initiatives and guidelines
on hospital doctors’ antibiotic prescribing practice.
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Key findings
 The age-standardised antibiotic prescribing rate in
England and Wales in 1998 was 575 per 1,000 in
males and 800 per 1,000 in females.
 Antibiotic were prescribed most frequently to
children and the elderly.
 There was a decline in the use of antibiotic
between 1994 and 1998, particularly among
children.
 Age-standardised prescribing rates were highest in
the most deprived electoral wards and the rate of
fall in prescribing was also lowest in these areas.
 There was more than five-fold variation in
prescribing rates among the 210 practices in this
study, from 289 to 1,597 per 1,000 patients.
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Healthy life expectancy
in England at
subnational level
National  Stat ist ics
Beverley Bissett
Office for National Statistics
INTRODUCTION
Health expectancies are a measure of the health of the population that
in a single index combine both the mortality and morbidity rates of
the population. They thus consider quality as well as quantity of life.
Healthy life expectancy (HLE), defined as expected years of life in
good or fairly good health, is a health expectancy measure that has
been calculated for Great Britain and England and published in
Health Statistics Quarterly 07.1,2 This index is being used to monitor
overall health in three government strategies in the United Kingdom
(UK).3,4,5
Following the publication of The NHS Plan in England,6 and its
counterparts in Wales7 and Scotland,8 the policy focus has been on
monitoring and reducing health inequalities. Because of the unique
consideration of both morbidity and mortality in health expectancy
measures, HLE is also being investigated for use in NHS resource
allocation. Such uses of HLE require estimates to be produced for
smaller geographic breakdowns than by country. This article presents
the results of an investigation into producing HLE at subnational
geographic areas in England, for example, NHS Executive Regional
Offices (hereafter referred to as NHS regions), health authorities
(HAs) and primary care groups (PCGs). The weaknesses in the
methodology used at the national level are discussed and solutions for
improving reliability are considered (including using other data
sources). The implementation of Shifting the Balance of Power9 from
April 2002, will lead to significant structural changes in the NHS, but
the general principles examined in this paper will remain pertinent.
Healthy life expectancy in
England is increasing over time,
but not by as much as life
expectancy. Thus, people can
expect to live more years of life
in ‘not good’ health. This article
investigates the feasibility of
producing healthy life
expectancy estimates for
subnational geographic areas of
England in the 1990s. By
adapting the methods used in
the national calculations, it is
feasible to produce healthy life
expectancy estimates for NHS
regions and health authorities.
The analysis shows inequalities
in healthy life expectancy
between males and females and
also between the north and
south of England.
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METHODS
Healthy life expectancy in Great Britain and England have been
calculated using Sullivan’s method, with the British General Household
Survey (GHS) and the British Census as the sources of morbidity data.
Full details of the methodology and results are in Kelly et al’s article.1
Sullivan’s method has been used here to calculate HLE for the eight
NHS regions and ninety-nine health authorities in England, with the
boundaries defined as at 1 April 1999.
Table 1 shows the approximate average populations in 1999 for various
geographical breakdowns in England.
figures include the number of people in the sample who are under 16
years of age and, therefore, are not asked to assess their general health
(between 20 and 25 per cent of the sample each year). The figures also
include other respondents who may not have answered this question for
one reason or another. Several options are available for increasing the
survey sample size to help improve the reliability of the HLE estimates:
• Increasing the width of the age interval
For example, the age groups could be broadened from the 5-year
age groups used in the national level calculations to 0–15, 16–44,
45–64, 65 and over. The general health question is not asked of
GHS respondents aged 0–15. In previous calculations using these
data the ill health rate of 16– 19-year–olds has been used as a proxy
for the ill health rate of those under 16.1 The similar assumption in
this case would involve applying the ill health rate of the 16–44 age
group to those under 16 which is not plausible. Further, increasing
the width of the interval does not increase the overall sample size.
• Increasing the number of years of data used
Although this does increase the sample size, this solution has the
adverse effect of losing the ability to produce a time trend. It is
further complicated by the fact that there was no GHS in 1997 or
1999, thus, for example, any five year period beginning between
1993 and 1999 would have a maximum of four years of data and in
some cases only three.
• Producing a measure for both sexes combined instead of sex-
specific estimates
Sex-specific measures are more meaningful than persons-based
measures, as men and women suffer different health problems at
different times of their lives. However, producing a persons-based
measure allows a larger sample size and so estimates can be
produced with tighter confidence intervals. It also negates the need
to weight sex-specific measures when a single indicator of
population health is required.
To produce estimates for the eight NHS regions it was necessary to
combine four years of data from the GHS, and thus produce measures
for two time points: 1992–95 and 1995–98, the latter point containing
only three years of morbidity data. These two time periods were chosen
because of the availability of the raw data (to boundaries as defined at 1
April 1999) and because the number of data points with less than the
full complement of years is minimised. The next data point in this
series would be 1998–2001, which would again contain only three years
of data. It would not be possible to calculate measures at this level for
any four-year period which spanned both 1997 and 1999.
To produce estimates for the 99 HAs, data were combined for the
seven–year period 1992–98, which contains six data collection years.
Male and female data were also combined to produce a persons-based
measure.
England 49,753
NHS Region 6,219
Health Authority 503
Primary Care Trust (PCT) 145
Primary Care Group (PCG) 115
Electoral Ward 5
Average populations of geographical areas in
England, based on ONS mid-year population
estimates, 1999
Table 1
The main issue with regard to producing HLE estimates at subnational
level is the availability of mortality and morbidity data that allow robust
calculations with reasonable confidence intervals.
Mortality Data
The raw data required for calculation of life tables are age- and sex-
specific population estimates and numbers of deaths by age and sex for
the time period. Abridged life tables were produced by ONS for NHS
regions for the time periods 1992–95 and 1995–98, and for HAs for the
time period 1994–98. The methods used are equivalent to those used by
the Government Actuary’s Department in producing the national life
tables, used by Kelly et al.1
Morbidity Data
Ill health rates for the general population were calculated from the
responses to the following question in the General Household Survey:
Over the last twelve months would you say your health has on the
whole been good, fairly good or not good?
The method for calculating HLE uses a reverse cumulative function
such that the number of expected years in good health is the sum of the
expected years in good health for this and all older age groups. Thus
errors at each age are dependent on the errors in the other age groups.
The absolute errors and confidence intervals obtained at younger ages
are relatively large compared to the older age groups. However, for the
percentage errors it is the older age groups that have the larger errors.
ONS recommended that decisions on acceptable errors be based on the
maximum percentage error in the output table as this would be in the
oldest age group and would feed into the estimates for all the younger
age groups.10
The sample size of the survey used to obtain the ill health rates of the
population is the main contributing factor to the error in the HLE
estimates. Table 2 shows the available size of the GHS sample. These
Years Number in Sample
Males Females Total
1998 9,104 9,725 18,829
1996–98* 17,511 18,757 36,268
1995–98* 27,298 29,062 56,360
1992–98* 57,084 61,226 118,310
* There was no GHS in 1997.
GHS sample size for EnglandTable 2
Thousands
23   Nat ional  Stat ist ics
Health Stat ist ics Quarterly  14  Summer 2002
Communal Establishment Adjustment
The GHS is, by definition, a household survey. The sample does not
therefore include members of the population resident in communal
establishments, such as hospitals, nursing homes, hotels etc. The data
used to adjust the ill health rate for this part of the population are taken
from the British Census. At the national level, the size of the
institutionalised population was estimated by interpolating between and
extrapolating from the 1981 and 1991 Census data, giving an assumed
growth during the 1990s. The ill health rate was taken as the limiting
long-standing illness (LLI) rate for this population in 1991 (as no data
are available for 1981) and assuming that the rate had not changed.
The communal establishment population estimates derived by this
method seem somewhat exaggerated, especially when taking into
account the effect of the NHS and Community Care Act 1990, the aim
of which was to help people live in their own homes rather than in
institutions.11 For this reason, and the fact that 1981 Census data are not
readily available on health authority boundaries as at 1 April 1999, the
subnational HLE estimates were calculated assuming that the number
of people resident in communal establishments throughout the 1990s
was the same as at the 1991 Census.
RESULTS
England
Healthy life expectancy has been calculated for the years 1981 to 1997
on a three year moving average basis. Figure 1 shows that for males and
females in England, both life expectancy and healthy life expectancy
are increasing, although life expectancy at a faster rate. This means that
the gap between life expectancy and healthy life expectancy is widening
such that men and women born in 1997 can expect to spend more years
of life in ‘not good’ health than those born in 1981. There is also a
difference between the sexes such that women not only have longer life
and healthy life expectancies, but also can expect to live more years and
a larger proportion of their life in ‘not good’ health than men.
NHS Regions
Figures 2a and 2b show the estimates of life expectancy and healthy life
expectancy at birth for males and females, respectively, in the eight
NHS regions in England. Consistent with the national level data, life
expectancy and healthy life expectancy are higher for females than
males.
The changes in healthy life expectancy between 1992–95 and 1995–98
shown in the graphs are not significant for either men or women, as in
all cases the confidence intervals for the estimates overlap. Life
expectancy in all areas has increased to some degree between the two
time periods, thus the gap between life expectancy and HLE is
widening at regional level. The graphs also show that HLE estimates for
NHS regions in the north of England are lower than for those NHS
regions in the south.
Health Authorities
Table 3 shows HLE for all persons, by health authority in England for
1992–98. A health authority has been coded as low if the 95%
confidence interval around the HLE estimate excludes and is lower than
the 95% confidence interval around the estimate for England for
1992–98. Similarly, a health authority has been coded as high if the 95%
confidence interval around the HLE estimate excludes and is higher
than the 95% confidence interval around the HLE estimate for England.
Figure 3 shows a map of the health authorities in England shaded
according to the healthy life expectancy estimate for all persons and the
coding in Table 3 for each area. The map clearly illustrates that HAs
with low HLE are concentrated in the north of the country, while those
with high HLE are in the south.
Figure 1 Life expectancy and healthy life expectancy at birth, England, 1980 to 1998*
* 3-year moving average, plotted on central year.
† HLE data for 1996 unavailable.
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South East
Berkshire 71.5 High
Buckinghamshire 70.5 High
East Kent 67.7 NS
East Surrey 72.7 High
East Sussex, Brighton and Hove 70.0 High
Isle of Wight 70.5 NS
Northamptonshire 70.2 High
North and Mid Hampshire 71.3 High
Oxfordshire 72.3 High
Portsmouth and South East Hampshire 68.4 NS
Southampton and South West Hampshire 71.1 High
West Kent 70.3 High
West Surrey 72.1 High
West Sussex 70.2 High
South West
Avon 70.0 High
Cornwall and Isles of Scilly 68.7 NS
Dorset 71.4 High
Gloucestershire 71.7 High
North and East Devon 72.3 High
Somerset 69.4 NS
South and West Devon 69.8 High
Wiltshire 72.2 High
West Midlands
Birmingham 65.9 Low
Coventry 64.3 Low
Dudley 65.0 Low
Herefordshire 72.0 High
North Staffordshire 67.7 NS
Sandwell 64.2 Low
Shropshire 67.9 NS
Solihull 71.2 High
South Staffordshire 68.3 NS
Walsall 64.0 Low
Warwickshire 69.1 NS
Wolverhampton 64.6 Low
Worcestershire 69.7 High
North West
Bury and Rochdale 65.6 Low
East Lancashire 64.7 Low
Liverpool 62.4 Low
Manchester 61.0 Low
Morecambe Bay 69.8 NS
North Cheshire 66.3 NS
North West Lancashire 64.8 Low
St Helens and Knowsley 64.2 Low
Salford and Trafford 64.2 Low
Sefton 66.1 Low
South Cheshire 70.6 High
South Lancashire 65.5 Low
Stockport 70.7 High
West Pennine 64.1 Low
Wigan and Bolton 62.6 Low
Wirral 66.8 NS
All Persons Significance*
HLE
England 68.3
Northern and  Yorkshire
Bradford 66.0 Low
Calderdale and Kirklees 65.6 Low
County Durham 64.9 Low
East Riding 68.0 NS
Gateshead and South Tyneside 64.0 Low
Leeds 66.6 Low
Newcastle and North Tyneside 64.5 Low
North Cumbria 66.9 NS
Northumberland 66.7 NS
North Yorkshire 69.1 NS
Sunderland 63.2 Low
Tees 63.7 Low
Wakefield 63.8 Low
Trent
Barnsley 62.1 Low
Doncaster 64.7 Low
Leicestershire 68.3 NS
Lincolnshire 69.3 NS
North Derbyshire 67.4 NS
North Nottinghamshire 65.8 Low
Nottingham 68.4 NS
Rotherham 66.6 NS
Sheffield 67.7 NS
Southern Derbyshire 66.9 NS
South Humber 69.4 NS
Eastern
Bedfordshire 68.2 NS
Cambridgeshire 71.2 High
East and North Hertfordshire 71.9 High
Norfolk 69.9 High
North Essex 70.2 High
South Essex 68.6 NS
Suffolk 72.6 High
West Hertfordshire 71.4 High
London
Barking and Havering 69.9 High
Barnet 71.7 High
Bexley and Greenwich 69.6 NS
Brent and Harrow 69.9 NS
Bromley 72.1 High
Camden and Islington 67.4 NS
Croydon 70.0 NS
Ealing, Hammersmith and Hounslow 67.9 NS
East London and The City 63.7 Low
Enfield and Haringey 67.9 NS
Hillingdon 70.7 High
Kensington & Chelsea and Westminster 71.7 High
Kingston and Richmond 72.2 High
Lambeth, Southwark and Lewisham 63.3 Low
Merton, Sutton and Wandsworth 70.6 High
Redbridge and Waltham Forest 68.1 NS
Healthy life expectancy (HLE) for all persons at birth, by health authority, England 1992–98Table 3
Figure 2 Life expectancy (LE) and healthy life expectancy (HLE) at birth,  by NHS region, England, 1992 to 1998
All Persons Significance*
HLE
* Low = significantly lower than England, High = significantly higher than England, NS = not significantly different from England.
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Healthy Life Expectancy
(difference from the estimate for England)*
significantly higher
significantly lower
not significant
*see table 3 and the text for an explanation of the significance coding
See Inset
Figure 3 Healthy life expectancy for all persons at birth, by health authority, England, 1992–98
Healthy life expectancy
(difference from the estimate for England)*
*  Se  Table 3 and the text for an explanation of the significance coding.
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DISCUSSION
Geographic Variations
The healthy life expectancy results show a north-south divide within
England, which has previously been found in studies of geographic
variations in health in the UK. For example, Fitzpatrick et al found a
north-south divide in all-age mortality at regional level in England, with
higher mortality rates in the northern regions than in the southern
regions.12 Further to this, Griffiths and Fitzpatrick demonstrated that the
pattern extended to geographic variations in life expectancy.13
In the field of health expectancy, expected years of life free from
limiting long-standing illness by regional health authority and by local
authority have previously been calculated using data from the 1991
Census.14 The results also showed similar geographic variations to those
reported here.
Caution must be exercised when interpreting results that show
geographic variation. Au et al studied regional variations in health
status in the United States and showed that when considering other
confounding variables such as socio-economic factors, geographic site
only accounted for 1 per cent of the variation in health status of the
study participants.15 The results could only be applied to their specific
study population, but demonstrate the care that is required in other
studies. Further analysis of HLE, taking into account other variables,
may show a similar effect. However, the north-south divide in health
inequalities in England is a well documented phenomenon that has been
replicated here.
Methodological Considerations
Three aspects of the methodology used in the national calculations were
revised to produce these smaller area estimates:
i) a persons-based measure was produced;
ii) interpolation and extrapolation of the Census data were not used in
the adjustment for residents of communal establishments; and
iii) more years of data were combined.
i) Figure 4 shows the health authority HLE estimates for males,
females and all persons, ranked by the latter measure. Intuitively,
given the national and NHS region results, the measure for both
sexes combined should lie half way between the male and female
measures, with the male estimate being lower and female higher.
However, the graph shows that this is not always the case as in
some health authorities males can expect more years of life in good
or fairly good health than the general population (persons-based
measure) or even females. These anomalies are due to small sample
sizes in the GHS for this geographic breakdown. This is illustrated,
for example, by one health authority where, in the 16 to 19 age
group, 0 out of 16 males and 1 out of 4 females assessed their
health as ‘not good’, giving ill health rates of 0 per cent and 25 per
cent respectively. When these are combined, there is 1 in 20 people
– that is 5 per cent – with not good health. These very different
morbidity rates, when applied to the life expectancy, result in the
HLE figures not following the expected trend.
ii) The adjustment made for residents of communal establishments is
crude and even more basic than that used in the national
calculations. In the UK, there is a dearth of data for residents of
communal establishments. Adjustments to the calculations have
been made using the LLI data from the 1991 Census as this is
currently the best available data source. These data are now
somewhat dated, especially following the changes resulting from
the government policies of the 1990s.
The importance of an adjustment for the institutionalised
population when using data from household surveys is highlighted
by Bone et al.14 Figure 5a shows the HLE at birth estimates by
health authority, with and without the adjustment for residents of
communal establishments. It is clear that making the adjustment to
the calculation affects the ranking of the health authorities’ HLE
estimates. The majority of people in communal establishments,
particularly those with ill health, are over the age of 65. It is
therefore even more important to make the adjustment when
calculating HLE for this age group. Figure 5b shows the HLE
estimates at age 65, by health authority – the difference that the
adjustment makes to the ranking is greater than for the at birth
estimates.
Figure 4 Healthy life expectancy at birth, by health authority, England, 1992–98
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Figure 5a Healthy life expectancy (HLE) for all persons at birth, adjusted and unadjusted for institutionalised population, by
health authority, England, 1992–98
Figure 5b Healthy life expectancy (HLE) for all persons at age 65, adjusted and unadjusted for institutionalised population, by
health authority, England, 1992–98
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Some researchers have assumed that all residents of communal
establishments are in ill health and used this as the basis for their
adjustment. These studies tend to consider only the health and care
establishments, eg hospitals and nursing homes. However, analysis
of the 1991 Census data shows that the LLI rate in every type of
establishment is significantly different from the household rate in
all age groups, except for a few age groups in detention, defence
and education establishments. Thus in this study the adjustment was
made for all types of establishment. This is consistent with the
national estimates and the fact that the GHS does not survey any
type of establishment.
iii) As smaller geographic areas are considered, the overall sample size
must increase to maintain the reliability of the estimates. When
adding across many years of data, changes in health are masked.
For example, figure 6 shows that the ‘not good’ health rate between
1977 and 1998, or even between 1992 and 1998, has not remained
constant. This will not be reflected in an HLE estimate that includes
all of these data in the one point. Also, in some cases at health
authority level there are still small numbers in the cells of the
calculation and as such these are subject to high variability. Further
smaller geographic breakdowns, for example, by primary care
group, were not considered feasible or representative due to the
small numbers a) of deaths and b) in the survey sample.
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Figure 6 Age-standardised ‘not good’ health rates from the GHS, England, 1977 to 1998*
The data used in this methodology does not allow the production of
meaningful time trends for subnational estimates. A time trend from 1981
to 1997, containing 16 data points has been calculated for the national
estimates. GHS data for years prior to 1992 are not readily available on
health authority boundaries defined as at 1 April 1999. It is therefore not
viable to use earlier data to produce more data points in a longer time trend
than the two data points for NHS regions and one for HAs in the 1990s.
Future Work
An option for improving the reliability of HLE estimates, not covered
in this article, is to use another survey. The Health Survey for England
has been carried out every year since 1991, and since 1995 the sample
has included children aged 2 and over. This, along with the geographic
specificity, allows a larger sample size for producing estimates.
However, the Health Survey for England uses a different question to
assess general health:
How is your health in general? Would you say it was:
Very good, good, fair, bad, or very bad?
The production of estimates using Health Survey for England data and
how these compare with estimates using GHS data will be considered
in a forthcoming paper.
The advantage of using morbidity data from the GHS in these HLE
estimates is that the format of the general health question is the same as
was asked in the 2001 Census. It will therefore be possible to validate
these subnational estimates and the adjustment for communal
establishments when the 2001 Census results become available. The
estimates are also directly comparable to the previously published HLE
estimates for Great Britain.1,2
The GHS was re-launched in 2000 following a full review of the survey.
The new format includes weighting which effectively will increase the
sample size significantly (by up to 1000 respondents). For the first time,
the general health question was also asked of respondents under the age
of 16. The effect of these changes on the healthy life expectancy
estimates will need to be investigated when the results become available.
Healthy life expectancy (as defined in this article) is one indicator that
is being monitored in three Government strategies.3,4,5 It is not being
used as a target, in part, because of the subjective nature of the data
used to produce the measure. However, it has been shown that self
assessed general health correlates with health service usage,16 an
important outcome when considering a measure to feed into resource
allocation formulae.
From April 2002 the NHS will be reorganised such that there are 28
Strategic Health Authorities (StHAs) with much of the work of the
current health authorities, including control of local budgets, being
taken on by PCGs/PCTs.9 Public Health Observatories have been set up
to monitor health and health inequalities at local levels, co-ordinating
the information from different sources. In the case of healthy life
expectancy, as defined in this article, the data availability means that it
should be possible to produce reliable estimates for StHAs, subject to
the clarification of the boundaries and population estimates. There
would be a limited, if any, time trend. Assuming the current estimates
of the average populations (Table 1), it will not be possible to use this
methodology to produce estimates for PCGs and PCTs. However, as
PCTs merge in the future, the size of the populations will increase and it
may be possible to use the GHS data to produce some HLE estimates at
this level.
CONCLUSION
The work presented here complements and extends that of Kelly et al.1
Healthy life expectancy in England seems to be increasing over time,
although not by as much as life expectancy. Thus people can expect
more years of life, more years of healthy life but also more years in ‘not
good’ health. It is possible to produce HLE estimates for NHS regions
and health authorities by adapting the methodology used in the analysis
at national level. The analyses at subnational level show a north-south
divide, such that the lower HLE estimates are concentrated in the north
of England, while the higher HLE estimates are concentrated in the
south of the country.
* There was no GHS in 1997.
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Key findings
• Healthy life expectancy (HLE) estimates for NHS
regions and health authorities have been produced
by adapting the methodology used for the national
level calculations.
• Analysis of healthy life expectancy at subnational
levels has shown a north-south divide – HLE
estimates for areas in the north of England are
lower than for those in the south.
• Within NHS regions, there is a difference between
the sexes, such that women can expect to live more
years in good or fairly good health than men.
• For health authorities, the small sample sizes in the
General Household Survey mean that it is not
feasible to produce reliable sex-specific HLE
estimates.
• Including a communal establishment adjustment in
the HLE calculation is important for subnational
estimates. Comparing the adjusted and unadjusted
figures shows a clear difference in the rankings of
the subnational areas.
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Smoking behaviour and
socio-economic status:
a cohort analysis,
1974 to 1998
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INTRODUCTION
Smoking is widely recognised as a major contributor to disease and
premature death.1,2 As smoking behaviour varies by socio-economic
status, it is also a major contributor to the persistence of health
inequalities in Britain.3 Over the last quarter of a century the prevalence
of cigarette smoking in Britain has declined substantially. In 1974, 51
per cent of men and 41 per cent of women over age 16 were current
cigarette smokers; by 1998 these proportions had fallen to 28 per cent
and 26 per cent respectively.4 However, while the prevalence of
smoking declined steadily throughout the 1970s and 1980s, the
downward trend appears to have levelled out during the 1990s (see
Figure 1). In response to the apparent slow down in the improvement in
smoking behaviour, the Department of Health published Smoking Kills
– a White Paper on Tobacco in December 1998. The White Paper
included revised targets for reducing the prevalence of cigarette
smoking amongst all adults to 24 per cent by 2010. The White Paper
also highlighted that ‘if we are to reduce smoking overall and reduce
health inequalities we must start with the groups who smoke the most’.5
In the light of these concerns, this paper examines trends in the
prevalence of cigarette smoking by age, gender and socio-economic
status. A unique feature of the analysis is that patterns of smoking are
examined both cross-sectionally and by birth cohort, allowing insight
into the dynamics of smoking over the life-cycle and across time.
DATA AND METHOD
There have been a number of birth cohort studies on smoking
behaviour,6,7,8,9 but to date there has been no analysis of the prevalence
of smoking by different birth cohorts in Britain. In part this has been
due to a lack of data. The majority of international birth cohort studies
on smoking have used retrospective data, with recall questions
SUMMARY
Smoking is widely recognised as a
major contributor to disease and
premature death. As smoking
behaviour varies by socio-
economic status, it is also a major
contributor to the persistence of
health inequalities in Britain. This
paper uses data from the GHS
(1974–1998) to examine trends in
the prevalence of cigarette
smoking by age, gender and socio-
economic status. Patterns of
smoking are examined both
cross-sectionally and by birth
cohort, allowing insight into the
dynamics of smoking over the life-
cycle and across time. Findings
indicate that the overall
prevalence of smoking at any age
is lower amongst successive birth
cohorts and smoking cessation is
occurring at earlier ages.
However, there is a clear
difference in smoking behaviour
by socio-economic group within
cohorts, with a higher proportion
smoking amongst manual
occupations than non-manual
occupations, and this class effect
appears to be widening within
successive younger cohorts. This
suggests that although overall
deaths from smoking are falling,
inequalities in smoking related
diseases and deaths look likely to
persist well into the 21st century.
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Figure 1 Prevalence of cigarette smoking by sex, Great
Britain, 1974 to 1998
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regarding the dates of smoking initiation and cessation. There are a
number of problems inherent within such an approach. In particular, the
effects of selective mortality, as well as possible biases in recall errors
between older and younger cohorts, may confound comparisons
between cohorts. A recent study in Finland adopted an alternative
approach, utilising data from six cross-sectional surveys containing
self-reported data on smoking status.10 These data were then used to
construct synthetic birth cohorts to analyse trends in smoking in eastern
Finland during the period 1972 to 1997. This paper adopts a similar
approach to examine the smoking behaviour of representatives of four
British birth cohorts born in the years 1916 to 1920, 1931 to 1935, 1946
Figure 2 Prevalence of cigarette smoking by age and sex, Great Britain, 1974 to 1998
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to 1950 and 1961 to 1965. It builds upon earlier research examining
demographic and socio-economic circumstances amongst the same four
birth cohorts.11,12
The General Household Survey (GHS), an annual cross-sectional
survey of individuals living in private households Britain, has included
questions on smoking behaviour in alternate years since 1974. Thus 13
years of GHS data, spanning the period 1974 to 1998,13 can be used to
generate pseudo-cohorts. For example, those aged 54 to 58 years in the
1974 GHS are taken as being representative of the birth cohort born in
1916 to 1920. The same birth cohort is then represented by those aged
56 to 60 in 1976, 58 to 62 in 1978, and finally those aged 78 to 82 in
1998.14 This constitutes a pseudo-cohort or quasi-cohort approach since
the individuals are not the same from year to year. Rather than tracking
individuals per se, it is the group means or proportions that are taken.
Thus the unit of analysis is the cohort and what is measured is the
average experience for the cohort. Since a fresh sample is drawn from
the surviving population each year, the cohort mean remains
representative of that population and there is no problem of sample
attrition for reasons other than mortality, as with panel data. As
information is collected on current smoking status, recall biases are
minimised.
One limitation in employing such a method is that there may be
problems with consistency of data, particularly where there have been
changes in question wording or definitions between surveys. This
problem is encountered in any analysis of cross-sectional data over
time. Fortunately there has been a remarkable degree of consistency in
the questions regarding smoking behaviour within the GHS. However,
there have been some changes to the way in which an individual’s
socio-economic group is assigned. Prior to 1992, the GHS classified
married or cohabiting women, whose husbands were in the household,
according to their partner’s present (or last) job rather than their own. In
order to permit analysis of changes over time this definition has been
retained, despite the obvious limitations it involves for women. Pseudo-
cohort analysis is also subject to the problem of sampling error in the
successive cross-sectional samples. However, the large sample size of
the GHS means that the sample errors around the estimates are
relatively small.15
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TRENDS IN SMOKING BEHAVIOUR BY AGE AND BIRTH
COHORT
The prevalence of cigarette smoking amongst men and women varies by
age, rising through the twenties and thirties and then falling back again
at later ages (Figure 2). Within each age group, the proportion smoking
has fallen over time – with the notable exception of 20- to 24-year-olds,
where the proportion reporting that they currently smoked fell between
the 1970s and 1980s, but has since risen constituting 42 per cent of men
and 39 per cent of women in this age group in 1998.
Changes in patterns of smoking by age reflect both period and cohort
effects, and a clearer picture of trends in smoking behaviour across the
life course is obtained by examining the patterns within particular birth
cohorts. Figure 3 presents the proportion of respondents that report
‘ever having smoked’ using 3 year moving averages plotted against the
mid-point of the age group for the cohort. ‘Ever smokers’ include both
current smokers and ex-smokers.16 The general decline in the propensity
to smoke over the last three decades is reflected in the lower proportion
of men and women who state that they have ever smoked amongst
successive birth cohorts at all ages. Within birth cohorts, there is a
slight downward trend by age at older ages, reflecting the differential
survivorship of lifetime non-smokers as compared with lifetime ever-
smokers. A more puzzling observation is the fall during their thirties in
the proportion who report ever smoking amongst the 1960s cohort. One
possible explanation is that people within this birth cohort who
experimented with smoking during their teens and early twenties may,
during their thirties, tend to classify themselves as never having smoked
due to the growing social stigma now attached to smoking.
Figure 4 shows the prevalence of smoking amongst each cohort by age.
A decrease in the prevalence of smoking by age within birth cohorts
may be the result of either smoking cessation or selective mortality,
with smokers being more likely to die than non-smokers. Selective
mortality is only likely to affect the oldest age groups, and therefore the
downward gradients in Figure 4 primarily reflect the tendency to give
up smoking with increasing age amongst each cohort. Only for the
youngest cohort is there any upward trend in the prevalence of smoking,
as young people join the ranks of smokers during their late teens and
early twenties. The decrease in the proportion smoking by age observed
within birth cohorts is much greater than that observed in cross-
sectional data.
Although smoking is generally more common amongst men than
women at young ages, men are also more likely to give up than women.
Amongst the cohort born 1946 to 1950, at age 26, 51 per cent of men
reported that they currently smoked, compared to 45 of women.
However, amongst the same birth cohort at age 40 the gender
differential has reversed, with a slightly higher proportion of women
currently smoked than men (36 per cent versus 34 per cent). Similar
differences in smoking behaviour by gender have been reported in birth
cohort studies for other countries, such as the US,17 West Germany6 and
Canada.7 A previous study using GHS data in the Britain attributed the
differentials by gender to differing responses to anti-smoking
campaigns, with women being found to be less responsive to tobacco
related health publicity than men.18
Patterns of smoking behaviour by gender and birth cohort are reflected in
Table 1, which illustrates the trends in the death rates from some major
smoking-related diseases, including cancer of the trachea, bronchus or
lung. Ischaemic heart disease (IHD), bronchitis and emphysema (B&E),
and chronic airways obstruction (CAO) are also recognised as being
related to smoking, although the aetiology is less clear cut. The likelihood
of dying from lung cancer, IHD and B&E at any given chronological age
falls between successive birth cohorts – with the notable exception of a
rise in lung cancer between women born in 1916 and those born in 1931.
Death rates from CAO appear to be increasing between successive
cohorts. However CAO was only introduced as a separate disease
classification in ICD-9 in 1978, and the rise may reflect the increasing
tendency for doctors to enter this on the death certificate as they become
more familiar with the classification over time.
Figure 3 Percentage of men and women who have ever smoked by birth cohort
Source: Author's own analysis of GHS 1974 to 1998 using 3-year moving averages.
Note: Age is the mid-point of the 5-year age range of each birth cohort in the relevant GHS year. For example, the cohort born in 1946 to 50 is aged 30 to 34 in 1980.
Thus the mid-point of 32 is taken to represent that cohort in that year.
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Lung cancer (inc bronchus & trachea) (ICD 162)  Ischaemic heart disease (ICD 410-414)
Birth Cohort Birth Cohort
Age group 1916 1931 1946 1961 1916 1931 1946 1961
Men
25–29 9 2 26 15
30–34 16 7 89 60
35–39 40 17 246 120
40–44 174 100 947 529
45–49 393 219 1,857 1,107
50–54 756 407 3,046 1,289
55–59 2,060 1,305 5,644 4,366
60–64 3,301 1,980 8,931 7,191
65–69 4,493 2,685 12,764 7,137
70–74 5,738 17,333
75–79 6,182 28,023
80–84 5,936 26,729
Women
25–29 3 1 6 3
30–34 7 4 20 13
35–39 24 14 40 26
40–44 67 63 151 80
45–49 157 135 315 154
50–54 299 254 614 260
55–59 493 555 1,327 1,134
60–64 844 915 2,734 1,904
65–69 1,257 1,302 4,832 2,731
70–74 1,691 8,041
75–79 1,956 11,799
80–84 1,997 15,856
Bronchitis and emphysema (ICD 490-492) Chronic airways obstruction (ICD 496)
Men
25–29 3 1 0
30–34 3 1 0
35–39 5 1 1 1
40–44 44 7 5
45–49 76 15 19
50–54 106 26 50 59
55–59 814 136 203
60–64 1,173 240 645
65–69 1,352 235 811 1,042
70–74 1,361 2,475
75–79 1,539 5,388
80–84 1,095 6,216
Women
25–29 2 0 0
30–34 2 0 0
35–39 2 1 1 1
40–44 22 4 3
45–49 46 7 11
50–54 61 15 37 49
55–59 222 70 145
60–64 328 91 340
65–69 368 113 278 759
70–74 371 800
75–79 350 1,586
80–84 284 2,418
Source: Derived using data from Table 6b ONS (2001) Mortality Statistics Series DH2 No.27 and ONS Twentieth Century Mortality data file for period 1971–2000.
Table 1 Death rates from malignant neoplasm of trachea, bronchus and lung (ICD 162) and from Ischaemic heart disease (ICD
410–414) by age, gender and birth cohort (rates per million population), England and Wales
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Table 2 Standardised Mortality Ratios by socio-economic group for some major smoking related diseases, England and Wales,
men aged 20 to 64,  1991–93
Lung cancer (inc bronchus & trachea) Ischaemic heart disease Bronchitis and emphysema Chronic airways obstruction
(ICD 162) (ICD 410–414) (ICD 490–492) (ICD 496)
I Professional 45 63 44 21
II Managerial 61 73 43 42
IIINM Skilled 87 107 81 78
IIIM Skilled 138 125 125 131
IV Semi-skilled 132 121 137 146
V Unskilled 206 182 268 298
England and Wales 100 100 100 100
Source: Tables 10.3, 10.7 and 10.8 in Drever, F. and Whitehead, M. (eds) (1997) Health Inequalities decennial supplement no.15. Office for National Statistics. TSO: London.
Interestingly, although the death rates at any age are lower for women
than men, the proportionate improvement in mortality from lung cancer
between successive cohorts of women is also significantly lower. For
example, the likelihood of dying at age 50 to 54 fell from 756 per
million for men born in 1931 to 407 per million for men born in 1946,
i.e. a fall of 46 per cent; the corresponding fall for women was just 15
per cent. This differential by gender may reflect the differences in rates
of smoking cessation between men and women noted previously. If the
targets for reducing deaths from cancer set out in Our Healthier
Nation19 are to be achieved, then the gender differences in smoking
behaviour need to be addressed.
SOCIO-ECONOMIC DIFFERENTIALS
As Table 2 illustrates, deaths from smoking related diseases vary
substantially by social class and smoking is widely acknowledged as a
major contributor to both the current levels of morbidity and mortality
in Britain and to the persistence of health inequalities.5 Figure 5 shows
a clear gradient in the prevalence of cigarette smoking by socio-
economic group amongst both men and women. In 1998, men working
in ‘unskilled manual’ jobs were three times more likely to report that
they currently smoked than men employed in ‘professional’ occupations
(45 per cent versus 15 per cent). Similarly women in semi-skilled or
unskilled manual occupations and jobs in the personal service sector
were over twice as likely to smoke as professional women (33 per cent
versus 14 per cent).
Although the overall prevalence of smoking has fallen over time, the
improvement has been most marked amongst men and women from
non-manual socio-economic groups (Figure 6), with the result that the
differential between manual and non-manual groups widened during the
1970s and 1980s, levelling off in the 1990s. As Table 3 illustrates the
odds of a man smoking were one and a half times greater if they were
from a manual background compared to non-manual in 1974. By 1998,
however, the odds ratio had risen to 2.12, i.e. the odds of smoking are
now over 2 times greater when the man works in a manual occupation
than when he works in a non-manual occupation. Similarly for women
the odds ratio has risen from 1.33 in 1974 to 1.69 in 1998. Thus it
appears that public health campaigns aimed at reducing the prevalence
of smoking have met with a mixed response, with smoking increasingly
concentrated in lower socio-economic groups.
Figure 4 Percentage who currently smoke by birth cohort
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Source:  Author's own analysis of GHS 1994 to 1998 using 3-year moving averages.
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Figure 5 Prevalence of cigarette smoking by sex and socio-economic group, Great Britain, 1998
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Source:  GHS 1998, Table 8.7 (Office for National Statistics, 2000).
Table 3 Prevalence of cigarette smoking by sex and socio-economic group, Great Britain, 1974 to 1998
Men Women
Manual Non-manual Odds Ratio Manual Non-manual Odds Ratio
1974 0.56 0.45 1.56 0.45 0.38 1.33
1976 0.52 0.37 1.84 0.41 0.35 1.29
1978 0.51 0.36 1.85 0.41 0.32 1.48
1980 0.49 0.33 1.95 0.41 0.32 1.48
1982 0.44 0.28 2.02 0.38 0.29 1.50
1984 0.43 0.28 1.94 0.37 0.27 1.59
1986 0.40 0.26 1.90 0.36 0.26 1.60
1988 0.40 0.24 2.11 0.36 0.25 1.69
1990 0.38 0.23 2.05 0.34 0.25 1.55
1992 0.36 0.22 1.99 0.33 0.23 1.65
1994 0.35 0.21 2.03 0.31 0.21 1.69
1996 0.35 0.21 2.03 0.33 0.22 1.75
1998 0.36 0.21 2.12 0.31 0.21 1.69
Source: Derived using data from GHS 1974–1998, Table 8.7 Office for National Statistics 2000.
Note: The odds ratio is defined as the probability of occurrence over the probability of non-occurrence. In 1998, the probability of a man from manual background smoking was 0.36
and from a non-manual background was 0.21. Thus the odds of smoking for a manual man are 0.36/0.64 =0.562 and for a non-manual man are 0.21/0.79 = 0.266. The odds of
smoking are 2.12 times greater (i.e. 0.562/0.266) when the man works in a manual occupation than when he works in a non-manual occupation.
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Figure 6 Prevalence of cigarette smoking by sex and
socio-economic group, Great Britain, 1974 to 1998
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Source:  GHS 1998, Table 8.7 Office for National Statistics, 2000.
Figure 7 Percentage of men and women currently smoking by socio-economic group by birth cohort, Great Britain
SOCIO-ECONOMIC DIFFERENTIALS IN SMOKING
BEHAVIOUR ACROSS COHORTS
Further light can be shed by examining trends in smoking behaviour by
age for different socio-economic groups within birth cohorts. The
trajectories of the prevalence of cigarette smoking in Figure 7 suggest
that there is a lag in smoking cessation by socio-economic group
between birth cohorts. For example, the trajectory for manual women
from the 1931 to 1935 cohort appears to be following a similar path to
that of non-manual women from the 1916 to 1920 cohort. A similar
pattern is found amongst men. Such patterns are consistent with
diffusion theory of behaviour change, where changes in health related
behaviour are adopted first amongst the middle classes and then diffuse
through the population. The most well documented example of this was
the adoption of fertility regulating behaviour amongst the middle
classes at the end of the 19th century.20,21 If the smoking behaviour of
non-manual men and women in the previous birth cohort is a good
guide to future behaviour amongst manual men and women, then
significant reductions in the prevalence of smoking amongst manual
men and women born in 1931 to 1935 and 1946 to 1950 may occur.
However, the lower rate of smoking cessation amongst men and women
from non-manual groups born in 1946 to 1950 may indicate a slowing
down in improvement.
Inequalities in smoking behaviour between socio-economic groups
appear to be generally widening both within birth cohorts with rising
age, as non-manual groups give up smoking at a faster rate than non-
manual groups (Table 4a) and between cohorts at any given
chronological age (Table 4b). For example, amongst women aged 30,
the odds of a woman born in 1946 to 1950 smoking were 1.5 greater if
they were from a manual background compared to non-manual.
However amongst those women born in 1961 to 1965 the odds had
risen to 2.06 at the same age.
Source:  Authors' own analysis GHS 1974 to 1998 using 5-year moving averages. M=manual (IIIM, IV & V); NM=Non-manual (I,II & IIINM).
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Table 4a Prevalence of cigarette smoking within birth cohort, by sex, socio-economic group and age
Men Women
Manual Non manual Odds Ratio Manual Non manual Odds ratio
1916–20
Age 60 0.50 0.35 1.86 0.42 0.34 1.41
Age 75 0.22 0.11 2.28 0.19 0.15 1.33
widening reducing
1931–35
Age 45 0.54 0.38 1.92 0.52 0.38 1.77
Age 60 0.29 0.17 1.99 0.35 0.20 2.15
widening widening
1946–50
Age 30 0.55 0.35 2.27 0.49 0.39 1.50
Age 45 0.38 0.23 2.05 0.40 0.26 1.90
reducing widening
Source: Authors’ own analysis of GHS 1974 to 1998.
Men Women
Manual Non-manual Odds Ratio Manual Non-manual Odds ratio
Age 30
1946–50 0.55 0.35 2.27 0.49 0.39 1.50
1961–65 0.42 0.26 2.06 0.42 0.26 2.06
reducing widening
Age 45
1931–35 0.54 0.38 1.92 0.52 0.38 1.77
1946–50 0.38 0.23 2.05 0.40 0.26 1.90
widening widening
Age 60
1916–20 0.50 0.35 1.86 0.42 0.34 1.41
1931–35 0.29 0.17 1.99 0.35 0.20 2.15
widening widening
Source: Authors’ own analysis of GHS 1974 to 1998.
Table 4b Prevalence of cigarette smoking at age 30, 45 and 60, by sex, socio-economic group and birth cohort
DISCUSSION
A major concern of health policy analysts at the start of the 21st century
has been to reduce the level of health inequalities in Britain.22 Although
life expectancy has improved significantly over the last 30 years, these
improvements have not been shared equally across society. Between
1972 and 1976 and 1997 and 1999 men in Social Class I gained 6.5
years compared to 4.6 amongst men in Social Class V.23 There is now a
7.4 year difference in the expectation of life at birth between men in
Social Class I (78.5 years) and Social Classes V (71.1 years); and a 5.7
year differential for women (82.8 years compared with 77.1 years).23
The causes of such inequalities in health are complex and multi-faceted.
However it is clear that behaviours such as smoking that are known to
be related to social class play a major role in perpetuating such
inequalities.
The analysis here of smoking behaviour by class within birth cohort has
mixed messages for policy makers. The good news is that overall
prevalence of smoking at any age is lower amongst successive birth
cohorts and smoking cessation is occurring at earlier ages than in
previous cohort. Furthermore, if manual workers follow the behaviour
of their non-manual predecessors then we should observe a
continuation of the fall in smoking amongst manual groups.
However, the analysis also provides evidence that the rate of smoking
cessation is slowing down among non-manual workers in the 1946 to
1950 and 1961 to 1965 cohorts. The bad news is that amongst non-
manual men born in 1946 to 1950, the prevalence of smoking appears
to be levelling out at over 20 per cent and amongst manual men
prevalence has stabilised at over 40 per cent. Moreover, rates of
‘giving-up’ appear to be slower amongst women born in the 1960s than
previous generations.
Inequalities between social classes are also widening rather than
narrowing both between successive cohorts of men and women at the
same age and within cohorts with increasing age. This will have
significant implications for the persistence of inequalities in health
outcomes, given that disadvantages in health are known to be
accumulated across an individuals’ lifetime. Unless policies are adopted
that both reduce smoking overall and narrow the disparities between
men and women and socio-economic groups, inequalities in health
outcome look likely to persist well into the 21st century.
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Key Findings
 Overall prevalence of smoking at any age is lower
among successive birth cohorts.
 Smoking cessation is occurring at earlier ages than
in previous cohorts.
 There is a clear difference in smoking behaviour by
socio-economic group within cohorts among women
and men, with a higher proportion smoking among
manual occupations than non-manual occupations.
For example, among the 1931 to 1935 cohort at age
45, 52 per cent of manual women smoke compared
with 38 per cent of non-manual women.
 The class effect in smoking widens with successive
younger cohorts. At age 30, the odds of smoking
among manual women from the 1960s cohort was
twice that of non-manual women, compared to 1.5
times among the 1940s cohort.
 There appears to a lag in smoking cessation by
socio-economic group by birth cohort, consistent
with diffusion theory of behaviour change, where
changes in health risk behaviour are adopted first
among the middle classes and then diffuse through
the population.
 If manual workers follow the behaviour of their
non-manual predecessors then we should observe a
continuation of the fall in smoking among manual
groups in the oldest cohorts.
 Among men born in the 1940s, the prevalence of
smoking is levelling out at over 20 per cent among
those employed in non-manual jobs and 40 per cent
among those in manual occupations. Rates of giving
up smoking also appear to be slowing down among
the 1960s cohort.
 Inequalities in smoking related diseases and deaths
look likely to persist well into the 21st century.
ACKNOWLEDGEMENTS
We are grateful to the Office for National Statistics, The Data Archive
and MIMAS computer services for access to the GHS data 1974 to
1998, which has been used by kind permission. We are also grateful to
ONS for access to unpublished data on ICD-8 and ICD-9, which were
used in the derivation of Table 1. We are indebted to Tamara Yiannakou
for her technical advice.  The analysis and interpretation of the data is
the responsibility of the authors alone. The research forms part of the
work of the ESRC SAGE Research Group funded under grant number
M565-21-1001.
NOTES AND REFERENCES
1. Doll R, Peto R, Whateley K et al (1994) Mortality in relation to
smoking: 40 years’ observation on male British doctors.  British
Medical Journal 309, 901–11.
2. Peto R, Lopez A, Boreham J et al (1994) Mortality from smoking in
developing countries 1950–2000, Imperial Cancer Research Fund
and World Health Organisation, Oxford University Press: Oxford.
3. Wardle J, Farell M, Hillsdon M, Jarvis M, Sutton S and Thorogood
M (1999) ‘Smoking, drinking, physical activity and screening
uptake and health inequalities’ pp 213–239 in Gordon D, Shaw  M,
Dorling D and Davey Smith G. (eds), Inequalities in health: the
evidence, Policy Press: Bristol.
4. Office for National Statistics (2000) Living In Britain: Results from
the 1998 General Household Survey, TSO: London.
5. Department of Health (1998) Smoking Kills - a White Paper on
Tobacco, TSO: London.
6. Brenner H (1993) A birth cohort analysis of the smoking epidemic
in West Germany. Journal of Epidemiology and Community Health
43, 54–58.
7. Ferrence R (1988) Sex differences in cigarette smoking in Canada,
1900-1978: a reconstructed cohort study. Canadian Journal of
Public Health 79, 160–65.
8. Harris J (1983) Cigarette smoking among successive birth cohorts
of men and women in the United States 1900–80.  Journal National
Cancer Institute 73, 473–79.
9. LaVecchia C, Decarli A and Pagano R (1986) Prevalence of
cigarette smoking among subsequent cohorts of Italian males and
females. Preventative Medicine 15, 606–13.
10. Laaksonen M, Uutela A, Vartiainen E et al (1999) Development of
smoking by birth cohort in the adult population in eastern Finland
1972–97. Tobacco Control 8, 161–68.
11. Evandrou M and Falkingham J (2000) Looking back to look
forward: lessons from four birth cohorts for ageing in the 21st
Century. Population Trends 99, 21–30.
12. Evandrou M and Falkingham J (2001) What future for the baby
boomers in retirement? Insurance Trends 31, 1–14.
13. Data from the 2000 GHS are now available. However, they have not
been used in this paper due to changes in weighting methodology
and in the definition of socio-economic group.
14. In 1974, the sample size of each of the birth cohorts was as follows:
1916–1920, 834 men, 932 women; 1931–1935, 994 men, 959
women; 1946–1950, 1,186 men, 1,181 women; 1961–1965, 1,510
men, 1,461 women. In 1998, the sample size of each of the birth
cohorts was: 1916–1920, 186 men, 284 women; 1931–1935, 474
men, 486 women; 1946–1950, 693 men, 742 women; 1961–1965,
770 men, 827 women.
15. Breeze E (1990) Reporting on sampling error. Series GHS no. 18,
OPCS, HMSO: London.
16. The questions in the GHS regarding smoking behaviour are as
follows: ‘Have you ever smoked a cigarette, a cigar or a pipe?’ and
‘Do you smoke cigarettes at all nowadays?’. Thus, in principle, a
person who has only smoked one cigarette in their lifetime may be
counted as ever having smoked.
17. Escobedo L and Peddicord J (1996) Smoking prevalence in US
birth cohorts: the influence of gender and education. American
Journal of Public Health 86, 231–36.
18. Townsend J, Roderick P and Cooper J (1994) Cigarette smoking by
socio-economic group, sex and age: effects of price, income and
health publicity. British Medical Journal 309, 923–7.
19. Department of Health (1999) Saving Lives: Our Healthier Nation.
TSO: London.
20. Cleland J and Wilson C (1987) Demand theories of the fertility
transition: An iconoclastic view. Population Studies 41, 5–30.
21. Lesthaeghe R (1983) A century of demographic and cultural change
in Western Europe. An exploration of underlying dimensions.
Population and Development Review 9(3).
22. Acheson D (1998) Independent Inquiry into Inequalities in Health.
TSO: London.
23. Office for National Statistics (2002) Trends in life expectancy by
social class 1972–1999. Health Statistics Update, Health variation
Team, 28th January 2002. Available at http://statbase/downloads/
theme_population/Life_Expect_Social_class_1972–99/
Life_Expect_Social_class_1972–99.pdf
39   Nat ional  Stat ist ics
Health Stat ist ics Quarter ly  14 Summer 2002
Page
Tables
 Nat ionalNotes to tables
Population
International ................................................................................. Selected countries
National ........................................................................................ Constituent countries of
the United Kingdom
Subnational ................................................................................... Health Regional Office areas
of England
Subnational ................................................................................... Government Office Regions
of England
Age and sex .................................................................................. Constituent countries of
the United Kingdom
Age, sex and legal marital status .................................................. England and Wales
Vital statistics
Summary ...................................................................................... Constituent countries of
the United Kingdom
Key demographic and health indicators ....................................... Constituent countries of
the United Kingdom
Live births
Age of mother ............................................................................... England and Wales
Outside marriage: age of mother and type of registration ............ England and Wales
Conceptions and abortions
Age of women at conception ........................................................ England and Wales (residents)
Abortions: age and gestation. ....................................................... England and Wales
Expectation of life
(In years) at birth and selected age ............................................... Constituent countries of
the United Kingdom
Deaths
Age and sex England and Wales
Subnational Health Regional Office areas
of England
Selected causes and sex England and Wales
1.1
1.2
1.3
1.4
1.5
1.6
2.1
2.2
3.1
3.2
4.1
4.2
5.1
6.1
6.2
6.3
41
42
44
45
46
47
50
52
54
55
56
57
58
59
60
61
62StatBase®
Health Statistics Quarterly tables are now available on StatBase® which can be accessed
via our website www.statistics.gov.uk
Symbols
.. not available
: not applicable
- nil or less than half the final digit shown
blank not yet available
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Notes to tables
Changes to tables
With the introduction of Health Statistics
Quarterly, the previous Population Trends
tables have been reviewed and some small
changes introduced, in particular, a new table,
Table 2.2, showing key demographic and
health indicators for the constituent countries
of the United Kingdom.
For most tables, years start at 1971 and then
continue at five-year intervals until 1991.
Individual years are shown thereafter. If a year
is not present the data are not available.
Population
The estimated and projected populations of an
area include all those usually resident in the
area, whatever their nationality. Members of
HM forces stationed outside the United
Kingdom are excluded. Students are taken to
be resident at their term-time addresses.
Figures for the United Kingdom do not include
the population of the Channel Islands or the
Isle of Man.
The population estimated for mid-1991
onwards are final figures based on the 1991
Census of Population with allowance for
subsequent births, deaths and migration.
Live births
For England and Wales, figures relate to
numbers occurring in a period; for Scotland
and Northern Ireland, figures relate to those
registered in a period. See also Note on page
63 of Population Trends 67.
Perinatal mortality
In October 1992 the legal definition of a
stillbirth was changed, from baby born dead
after 28 completed weeks of gestation or more,
to one born dead after 24 completed weeks of
gestation or more.
Expectation of life
The life tables on which these expectations are
based use current death rates to describe
mortality levels for each year. Each
individual year shown is based on a three-
year period, so that for instance 1986
represents 1985–87. More details may be
found in Population Trends 60, page 23.
Deaths
Figures for England and Wales represent the
numbers of deaths registered in each year up
to 1992, and the number of deaths occurring
in each year from 1993. Provisional figures
are registrations.
Figures for both Scotland and Northern
Ireland represent the number of deaths
registered in each year.
Age-standardised mortality
Directly age-standardised rates make
allowances for changes in the age structure
of the population. The age-standardised rate
for a particular condition is that which
would have occurred if the observed age-
specific rates for the condition had applied
in a given standard population. Tables 2.2
and 6.3 use the European Standard
Population. This is a hypothetical population
standard which is the same for both males
and females allowing standardised rates to
be compared for each sex, and between
males and females.
Abortions
Figures relate to numbers occurring in a
period.
Improvements to National Statistics on
abortions performed in England and Wales were
published in Health Statistics Quarterly 11. The
revised figures are presented in Table 4.2. These
changes include an improvement in the
calculation of quarterly abortion rates. The mid-
quarter population estimates, used to calculate
these rates, were produced by linear
interpolation as follows:
March quarter 7.5/12*(P2-P1)+P1
June quarter 10.5/12*(P2-P1)+P1
September quarter 1.5/12*(P3-P2)+P2
December quarter 4.5/12*(P3-P2)+P2
Where P1 = mid-year population  estimate of
previous year;
P2 = mid-year population estimate of
year being calculated;
P3 = population projection for next
year.
For example
March quarter 2000 = 7.5/12*(pop2000-
pop1999)+pop1999;
September quarter 2000 = 1.5/12*(pop2001-
pop2000)+pop2000.
Marriages and divorces
Marriages are tabulated according to date of
solemnisation. Divorces are tabulated
according to date of decree absolute, and the
term ‘divorces’ includes decrees of nullity.
The fact that a marriage or divorce has taken
place in England and Wales does not mean
that either one or both parties are resident
there.
Government Office Regions
Figures refer to Government Office Regions
(GORs) of England which were adopted as
the primary classification for the
presentation of regional statistics from April
1997.
Health Regional Office areas
Figures refer to new health regions of
England which are as constituted on 1 April
1996.
Sources
Figures for Scotland and Northern Ireland
shown in these tables (or included in totals
for the United Kingdom or Great Britain)
have been provided by their respective
General Register Offices, except for the
projections in Table 1.2 which are provided
by the Government Actuary.
Rounding
All figures are rounded independently;
constituent parts may not add to totals.
Generally numbers and rates per 1,000
population are rounded to one decimal place
(eg 123.4); where appropriate, for small
figures (below 10.0), two decimal places are
given (eg 7.62). Figures which are
provisional or estimated are given in less
detail (eg 123 or 7.6 respectively) if their
reliability does not justify giving the
standard amount of detail. Where, for some
other reason, figures need to be treated with
particular caution, an explanation is given as
a footnote.
Latest figures
Figures for the latest quarters and years may
be provisional (see note above on rounding)
and will be updated in future issues when
later information becomes available. Where
figures are not yet available, cells are left
blank. Population estimates and rates based
on them may be revised in the light of
results from future censuses of populations.
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Year United Austria Belgium Denmark Finland France Germany1 Greece Irish Italy Luxem- Nether- Portugal
Kingdom i ii ii ii ii ii ii ii Republic ii ii bourg ii lands ii ii
Population (thousands)
1971 55,928 7,501 9,673 4,963 4,612 51,251 78,313 8,831 2,992 54,073 342 13,194 8,644
1976 56,216 7,566 9,818 5,073 4,726 52,909 78,337 9,167 3,238 55,718 361 13,774 9,356
1981 56,357 7,569 9,859 5,121 4,800 54,182 78,408 9,729 3,443 56,502 365 14,247 9,851
1986 56,859 7,588 9,862 5,120 4,918 55,547 77,720 9,967 3,543 56,596 368 14,572 10,011
1991 57,814 7,813 10,004 5,154 5,014 57,055 80,014 10,247 3,534 56,751 387 15,070 9,871
1993 58,198 7,992 10,084 5,189 5,066 57,654 81,156 10,379 3,576 57,049 398 15,290 9,881
1994 58,401 8,030 10,116 5,206 5,088 57,900 81,438 10,426 3,590 57,204 404 15,383 9,902
1995 58,612 8,040 10,137 5,216 5,108 57,753 81,539 10,443 3,598 57,269 407 15,424 9,912
1996 58,807 8,059 10,157 5,263 5,125 58,375 81,915 10,476 3,636 57,397 416 15,530 9,927
1997 59,014 8,072 10,181 5,285 5,140 58,610 82,034 10,499 3,673 57,512 421 15,611 9,946
1998 59,237 8,078 10,203 5,304 5,153 58,851 82,047 10,516 3,714 57,588 426 15,707 9,968
1999 59,501 8.083 10,214 5,314 5,160 58,973 82,037 10,522 3,735 57,613 429 15,760 9,980
2000 59,756 8,103 10,239 5,330 5,171 58,744 82,164 10,543 3,776 57,680 436 15,864 10,178
2001 .. 8,121 10,263 5,349 5,181 59,040 82,193 10,565 3,781 57,884 441 15,987 10,243
Population changes (per 1,000 per annum)
1971–76 1.0 1.7 3.0 4.4 4.9 6.5 0.1 7.6 16.4 6.1 10.7 8.8 16.5
1976–81 0.5 0.1 0.8 1.9 3.1 4.8 0.2 12.3 12.7 2.8 2.5 6.9 10.6
1981–86 1.8 0.5 0.1  0.0 4.9 5.0 –1.8 4.9 5.8 0.3 1.8 4.6  3.2
1986–91 3.4 5.9 2.9 1.3 3.9 5.4 5.9 5.6 –0.5 0.5 10.2 6.8 –2.8
1991–96 3.4 5.8 2.7 2.4 3.4 2.4 3.8 3.8 3.6 1.8 10.3 4.7 0.8
1997–98 3.8 0.7 2.2 3.6 2.5 4.1 0.2 1.6 11.2 1.3 11.9 6.1 2.2
1998–99 4.5 0.6 1.1 1.9 1.4 2.1 0.1 0.6 5.7 1.4 7.0 3.4 1.2
1999–2000 4.3 2.5 2.4 3.0 2.1 – 3.9 1.5 2.0 11.0 1.2 16.3 6.6 19.8
2000–01 .. 2.2 2.3 3.6 1.9 5.0 0.4 2.1 1.3 2.8 11.5 7.8 6.4
Live birth rate (per 1,000 per annum)
1971–75 14.1 13.3 13.4 14.6 13.1 16.0 10.5 15.8 22.2 16.0 11.6 14.9 20.3
1976–80 12.5 11.5 12.5 12.0 13.6 14.1 10.5 15.6 21.3 12.6 11.2 12.6 17.9
1981–85 12.9 12.0 12.0 10.2 13.4 14.2 10.7 13.3 19.2 10.6 11.6 12.2 14.5
1986–90 13.6 11.6 12.1 11.5 12.7 13.8 9.8 10.6 15.8 9.8 12.2 12.8 11.9
1991–95 13.1 11.8 12.0 13.1 12.9 12.7 10.9 9.9 14.0 9.6 13.3 12.8 11.4
1996 12.5 11.0 11.2 12.9 11.8 12.6 9.7 9.6 14.0 9.2 13.7 12.2 11.1
1997 12.3 10.4 11.3 12.8 11.5 12.4 9.9 9.7 14.3 9.2 13.1 12.3 11.4
1998 12.1 10.1 11.2 12.5 11.1 12.6 9.6 9.6 14.4 9.0 12.6 12.7 11.4
1999 11.8 9.7 11.1 12.4 11.1 12.7 9.4 9.6 14.2 9.1 12.9 12.7 11.8
2000 11.4 9.7 11.3 12.6 11.0 13.2 9.2 9.6 14.4 9.3 13.1 13.0 11.8
Death rate (per 1,000 per annum)
1971–75 11.8 12.6 12.1 10.1 9.5 10.7 12.3 8.6 11.0 9.8 12.2 8.3 11.0
1976–80 11.9 12.3 11.6 10.5 9.3 10.2 12.2 8.8 10.2 9.7 11.5 8.1 10.1
1981–85 11.7 12.0 11.4 11.1 9.3 10.1 12.0 9.0 9.4 9.5 11.2 8.3 9.6
1986–90 11.4 11.1 10.8 11.5 9.8 9.5 11.6 9.3 9.1 9.4 10.5 8.5 9.6
1991–95 11.0 10.4 10.4 11.9 9.8 9.1 10.8 9.5 8.8 9.7 9.8 8.8 10.4
1996 10.8 10.0 10.3 11.6 9.6 9.2 10.8 9.6 8.7 9.6 9.4 8.9 10.8
1997 10.7 9.8 10.2 11.3 9.6 9.0 10.5 9.5 8.6 9.8 9.4 8.7 10.6
1998 10.6 9.7 10.3 11.0 9.6 9.2 10.4 9.8 8.4 9.9 9.1 8.8 10.5
1999 10.6 9.7 10.3 11.1 9.6 9.2 10.3 9.8 8.4 9.8 8.8 8.9 10.6
2000 10.2 9.5 10.3 10.9 9.5 9.1 10.1 9.8 8.2 9.7 8.6 8.8 10.3
Table 1.1 Population and vital rates: international
Selected countries Numbers (thousands)/Rates per thousand
Note: Figures may not add exactly due to rounding.
Population estimated as follows:
i At 30 June.
ii Estimated mid-year population at latest available date, as given in Council of Europe report:
Recent Demographic Developments in Europe.
iii The European Union consists of 15 member countries (EU15); live birth rates and death rates as
given in Eurostat report, Demographic Statistics.
iv At 1 July as given in the United Nations Demographic Yearbook or United Nations Monthly Bulletin of
Statistics .
1 Including former GDR throughout.
2 Estimates prepared by the Population Division of the United Nations –
Excludes Hong Kong.
3 Rates are based on births to, or deaths of, Japanese nationals only.
4 Rates are for 1990–1995.
5 Estimates prepared by Eurostat.
6 Including Hong Kong.
7 Including the Indian held port of Jammu and Kashmir, the final status of
which has not yet been determined.
. . Figures not available.
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Spain Sweden European Russian Australia Canada New China India7 Japan3 USA Year
ii ii Union iii Federation ii iv iv Zealand iv iv iv iv iv
Population (thousands)
34,216 8,098 342,631 130,934 13,067 22,026 2,899 852,290 551,311 105,145 207,661 1971
36,118 8,222 350,598 135,027 14,033 23,517 3,163 937,170 2 617,248 113,094 218,035 1976
37,741 8,320 356,490 139,225 14,923 24,900 3,195 1,008,460 2 675,185 117,902 229,958 1981
38,536 8,370 359,570 144,154 16,018 26,204 3,317 1,086,733 2 767,199 121,672 240,680 1986
38,920 8,617 366,259  147,885 17,284 28,030 3,480 1,170,100 2 851,900 123,964 252,618 1991
39,086 8,719 369,710 148,146 17,667 28,700 3,550 1,196,400 2 886,250 124,829 258,080 1993
39,149 8,781 371,011 147,968 17,855 29,040 3,600 1,208,800 2 903,940 125,178 260,602 1994
39,197 8,816 372,132 147,939 18,072 29,350 3,660 1,220,520 2 921,990 125,472 263,040 1995
39,270 8,841 373,188 147,373 18,311 29,670 3,710 1,232,460 2 939,540 127,761 265,460 1996
39,323 8,846 374,163 146,938 18,520 29,990 3,760 1,255,700 2 995,220 126,070 268,010 1997
39,371 8,851 371,014 146,534 18,730 30,250 3,790 1,256,700 2 970,930 126,410 270,560 1998
39,394 8,854 375,948 146,328 18,970 30,490 3,810 1,266,840 2 986,610 126,500 2 273,130 1999
39,733 8,862 376,579 145,560 19,160 30,750 3,830 1,275,130 1,002,140 126,870 281,420 2 2000
40,122 8,833 .. 144,819 . . .. .. .. .. .. .. 2001
Population changes (per 1,000 per annum)
11.1 3.1 4.7 6.3 14.8 13.5 18.2 19.9 23.9 15.1 10.0 1971–76
9.0 2.1 3.4 6.2 12.7 11.8 2.0 15.2 18.8 8.5 10.9 1976–81
4.2 1.2 1.7 7.1 14.7 10.5 7.6 15.5 27.3 6.4 9.3 1981–86
2.0 5.9 3.7 5.2 15.8 13.9 9.8 15.3 22.1 3.8 9.9 1986–91
1.4 4.6 3.2 0.8 9.1 9.4 10.3 8.6 16.5 2.4 8.3 1991–96
1.2 0.6 2.3 –2.7 11.3 8.7 8.0 10.0 16.4 2.7 8.5 1997–98
0.6 0.3 2.5 –1.4 12.8 7.9 5.3 8.1 16.1 0.7 8.8 1998–99
8.6 0.9 2.1 –5.2 10.0 8.5 5.2 6.5 15.7 2.9 32.0 1999–2000
9.8 2.4 .. –5.1 .. .. .. .. .. .. .. 2000–01
Live birth rate (per 1,000 per annum)
19.2 13.5 14.7 .. 18.8 15.9 20.4 27.2 35.6 18.6 15.3 1971–75
17.1 11.6 13.1 .. 15.7 15.5 16.8 18.6 33.4 14.9 15.2 1976–80
12.8 11.3 12.2 .. 15.6 15.1 15.8 19.2 .. 12.6 15.7 1981–85
10.8 13.2 12.0 .. 15.1 14.8 17.1 .. .. 10.6 16.0 1986–90
9.8 13.3 9.7 10.2 .. .. .. 18.5 4 .. .. .. 1991–95
9.2 10.8 10.8 8.8 13.9 12.2 15.4 9.8 27.3 9.6 14.7 1996
9.4 10.2 10.8 8.6 13.6 11.9 15.4 9.0 6 .. 9.5 14.5 1997
9.3 10.1 10.7 5 8.8 13.3 .. 14.6 8.0 6 .. 9.5 14.6 1998
9.6 10.0 .. 8.3 13.1 .. 15.0 7.5 6 .. 9.3 14.5 1999
9.9 10.2 .. 8.7 13.0 .. 14.8 8.0 6 .. 9.4 13.9 2000
Death rate (per 1,000 per annum)
8.5 10.5 10.8 .. 8.2 7.4 8.4 7.3 15.5 6.4 9.1 1971–75
8.0 10.9 10.6 .. 7.6 7.2 8.2 6.6 13.8 6.1 8.7 1976–80
7.7 11.0 10.4 .. 7.3 7.0 8.1 6.7 .. 6.1 8.6 1981–85
8.2 11.1 10.2 .. 7.2 7.3 8.2 .. .. 6.4 8.7 1986–90
8.7 10.9 10.0 13.7 .. .. .. .. .. .. .. 1991–95
8.9 10.6 10.0 14.1 7.0 7.1 7.6 5.0 8.9 7.1 8.7 1996
8.9 10.6 9.8 13.8 7.0 7.2 7.3 4.8 6 .. 7.2 8.6 1997
9.1 10.5 9.9 5 13.6 6.8 .. 6.9 4.9 6 .. 7.4 8.6 1998
9.1 10.7 .. 14.7 6.8 .. 7.4 4.9 6 .. 7.8 8.8 1999
9.3 10.5 .. 15.3 6.7 .. 7.0 4.9 6 .. .. 8.4 2000
Population and vital rates: internationalTable 1.1
continued
Selected countries Numbers (thousands)/Rates per thousand
See notes opposite.
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Mid-year United Great England England Wales Scotland Northern
Kingdom Britain and Wales Ireland
Estimates
1971 55,928 54,388 49,152 46,412 2,740 5,236 1,540
1976 56,216 54,693 49,459 46,660 2,799 5,233 1,524
1981 56,357 54,815 49,634 46,821 2,813 5,180 1,543
1986 56,859 55,285 50,162 47,342 2,820 5,123 1,574
1991 57,814 56,207 51,100 48,208 2,891 5,107 1,607
1992 58,013 56,388 51,277 48,378 2,899 5,111 1,625
1993 58,198 56,559 51,439 48,533 2,906 5,120 1,638
1994 58,401 56,753 51,621 48,707 2,913 5,132 1,648
1995 58,612 56,957 51,820 48,903 2,917 5,137 1,655
1996 58,807 57,138 52,010 49,089 2,921 5,128 1,669
1997 59,014 57,334 52,211 49,284 2,927 5,123 1,680
1998 59,237 57,548 52,428 49,495 2,933 5,120 1,689
1999 59,501 57,809 52,690 49,753 2,937 5,119 1,692
2000 59,756 58,058 52,943 49,997 2,946 5,115 1,698
of which (percentages)
0–4 6.0 6.0 6.0 6.0 5.7 5.6 7.0
5–15 14.2 14.1 14.2 14.2 14.4 13.9 17.0
16–44 40.8 40.8 40.7 40.9 38.2 41.4 41.9
45–64M/59F 20.9 21.0 21.0 20.9 21.8 21.0 18.8
65M/60F–74 10.7 10.7 10.7 10.6 11.7 11.3 9.4
75 and over 7.4 7.4 7.5 7.4 8.2 6.8 5.8
Projections1
2001 59,987 58,283 53,174 50,225 2,949 5,109 1,705
2006 60,946 59,214 54,136 51,165 2,971 5,078 1,732
2011 61,956 60,197 55,151 52,151 3,000 5,047 1,759
2016 63,038 61,255 56,241 53,207 3,034 5,014 1,783
2021 64,105 62,302 57,329 54,262 3,067 4,973 1,803
of which (percentages)
0–4 5.5 5.5 5.5 5.5 5.4 5.0 5.8
5–15 11.8 11.8 11.8 11.8 12.0 11.0 13.0
16–44 36.3 36.3 36.4 36.5 35.0 35.3 37.0
45–642 27.2 27.3 27.1 27.2 26.5 28.7 26.9
65–742 10.4 10.4 10.3 10.3 11.5 11.1 9.5
75 and over 8.7 8.8 8.8 8.7 9.7 8.9 7.9
Note:  Figures may not add exactly due to rounding.
1 These projections are based on the mid-2000 population estimates.
2 Between 2010 and 2020, state retirement age will change from 65 years for men and 60 years for women to 65 years for both sexes.
Table 1.2 Population: national
Constituent countries of the United Kingdom Numbers (thousands) and percentage age distribution
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Mid-year Northern and Trent Eastern London South South West North
Yorkshire East West Midlands West
Estimates
1971 6,723 4,483 4,380 7,750 7,136 4,132 5,146 6,662
1976 6,729 4,557 4,448 7,307 7,378 4,299 5,178 6,588
1981 6,718 4,608 4,781 7,018 7,621 4,300 5,187 6,488
1986 6,692 4,634 4,938 7,013 7,892 4,910 5,197 6,397
1991 6,285 5,035 5,150 6,890 8,266 4,718 5,266 6,600
1992 6.309 5,060 5,175 6,905 8,302 4,746 5,278 6,603
1993 6,323 5,081 5,193 6,933 8,329 4,768 5,290 6,617
1994 6,332 5,096 5,223 6,968 8,379 4,798 5,295 6,616
1995 6,337 5,109 5,257 7,007 8,446 4,827 5,306 6,614
1996 6,338 5,121 5,293 7,074 8,500 4,842 5,317 6,605
1997 6,336 5,128 5,334 7,122 8,569 4,876 5,321 6,598
1998 6,339 5,134 5,377 7,187 8,620 4,901 5,333 6,604
1999 6.336 5,148 5,419 7,285 8,699 4,936 5,336 6,595
2000 6,343 5,158 5,460 7,375 8,741 4,975 5,335 6,610
of which (percentages)
0–4 5.8 5.8 6.0 6.7 6.0 5.5 6.1 5.9
5–15 14.4 14.2 14.1 13.5 14.1 13.6 14.6 14.8
16–44 40.1 39.9 39.9 47.3 40.1 38.0 39.7 40.3
45–64M/59F 21.2 21.4 21.5 18.2 21.5 21.9 21.4 21.0
65M/60F–74 11.2 11.2 10.9 8.4 10.5 11.8 11.0 10.8
75 and over 7.4 7.6 7.6 6.0 7.8 9.1 7.3 7.2
Projections2
2001 6,365 5,184 5,448 7,215 8,757 4,977 5,343 6,582
2006 6,382 5,232 5,582 7,337 8,985 5,097 5,358 6,553
2011 6,405 5,277 5,702 7,470 9,191 5,213 5,372 6,530
2016 6,435 5,324 5,823 7,608 9,396 5,333 5,391 6,521
2021 6,464 5,371 5,941 7,736 9,594 5,452 5,411 6,515
of which (percentages)4
0–4 5.5 5.4 5.5 6.4 5.5 4.9 5.7 5.7
5–15 12.2 11.9 12.1 12.5 12.1 11.2 12.5 12.5
16–44 35.5 35.2 34.5 41.5 34.9 32.8 34.9 35.6
45–643 27.4 27.5 27.2 26.3 27.4 27.8 27.3 27.4
65–743 10.9 10.9 11.2 7.7 10.9 12.4 10.7 10.5
75 and over 8.5 9.0 9.5 5.6 9.2 10.8 8.9 8.3
Note: Figures may not add exactly due to rounding.
1 The Regional Office boundaries were revised from 1 April 1999. See Health Statistics Quarterly 03 In Brief for details of the changes. Earlier years’ figures have been revised to reflect the new
boundaries.
2 These projections are based on the mid-1996 population estimates and are consistent with the 1996-based national projections produced by the Government Actuary’s Department.
3 Between 2010 and 2020, state retirement age will change from 65 years for men and 60 years for women to 65 years for both sexes.
4 The percentages shown in this table are correct and show the proportion in each age group for 2021. These replace the percentage figures shown in Health Statistics Quarterly numbers 01,
02 and 03, and Population Trends 95 and 96, which were miscalculated.
Population: subnationalTable 1.3
Health Regional Office areas of England1  Numbers (thousands) and percentage age distribution
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Table 1.4 Population: subnational
Mid-year North North Yorkshire East West East London South South
East West1 and the Midlands Midlands East West
Humber
Estimates
1971 2,679 7,108 4,902 3,652 5,146 4,454 7,529 6,830 4,112
1976 2,671 7,043 4,924 3,774 5,178 4,672 7,089 7,029 4,280
1981 2,636 6,940 4,918 3,853 5,187 4,854 6,806 7,245 4,381
1986 2,601 6,852 4,906 3,919 5,197 5,012 6,803 7,492 4,560
1991 2,603 6,885 4,983 4,035 5,265 5,150 6,890 7,679 4,718
1992 2,609 6,890 5,002 4,062 5,278 5,175 6,905 7,712 4,746
1993 2,612 6,903 5,014 4,083 5,290 5,193 6,933 7,737 4,768
1994 2,610 6,902 5,025 4,102 5,295 5,223 6,968 7,784 4,798
1995 2,605 6,900 5,029 4,124 5,306 5,257 7,007 7,847 4,827
1996 2,600 6,891 5,036 4,141 5,317 5,293 7,074 7,895 4,842
1997 2,594 6,885 5,037 4,156 5,321 5,334 7,122 7,959 4,876
1998 2,590 6,891 5,043 4,169 5,333 5,377 7,187 8,004 4,901
1999 2,581 6,881 5,047 4,191 5,336 5,419 7,285 8,078 4,936
2000 2,577 6,894 5,058 4,208 5,335 5,460 7,375 8,115 4,975
of which (percentages)
0–4 5.6 5.9 5.9 5.8 6.1 6.0 6.7 5.9 5.5
5–15 14.3 14.7 14.4 14.2 14.6 14.1 13.5 14.1 13.6
16–44 40.0 40.2 40.4 39.8 39.7 39.9 47.3 40.1 38.0
45–64M/59F 21.3 21.1 21.0 21.7 21.4 21.5 18.2 21.4 21.9
65M/60F–74 11.6 10.9 10.9 11.0 11.0 10.9 8.4 10.6 11.8
75 and over 7.2 7.3 7.5 7.5 7.3 7.6 6.0 7.8 9.1
Projections2
2001 2,579 6,871 5,071 4,234 5,343 5,448 7,215 8,134 4,977
2006 2,555 6,843 5,098 4,312 5,358 5,582 7,337 8,344 5,098
2011 2,536 6,820 5,130 4,384 5,372 5,702 7,470 8,534 5,213
2016 2,521 6,813 5,165 4,455 5,391 5,823 7,609 8,722 5,333
2021 2,509 6,808 5,200 4,523 5,411 5,941 7,736 8,905 5,452
of which (percentages)4
0–4 5.4 5.7 5.6 5.4 5.7 5.5 6.4 5.4 4.9
5–15 12.1 12.4 12.2 12.0 12.5 12.1 12.5 12.1 11.2
16–44 35.1 35.4 35.9 35.1 34.9 34.5 41.5 34.9 32.8
45–643 27.7 27.5 27.3 27.4 27.3 27.2 26.3 27.4 27.8
65–743 11.2 10.6 10.6 11.1 10.7 11.2 7.7 10.9 12.4
75 and over 8.4 8.4 8.4 9.0 8.9 9.5 5.6 9.3 10.8
Note: Figures may not add exactly due to rounding.
1 The North West GOR was created on 3 August 1998 from a merger of the former North West and Merseyside GORs.
2 These projections are based on the mid-1996 population estimates and are consistent with the 1996-based national projections produced by the Government Actuary’s Department.
3 Between 2010 and 2020, state retirement age will change from 65 years for men and 60 years for women to 65 years for both sexes.
4 The percentages shown in this table are correct and show the proportion in each age group for 2021. These replace the percentage figures shown in Health Statistics Quarterly numbers 01,
02 and 03, and Population Trends 95 and 96, which were miscalculated.
Government Office Regions of England Numbers (thousands) and percentage age distribution
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Table 1.5 Population: age and sex
United Kingdom
Persons
1971 55,928 899 3,654 8,916 8,144 6,971 6,512 10,202 3,222 4,764 2,159 358 127 14,257 32,548 9,123
1976 56,216 677 3,043 9.176 8.126 7,868 6,361 9,836 3,131 5,112 2,348 390 147 13,797 32,757 9,663
1981 56,357 730 2,726 8,147 9,019 8,010 6,774 9,540 2,935 5,195 2,677 .. .. 12,543 33,780 10,035
1986 56,859 749 2,892 7,161 9,280 8,047 7,719 9,212 3,069 5,020 2,988 .. .. 11,676 34,847 10,336
1991 57,814 794 3,094 7,175 8,247 9,057 7,955 9,500 2,888 5,067 3,139 640 258 11,742 35,469 10,602
1995 58,612 734 3,101 7,528 7,448 9,411 7,931 10,445 2,784 5,127 3,055 721 326 12,107 35,849 10,656
1996 58,807 719 3,044 7,596 7,323 9,423 8,093 10,582 2,772 5,058 3,126 729 341 12,099 36,035 10,673
1997 59,014 736 2,976 7,667 7,230 9,360 8,294 10,697 2,781 5,005 3,176 734 358 12,107 36,213 10,693
1998 59,237 715 2,956 7,709 7,190 9,232 8,505 10,820 2,818 4,965 3,205 742 380 12,110 36,397 10,730
1999 59,501 708 2,916 7,763 7,199 9,064 8,746 10,951 2,861 4,929 3,222 750 393 12,114 36,634 10,753
2000 59,756 686 2,890 7,747 7,247 8,889 9,005 11,083 2,884 4,917 3,237 758 404 12,076 36,890 10,789
Males
1971 27,167 461 1,874 4,576 4,137 3,530 3,271 4,970 1,507 1,999 716 97 29 7,318 17,008 2,841
1976 27,360 348 1,564 4,711 4,145 3,981 3,214 4,820 1,466 2,204 775 101 31 7,083 17.167 3,111
1981 27.412 374 1,400 4,184 4,596 4,035 3,409 4,711 1,376 2,264 922 .. .. 6,439 17,646 3,327
1986 27.698 384 1,483 3,682 4,743 4,063 3,872 4,572 1,463 2,206 1,064 .. .. 5,998 18,264 3,437
1991 28,248 407 1,588 3,688 4,226 4,591 3,987 4,732 1,390 2,272 1,152 167 47 6,033 18,576 3,639
1995 28,731 376 1,588 3,862 3,824 4,796 3,984 5,201 1,358 2,330 1,148 201 63 6,208 18,780 3,742
1996 28,860 369 1,560 3,897 3,759 4,808 4,073 5,270 1,355 2,310 1,186 206 67 6,206 18,884 3,770
1997 28,992 377 1,526 3,933 3,709 4,782 4,181 5,326 1,360 2,298 1,216 211 72 6,210 18,984 3,798
1998 29,128 366 1,516 3,953 3,687 4,721 4,294 5,387 1,380 2,290 1,237 218 79 6,210 19,094 3,824
1999 29,299 363 1,495 3,980 3,694 4,642 4,425 5,454 1,400 2,284 1,255 223 83 6,211 19,243 3,845
2000 29,459 351 1,481 3.973 3,721 4,565 4,563 5,519 1,411 2,287 1,273 228 87 6,192 19,392 3,875
Females
1971 28,761 437 1,779 4,340 4,008 3,441 3,241 5,231 1,715 2,765 1,443 261 97 6,938 15,540 6,282
1976 28,856 330 1,479 4,465 3,980 3,887 3,147 5,015 1,665 2,908 1,573 289 116 6,714 15,590 6,552
1981 28,946 356 1,327 3,963 4,423 3,975 3,365 4,829 1,559 2,931 1,756 .. .. 6,104 16,134 6,708
1986 29,160 364 1,408 3,480 4,538 3,985 3,847 4,639 1,606 2,814 1,924 .. .. 5,678 16,583 6,899
1991 29,566 387 1,505 3,487 4,021 4,466 3,968 4,769 1,498 2,795 1,987 472 210 5,709 16,894 6,963
1995 29,881 358 1,513 3,665 3,624 4,616 3,947 5,244 1,427 2,797 1,907 519 263 5,898 17,068 6,914
1996 29,948 350 1,484 3,699 3,565 4,615 4,020 5,312 1,418 2,748 1,941 523 274 5.893 17,152 6,903
1997 30,022 359 1,450 3,734 3,521 4,579 4,113 5,372 1,421 2,707 1,960 522 286 5,897 17,229 6,896
1998 30,108 349 1,440 3,756 3,503 4,511 4,211 5,433 1,438 2,674 1,968 525 301 5,900 17,302 6,906
1999 30,202 345 1,421 3,783 3,505 4,422 4,321 5,497 1,460 2,645 1,967 527 309 5,903 17,391 6,908
2000 30,297 334 1,409 3,774 3,525 4,334 4,442 5,564 1,473 2,630 1,964 531 317 5,884 17,498 6,914
England and Wales
Persons
1971 49,152 782 3,170 7,705 7,117 6,164 5,736 9,034 2,853 4,228 1,926 323 115 12,334 28,710 8,108
1976 49,459 585 2,642 7,967 7,077 6,979 5,608 8,707 2,777 4,540 2,093 351 135 11,973 28,894 8,593
1981 49,634 634 2,372 7,085 7,873 7,086 5,996 8,433 2,607 4,619 2,388 383 157 10,910 29,796 8,928
1986 50,162 655 2,528 6,243 8,134 7,088 6,863 8,136 2,725 4,470 2,673 465 184 10,190 30,759 9,213
1991 51,100 702 2,728 6,281 7,237 8,008 7,056 8,407 2,553 4,506 2,810 576 233 10,303 31,351 9,446
1995 51,820 649 2,739 6,613 6,521 8,329 7,003 9,272 2,458 4,554 2,734 651 297 10,653 31,676 9,491
1996 52,010 636 2,688 6,683 6,411 8,342 7,146 9,397 2,447 4,490 2,800 658 311 10,655 31,851 9,505
1997 52,211 651 2,632 6,751 6,332 8,290 7,325 9,503 2,456 4,440 2,844 661 327 10,672 32,018 9,522
1998 52,428 633 2,615 6,793 6,303 8,177 7,515 9,613 2,490 4,400 2,871 669 348 10,682 32,192 9,554
1999 52,690 628 2,581 6,847 6,318 8,034 7,734 9,730 2,529 4,367 2,885 676 360 10,694 32,421 9,574
2000 52,943 609 2,559 6,837 6,366 7,896 7,970 9,847 2,551 4,356 2,898 684 371 10,668 32,669 9,607
Males
1971 23,897 402 1,626 3,957 3,615 3,129 2,891 4,414 1,337 1,778 637 86 26 6,334 15,036 2,527
1976 24,089 300 1,358 4,091 3,610 3,532 2,843 4,280 1,304 1,963 690 91 29 6,148 15,169 2,773
1981 24,160 324 1,218 3,639 4,011 3,569 3,024 4,178 1,227 2,020 825 94 32 5,601 15,589 2,970
1986 24,456 336 1,297 3,211 4,156 3,579 3,445 4,053 1,302 1,972 954 115 35 5,236 16,143 3,076
1991 24,995 360 1,401 3,231 3,710 4,065 3,539 4,199 1,234 2,027 1,035 151 43 5,296 16,442 3,257
1995 25,433 333 1,403 3,394 3,348 4,252 3,523 4,626 1,204 2,078 1,032 183 57 5,465 16,619 3,349
1996 25,557 327 1,378 3,430 3,291 4,265 3,602 4,689 1,201 2,059 1,066 188 61 5,466 16,716 3,375
1997 25,684 334 1,350 3,463 3,249 4,243 3,700 4,740 1,206 2,048 1,094 192 66 5,475 16,810 3,399
1998 25,817 324 1,342 3,484 3,233 4,190 3,803 4,795 1,224 2,040 1,113 197 72 5,479 16,915 3,422
1999 25,985 322 1,323 3,511 3,244 4,123 3,923 4,854 1,243 2,034 1,129 202 76 5,484 17,060 3,441
2000 26,142 312 1,311 3,507 3,271 4,059 4,050 4,911 1,253 2,036 1,145 206 80 5,471 17,204 3,468
Females
1971 25,255 380 1,544 3,749 3,502 3,036 2,845 4,620 1,516 2,450 1,289 236 89 6,000 13,673 5,581
1976 25,370 285 1,284 3,876 3,467 3,447 2,765 4,428 1,473 2,577 1,403 261 106 5,826 13,725 5,820
1981 25,474 310 1,154 3,446 3,863 3,517 2,972 4,255 1,380 2,599 1,564 289 126 5,309 14,207 5,958
1986 25,706 319 1,231 3,032 3,978 3,509 3,418 4,083 1,422 2,498 1,718 349 149 4,953 14,616 6,137
1991 26,104 342 1,328 3,050 3,527 3,943 3,517 4,208 1,319 2,479 1,775 425 191 5,007 14,908 6,189
1995 26,387 316 1,335 3,219 3,172 4,076 3,480 4,646 1,254 2,477 1,702 468 240 5,188 15,058 6,141
1996 26,453 310 1,310 3,253 3,120 4,077 3,544 4,709 1,246 2,430 1,733 471 250 5,188 15,134 6,130
1997 26,527 317 1,282 3,287 3,083 4,046 3,625 4,763 1,250 2,392 1,750 470 262 5,196 15,208 6,123
1998 26,611 309 1,274 3,309 3,070 3,987 3,712 4,819 1,266 2,361 1,758 472 276 5,203 15,277 6,132
1999 26,705 306 1,258 3,336 3,074 3,911 3,811 4,876 1,286 2,334 1,756 474 284 5,210 15,361 6,133
2000 26,801 297 1,248 3,300 3,094 3,837 3,920 4,936 1,298 2,320 1,753 477 291 5,197 15,465 6,139
.. Figures not available.
Age group
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Constituent countries of the United Kingdom Numbers (thousands)
National  Stat ist ics    48
Health Statistics Quarterly 14   Summer 2002
England
Persons
1971 46,412 739 2,996 7,272 6,731 5,840 5,421 8,515 2,690 3,976 1,816 306 109 11,648 27,128 7,636
1976 46,660 551 2,491 7,513 6,688 6,599 5,298 8,199 2,616 4,274 1,972 332 127 11,293 27,275 8,092
1981 46,821 598 2,235 6,678 7,440 6,703 5,663 7,948 2,449 4,347 2,249 362 149 10,285 28,133 8,403
1986 47,342 618 2,385 5,885 7,692 6,717 6,484 7,672 2,559 4,199 2,518 438 174 9,608 29,070 8,665
1991 48,208 663 2,574 5,916 6,840 7,599 6,665 7,920 2,399 4,222 2,645 543 220 9,711 29,627 8,870
1995 48,903 615 2,589 6,231 6,158 7,909 6.622 8,738 2,310 4,270 2,568 613 280 10,048 29,946 8,909
1996 49,089 603 2,543 6,298 6,054 7,922 6,761 8,856 2,299 4,210 2,629 620 293 10,053 30,114 8,922
1997 49,284 616 2,490 6,364 5,980 7,873 6,933 8,956 2,308 4,164 2,670 623 308 10,071 30,275 8,939
1998 49,495 599 2,475 6,406 5,954 7,765 7,117 9,060 2,340 4,127 2,694 630 327 10,083 30,443 8,968
1999 49,753 595 2,443 6,459 5,965 7,634 7,329 9,169 2,378 4,098 2,707 637 339 10,097 30,665 8,990
2000 49,997 578 2,422 6,451 6,006 7,506 7,556 9,280 2,398 4,088 2,719 644 349 10,074 30,902 9,021
Males
1971 22,569 380 1,537 3,734 3,421 2,965 2,733 4,161 1,261 1,671 599 107 25 5,982 14,209 2,377
1976 22,728 283 1,280 3,858 3,413 3,339 2,686 4,031 1,228 1,849 649 85 27 5,798 14,320 2,610
1981 22,795 306 1,147 3,430 3,790 3,377 2,856 3,938 1,154 1,902 777 89 30 5,280 14,717 2,798
1986 23,086 317 1.224 3,026 3,931 3,392 3,255 3,822 1,224 1,853 900 109 33 4,937 15,254 2,895
1991 23,588 340 1,322 3,043 3,507 3,859 3,344 3,957 1,159 1,900 975 143 41 4,991 15,539 3,058
1995 24,008 315 1,327 3,198 3,160 4,039 3,333 4,360 1,132 1,948 969 173 54 5,155 15,709 3,144
1996 24,129 309 1,304 3,233 3,106 4,051 3,410 4,420 1,129 1,931 1,002 177 58 5,158 15,803 3,167
1997 24,251 316 1,278 3,265 3,067 4,030 3,504 4,468 1,134 1,921 1,027 181 62 5,168 15,893 3,191
1998 24,378 307 1,270 3,285 3,052 3,978 3,603 4,519 1,151 1,913 1,045 186 68 5,172 15,994 3,212
1999 24,543 305 1,252 3,312 3,061 3,918 3,720 4,575 1,169 1,908 1,060 191 72 5,178 16,134 3,231
2000 24,697 296 1,241 3,310 3,087 3,859 3,842 4,630 1,178 1,911 1,074 195 75 5,167 16,275 3,256
Females
1971 23,843 359 1,459 3,538 3,310 2,875 2,688 4,354 1,429 2,305 1,217 309 85 5,666 12,918 5,259
1976 23,932 269 1,211 3,656 3,275 3,260 2,612 4,168 1,387 2,425 1,323 246 100 5,495 14,968 5,481
1981 24,026 292 1,088 3,248 3,650 3,327 2,807 4,009 1,295 2,445 1,472 273 119 5,004 13,416 5,605
1986 24,257 301 1,161 2,859 3,761 3,325 3,229 3,850 1,335 2,346 1,618 330 141 4,671 13,816 5,770
1991 24,620 324 1,253 2,873 3,333 3,739 3,322 3,964 1,239 2,323 1,670 400 179 4,720 14,088 5,812
1995 24,896 300 1,262 3,033 2,998 3,871 3,289 4,378 1,178 2,322 1,598 441 226 4,893 14,237 5,765
1996 24,960 293 1,239 3,065 2,948 3,872 3,351 4,437 1,170 2,279 1,627 443 235 4,894 14,311 5,755
1997 25,033 300 1,213 3,099 2,913 3,843 3,429 4,488 1,174 2,244 1,643 442 246 4,903 14,382 5,748
1998 25,117 292 1,205 3,120 2,902 3,787 3,514 4,540 1,189 2,214 1,649 444 260 4,911 14,450 5,756
1999 25,210 290 1,191 3,146 2,904 3,716 3,609 4,594 1,209 2,190 1,647 446 267 4,919 14,531 5,760
2000 25,300 282 1,181 3,142 2,919 3,647 3,714 4,651 1,221 2,177 1,644 450 274 4,908 14,627 5,765
Wales
Persons
1971 2,740 43 173 433 386 325 315 519 164 252 110 16 6 686 1,582 472
1976 2,799 33 151 453 388 379 309 509 161 267 121 19 7 680 1,618 501
1981 2,813 36 136 407 434 383 333 485 158 272 139 21 8 626 1,663 525
1986 2,820 37 143 358 441 371 378 464 166 271 155 26 10 582 1,690 548
1991 2,891 39 154 365 397 409 391 486 154 284 165 33 13 592 1,724 576
1995 2,917 35 149 383 363 420 380 534 148 284 166 37 17 605 1,730 581
1996 2,921 34 145 385 357 420 385 541 148 280 171 38 18 602 1,737 582
1997 2,927 35 141 387 352 417 392 547 148 276 174 39 19 601 1,743 583
1998 2,933 34 140 388 349 413 398 553 150 273 177 39 20 599 1,749 585
1999 2,937 33 138 388 353 400 405 561 151 269 178 39 21 597 1,756 584
2000 2,946 31 137 385 360 390 415 567 153 268 179 40 22 593 1,767 586
Males
1971 1,329 22 89 222 194 164 158 253 76 107 38 6 1 352 827 150
1976 1,361 17 78 233 197 193 157 249 75 114 41 5 2 350 849 162
1981 1,365 18 70 209 221 193 168 240 73 118 48 5 2 321 871 173
1986 1,370 19 73 185 225 187 190 231 79 119 54 7 2 300 889 181
1991 1,407 20 79 188 203 206 195 242 74 128 60 8 2 305 904 199
1995 1,425 18 76 196 188 214 190 266 72 130 62 10 4 310 910 206
1996 1,428 17 74 197 185 214 192 269 72 128 65 10 4 308 913 207
1997 1,433 18 72 198 182 214 196 272 72 127 67 11 4 308 917 208
1998 1,439 17 72 199 181 212 199 275 73 126 68 11 4 307 922 210
1999 1,442 17 71 199 183 206 203 279 74 125 69 12 4 306 926 210
2000 1,445 16 70 197 185 200 208 282 75 125 71 12 4 304 929 212
Females
1971 1,412 21 85 211 191 161 157 265 88 146 73 16 4 335 755 322
1976 1,438 16 73 220 191 187 153 260 86 152 80 14 6 330 770 339
1981 1,448 18 66 199 213 190 165 246 85 154 91 16 6 305 791 352
1986 1,450 18 70 173 217 184 188 233 87 152 101 20 8 282 800 367
1991 1,484 19 75 177 194 203 195 244 80 156 105 25 11 288 820 377
1995 1,491 17 73 187 175 206 190 268 76 154 104 27 14 295 820 376
1996 1,493 16 71 188 172 206 193 272 76 151 106 28 15 294 824 375
1997 1,494 17 69 189 170 204 196 275 76 148 107 28 15 293 826 375
1998 1,495 16 68 189 168 201 198 278 76 147 109 28 16 292 827 375
1999 1,495 16 67 189 170 195 202 282 77 144 109 27 17 291 831 374
2000 1,501 15 67 188 175 190 207 285 77 143 109 28 17 290 838 374
Population: age and sex
Age group
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Table 1.5
continued
Population: age and sex
Scotland
Persons
1971 5,236 86 358 912 781 617 612 926 294 430 183 29 9 1,440 2,986 810
1976 5,233 67 291 904 806 692 591 897 282 460 202 31 11 1,352 3,023 858
1981 5,180 69 249 780 875 724 603 880 260 460 232 35 14 1,188 3,110 882
1986 5,123 66 257 657 870 742 665 849 273 435 251 41 15 1,063 3,171 889
1991 5,107 66 259 634 754 809 699 853 265 441 259 50 19 1,023 3,174 910
1995 5,137 61 261 649 677 827 715 911 258 450 250 55 22 1,036 3,187 914
1996 5,128 59 255 647 663 821 728 919 256 446 255 56 23 1,028 3,185 915
1997 5,123 60 247 649 651 809 744 924 255 443 259 56 24 1,021 3,185 917
1998 5,120 58 243 650 643 793 760 932 257 442 260 57 24 1,014 3,186 920
1999 5,119 57 238 651 641 771 776 942 259 440 262 58 25 1,008 3,190 921
2000 5,115 54 234 648 641 747 792 952 259 440 264 58 25 1,001 3,190 924
Males
1971 2,516 44 184 467 394 306 299 440 134 176 60 8 2 738 1,530 247
1976 2,517 34 149 463 408 347 290 429 128 193 65 8 2 693 1,556 269
1981 2,495 35 128 400 445 364 298 424 118 194 77 8 3 610 1,603 282
1986 2,474 34 131 337 445 375 332 410 127 184 86 10 3 545 1,647 283
1991 2,470 34 133 325 385 407 348 415 124 192 91 12 3 524 1,646 299
1995 2,489 31 133 332 346 416 356 446 121 198 90 14 4 530 1,653 307
1996 2,486 30 130 331 339 413 362 450 121 197 92 15 4 526 1,651 309
1997 2,484 31 126 332 333 407 371 453 121 196 95 15 5 522 1,651 311
1998 2,484 30 124 332 329 399 378 457 122 197 96 16 5 519 1,652 314
1999 2,486 29 122 333 327 388 386 462 123 196 98 16 5 516 1,654 315
2000 2,485 28 120 332 327 376 394 467 123 197 99 17 6 512 1,654 318
Females
1971 2,720 42 174 445 387 311 313 485 160 254 122 20 7 701 1,455 563
1976 2,716 32 142 440 398 345 301 468 154 267 137 23 8 659 1,468 589
1981 2,685 33 121 380 430 359 305 456 142 265 155 27 11 579 1,506 600
1986 2,649 32 126 320 425 368 334 439 146 250 165 32 12 518 1,525 606
1991 2,637 32 126 309 369 402 351 437 141 249 168 37 16 499 1,528 611
1995 2,647 30 128 317 331 411 359 465 136 252 160 40 18 506 1,534 607
1996 2,642 29 125 316 324 408 366 469 135 249 163 41 19 502 1,534 606
1997 2,638 29 121 317 318 403 374 471 135 247 164 41 19 498 1,534 605
1998 2,636 28 118 317 315 394 382 475 135 245 164 41 19 495 1,535 606
1999 2,634 28 116 318 314 383 390 480 136 244 165 41 20 492 1,536 606
2000 2,630 26 114 316 314 370 398 485 137 243 165 42 20 488 1,536 606
Northern Ireland
Persons
1971 1,540 31 126 299 247 189 165 243 74 106 51 7 2 483 853 205
1976 1,524 26 111 306 243 198 163 231 73 111 53 8 2 471 840 212
1981 1,543 27 106 282 271 200 175 227 68 116 57 .. .. 444 874 224
1986 1,574 28 107 261 277 217 190 227 71 115 64 .. .. 423 917 234
1991 1,607 26 106 260 256 240 200 241 70 120 69 14 6 417 945 246
1995 1,655 24 102 265 250 255 213 261 69 123 71 15 7 418 985 252
1996 1,669 24 100 266 249 260 218 266 69 123 72 15 7 417 999 253
1997 1,680 25 98 267 247 261 225 270 70 122 73 16 7 415 1,010 255
1998 1,689 24 98 266 244 262 230 275 71 122 74 16 8 414 1,018 257
1999 1,692 23 97 265 241 259 236 279 72 122 75 16 7 411 1,022 258
2000 1,698 22 96 263 240 256 242 283 73 122 75 16 8 408 1,031 259
Males
1971 755 16 64 152 127 95 81 116 36 45 19 2 1 246 441 67
1976 754 13 58 157 127 102 81 111 34 47 19 3 0 242 442 70
1981 757 14 54 145 140 102 87 109 32 50 21 .. .. 228 454 75
1986 768 14 55 134 142 109 95 110 33 50 23 .. .. 217 474 77
1991 783 13 54 133 131 119 100 118 32 53 26 4 1 213 487 83
1995 809 12 52 136 129 127 106 128 32 54 26 4 1 214 509 86
1996 816 12 51 136 128 130 108 131 33 54 27 4 2 213 516 87
1997 823 12 50 137 128 131 111 133 33 54 28 4 2 213 523 87
1998 827 12 50 136 126 132 113 135 34 54 28 4 2 212 527 88
1999 829 12 50 136 124 131 116 137 35 54 28 5 2 211 529 89
2000 832 12 49 135 123 130 119 140 35 54 29 5 2 209 533 89
Females
1971 786 15 62 147 119 95 84 126 39 61 32 5 2 237 411 138
1976 769 13 53 149 116 96 81 120 38 64 33 6 2 229 398 143
1981 786 13 52 137 130 98 88 118 37 66 37 .. .. 216 420 150
1986 805 13 52 127 135 107 96 118 38 65 41 .. .. 206 442 157
1991 824 13 52 127 125 121 100 123 38 67 44 10 4 203 458 163
1995 846 12 50 129 121 128 107 133 36 69 44 11 5 204 476 166
1996 853 11 49 129 121 130 110 135 36 69 45 11 5 203 483 167
1997 857 12 48 130 119 129 114 137 37 68 45 11 6 202 487 168
1998 861 12 48 130 118 129 117 139 37 68 46 12 6 202 491 168
1999 863 11 47 129 117 128 120 141 38 68 46 12 6 201 493 169
2000 866 11 47 128 117 126 124 143 38 68 46 12 6 199 497 170
Age group
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Table 1.6 Population: age, sex and legal marital status
Total Males Females
Mid-year
population
Single Married Divorced Widowed Total Single Married Divorced Widowed Total
Aged
16 and over
1971 36,818 4,173 12,522 187 682 17,563 3,583 12,566 296 2,810 19,255
1976 37,486 4,369 12,511 376 686 17,941 3,597 12,538 533 2,877 19,545
1981 38,724 5,013 12,238 611 698 18,559 4,114 12,284 828 2,939 20,165
1986 39,887 5,673 11,886 919 695 19,173 4,613 11,994 1,164 2,943 20,714
1991 40,796 6,024 11,745 1,200 731 19,699 4,822 11,838 1,459 2,978 21,097
1994 41,003 6,221 11,492 1,413 730 19,855 4,958 11,583 1,684 2,922 21,147
1995 41,167 6,345 11,415 1,480 729 19,968 5,058 11,488 1,754 2,898 21,199
1996 41,356 6,482 11,339 1,543 728 20,091 5,171 11,406 1,819 2,870 21,265
1997 41,540 6,622 11,256 1,604 726 20,209 5,292 11,319 1,882 2,838 21,331
1998 41,746 6,768 11,185 1,659 725 20,338 5,415 11,244 1,940 2,808 21,408
1999 41,996 6,936 11,128 1,716 721 20,501 5,539 11,185 2,001 2,771 21,495
20001 42,275 7,109 11,074 1,770 718 20,672 5,667 11,136 2,063 2,737 21,604
16–19
1971 2,666 1,327 34 0 0 1,362 1,163 142 0 0 1,305
1976 2,901 1,454 28 0 0 1,482 1,289 129 0 0 1,419
1981 3,310 1,675 20 0 0 1,694 1,523 93 0 0 1,616
1986 3,144 1,601 10 0 0 1,611 1,483 49 1 0 1,533
1991 2,680 1,372 8 0 0 1,380 1,267 32 0 0 1,300
1994 2,360 1,212 3 0 0 1,215 1,131 14 0 0 1,145
1995 2,374 1,220 3 0 0 1,222 1,139 13 0 0 1,152
1996 2,436 1,251 2 0 0 1,253 1,171 12 0 0 1,183
1997 2,517 1,291 2 0 0 1,293 1,212 11 0 0 1,224
1998 2,578 1,322 2 0 0 1,324 1,242 11 0 0 1,254
1999 2,595 1,332 2 0 0 1,334 1,250 11 0 0 1,261
2000 2,571 1,322 2 0 0 1,324 1,237 9 0 0 1,246
20–24
1971 3,773 1,211 689 3 0 1,904 745 1,113 9 2 1,869
1976 3,395 1,167 557 4 0 1,728 725 925 16 2 1,667
1981 3,744 1,420 466 10 1 1,896 1,007 811 27 2 1,847
1986 4,203 1,794 322 14 0 2,130 1,382 658 32 1 2,072
1991 3,966 1,764 249 12 0 2,025 1,421 490 29 1 1,941
1994 3,625 1,699 152 7 0 1,858 1,416 330 20 1 1,767
1995 3,495 1,658 127 6 0 1,791 1,404 282 17 0 1,703
1996 3,329 1,597 105 5 0 1,707 1,369 238 15 0 1,622
1997 3,177 1,536 87 4 0 1,628 1,333 204 12 0 1,549
1998 3,084 1,500 76 3 0 1,579 1,314 180 10 0 1,505
1999 3,085 1,511 68 3 0 1,582 1,328 165 9 0 1,503
2000 3,132 1,541 63 2 0 1,606 1,363 154 8 0 1,525
25–29
1971 3,267 431 1,206 16 1 1,654 215 1,367 29 4 1,614
1976 3,758 533 1,326 39 2 1,900 267 1,522 65 5 1,859
1981 3,372 588 1,057 54 1 1,700 331 1,247 89 4 1,671
1986 3,724 841 956 79 1 1,877 527 1,204 113 4 1,847
1991 4,246 1,183 894 85 1 2,163 800 1,158 123 2 2,083
1994 4,168 1,293 754 76 1 2,124 908 1,011 122 2 2,044
1995 4,094 1,326 696 70 1 2,092 936 947 116 2 2,002
1996 4,045 1,368 639 64 1 2,071 977 887 109 2 1,975
1997 3,972 1,401 577 58 1 2,037 1,014 818 101 2 1,935
1998 3,883 1,422 520 51 0 1,994 1,047 750 91 2 1,889
1999 3,774 1,426 469 45 0 1,941 1,062 686 84 2 1,833
20001 3,685 1,429 426 39 0 1,895 1,080 632 75 2 1,790
Note: Population estimates by marital status for 1971 and 1976 are based on the 1971 Census; those for 1981 and 1986 are based on the 1981 Census and have not been rebased using
the 1991 Census.
1. There was an error in the mid-2000 marital status estimates by gender that were published in this table of PT 106. The error was due to the incorrect use of deaths data by gender in
the processing. Total populations including totals by gender and the estimates of the number of single and divorced people are not effected by the error. There is an apparent difference
in single females aged 25–29 but this small and is purely due to rounding of the recompiled estimates by marital status. The figures supplied in this table are now correct.
England and Wales Numbers (thousands)
51   Nat ional  Stat ist ics
Health Statistics Quarterly 14   Summer 2002
England and WalesTable 1.6
continued
Population: age, sex and legal marital status
Total Males Females
Mid-year
population
Single Married Divorced Widowed Total Single Married Divorced Widowed Total
30–34
1971 2,897 206 1,244 23 3 1,475 111 1,269 34 8 1,422
1976 3,220 236 1,338 55 3 1,632 118 1,388 75 8 1,588
1981 3,715 318 1,451 97 3 1,869 165 1,544 129 9 1,846
1986 3,341 356 1,200 125 2 1,683 206 1,292 154 6 1,658
1991 3,762 535 1,206 160 2 1,903 335 1,330 189 5 1,859
1994 4,126 732 1,187 179 2 2,100 467 1,340 213 5 2,025
1995 4,235 799 1,177 182 2 2,160 518 1,333 218 5 2,075
1996 4,296 855 1,155 181 2 2,194 560 1,316 221 5 2,103
1997 4,318 903 1,125 177 3 2,207 598 1,287 222 5 2,111
1998 4,294 938 1,085 171 3 2,196 627 1,247 219 5 2,098
1999 4,260 976 1,041 163 2 2,182 652 1,205 216 5 2,078
20001 4,211 1,016 993 153 2 2,164 675 1,158 209 5 2,047
35–44
1971 5,736 317 2,513 48 13 2,891 201 2,529 66 48 2,845
1976 5,608 286 2,442 104 12 2,843 167 2,427 129 42 2,765
1981 5,996 316 2,519 178 12 3,024 170 2,540 222 41 2,972
1986 6,863 397 2,743 293 12 3,444 213 2,816 350 39 3,419
1991 7,056 482 2,658 388 12 3,539 280 2,760 444 34 3,517
1994 6,925 556 2,463 444 12 3,475 343 2,587 491 29 3,449
1995 7,003 601 2,446 464 12 3,523 374 2,568 509 29 3,480
1996 7,146 657 2,449 483 13 3,602 414 2,575 527 28 3,544
1997 7,325 725 2,458 503 13 3,700 459 2,593 545 28 3,625
1998 7,515 802 2,467 520 14 3,803 510 2,612 563 27 3,712
1999 7,734 890 2,483 537 14 3,923 570 2,634 579 27 3,811
20001 7,970 981 2,503 552 14 4,050 635 2,659 600 27 3,920
45–64
1971 11,887 502 4,995 81 173 5,751 569 4,709 125 733 6,136
1976 11,484 496 4,787 141 160 5,583 462 4,568 188 683 5,901
1981 11,040 480 4,560 218 147 5,405 386 4,358 271 620 5,635
1986 10,860 461 4,423 332 141 5,356 326 4,221 388 569 5,504
1991 10,960 456 4,394 456 127 5,433 292 4,211 521 503 5,527
1994 11,596 489 4,564 587 120 5,759 300 4,422 659 456 5,837
1995 11,730 500 4,581 630 119 5,830 305 4,452 703 440 5,900
1996 11,844 512 4,587 673 118 5,890 310 4,473 746 425 5,954
1997 11,959 524 4,590 715 117 5,946 318 4,494 789 412 6,013
1998 12,103 541 4,604 758 117 6,019 328 4,523 832 401 6,085
1999 12,259 560 4,618 802 117 6,097 340 4,554 875 392 6,162
20001 12,398 579 4,621 846 117 6,164 353 4,577 920 384 6,234
65 and over
1971 6,592 179 1,840 17 492 2,527 580 1,437 32 2,016 4,065
1976 7,119 197 2,033 33 510 2,773 569 1,579 60 2,138 4,347
1981 7,548 216 2,167 54 534 2,971 533 1,692 90 2,263 4,578
1986 7,752 223 2,233 76 539 3,070 475 1,754 127 2,325 4,681
1991 8,127 231 2,337 99 589 3,257 427 1,858 153 2,433 4,870
1994 8,203 239 2,368 121 595 3,323 393 1,879 179 2,429 4,880
1995 8,237 241 2,385 128 595 3,349 382 1,893 190 2,422 4,887
1996 8,259 242 2,401 137 594 3,375 370 1,904 201 2,410 4,884
1997 8,272 242 2,417 147 593 3,399 358 1,912 213 2,390 4,873
1998 8,288 242 2,432 156 592 3,422 347 1,921 225 2,372 4,866
1999 8,288 241 2,446 166 587 3,441 336 1,930 237 2,344 4,847
20001 8,308 240 2,466 177 585 3,468 324 1,948 251 2,318 4,841
England and Wales Numbers (thousands)
See note opposite.
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Table 2.1 Vital statistics summary
United Kingdom
1976 675.5 12.0 61.1 90 406.0 .. 135.4 .. 680.8 12.1 9.79 14.5 6.68 9.9 12.3 18.0
1981 730.7 13.0 91.3 125 397.8 49.4 156.4 11.3 658.0 11.7 8.16 11.2 4.93 6.7 8.79 12.0
1986 754.8 13.3 154.3 204 393.9 43.5 168.2 12.5 660.7 11.6 7.18 9.5 4.00 5.3 7.31 9.6
1991 792.3 13.7 236.1 298 349.7 36.0 173.5 13.0 646.2 11.3 5.82 7.4 3.46 4.4 6.45 8.1
1996 733.2 12.5 260.4 355 317.5 .. 171.7 .. 636.0 10.8 4.50 6.1 3.00 4.1 6.41 8.7
1997 726.6 12.3 267.0 368 310.2 .. 161.1 .. 629.7 10.7 4.25 5.9 2.81 3.9 6.06 8.3
1998 716.9 12.1 269.7 376 304.8 .. 160.1 .. 629.2 10.6 4.08 5.7 2.72 3.8 5.94 8.2
1999 700.0 11.8 271.6 388 301.1 .. 158.7 .. 632.1 10.6 4.05 5.8 2.73 3.9 5.79 8.2
2000 679.0 11.4 268.1 395 305.9p .. 154.6p .. 608.4 10.2 3.79 5.6 2.63 3.9 5.56 8.1
2001 669.3p 11.2p 268.2p 401p .. .. .. .. .. .. .. .. .. .. .. ..
2000 March 168.2 11.3 66.7 397 35.9p .. 39.9p .. 176.8 11.9     0.97 5.7 0.67 4.0 1.43 8.4
June 169.2 11.4 65.1 385 84.7p .. 39.4p .. 142.4 9.6 0.94 5.5 0.64 3.8 1.35 7.9
Sept 173.8 11.6 69.2 398 132.5p .. 37.6p .. 136.1 9.1 0.96 5.5 0.69 4.0 1.43 8.2
Dec 167.8 11.2 67.1 400 52.9p .. 37.4p .. 153.1 10.2 0.93 5.5 0.63 3.7 1.36 8.1
2001 March 164.9p 11.2p 65.9p 400p ..  ..  ..  .. 167.6p 11.4p 0.96p 5.8p 0.63p 3.8p 1.36p 8.2p
June 167.0p 11.2p 65.2p 391p .. .. .. .. 146.3p 9.8p .. .. .. .. .. ..
Sept 171.7p 11.4p 69.2p 403p .. .. .. .. 137.6p 9.1p .. .. .. .. .. ..
Dec 165.8p 11.0p 67.9p 410p .. .. .. .. .. .. .. .. .. .. .. ..
England and Wales
1976 584.3 11.8 53.8 92 358.6 57.7 126.7 10.1 598.5 12.1 8.34 14.3 5.66 9.7 10.5 17.7
1981 634.5 12.8 81.0 128 352.0 49.6 145.7 11.9 577.9 11.6 7.02 11.1 4.23 6.7 7.56 11.8
1986 661.0 13.2 141.3 214 347.9 43.5 153.9 12.9 581.2 11.6 6.31 9.6 3.49 5.3 6.37 9.6
1991 699.2 13.7 211.3 302 306.8 35.6 158.7 13.5 570.0 11.2 5.16 7.4 3.05 4.4 5.65 8.0
1996 649.5 12.5 232.7 358 279.0 30.0 157.1 13.8 560.1 10.8 3.99 6.1 2.68 4.1 5.62 8.6
1997 643.1 12.3 238.2 370 272.5 28.7 146.7 13.0 555.3 10.6 3.80 5.9 2.52 3.9 5.38 8.3
1998 635.9 12.1 240.6 378 267.3 27.7 145.2 12.9 555.0 10.6 3.63 5.7 2.42 3.8 5.26 8.2
1999 621.9 11.8 241.9 389 263.5 26.8 144.6 13.0 556.1 10.6 3.62 5.8 2.44 3.9 5.14 8.2
2000 604.4 11.4 238.6 395 268.0p 26.7p 141.1p 12.7p 535.7 10.1 3.38 5.6 2.34 3.9 4.96 8.2
2001 594.9p 11.2p 238.2p 401p .. .. .. .. 532.5p 10.1p 3.27p 5.5p 2.15p 3.6p 4.76p 8.0p
2000 March 148.7 11.3 59.0 397 31.5p 12.6p 36.5p 13.3p 155.3 11.8 0.85 5.7 0.59 3.9 1.27 8.5
June 150.7 11.4 57.9 385 74.1p 29.7p 35.8p 12.9p 125.2 9.5 0.83 5.5 0.57 3.8 1.20 7.9
Sept 155.0 11.6 61.7 398 116.7p 46.3p 34.4p 12.3p 119.9 9.0 0.86 5.5 0.62 4.0 1.27 8.1
Dec 150.1 11.3 60.1 400 45.6p 18.1p 34.4p 12.3p 135.3 10.2 0.83 5.6 0.56 3.7 1.22 8.1
2001 March 145.5p 11.1p 58.0p 398p 28.7p 11.6p 35.9p 13.1p 147.7p 11.3p 0.83p 5.7p 0.53p 3.7p 1.18p 8.1p
June 148.7p 11.3p 58.1p 391p 70.2p 28.1p 35.7p 12.9p 129.0p 9.8p 0.77p 5.2p 0.51p 3.4p 1.18p 7.9p
Sept 152.9p 11.5p 61.8p 404p .. .. 35.3p 12.6p 121.0p 9.1p 0.83p 5.4p 0.56p 3.6p 1.17p 7.6p
Dec 147.7p 11.1p 60.5p 410p .. .. .. .. 134.8p 10.1p 0.85p 5.7p 0.55p 3.7p 1.22p 8.2p
England
1976 550.4 11.8 50.8 92 339.0 .. .. .. 560.3 12.0 7.83 14.2 5.32 9.7 9.81 17.6
1981 598.2 12.8 76.9 129 332.2 .. .. .. 541.0 11.6 6.50 10.9 3.93 6.6 7.04 11.7
1986 623.6 13.2 133.5 214 328.4 .. 146.0 .. 544.5 11.5 5.92 9.5 3.27 5.2 5.98 9.5
1991 660.8 13.7 198.9 301 290.1 .. 150.1 .. 534.0 11.2 4.86 7.3 2.87 4.3 5.33 8.0
1996 614.2 12.5 218.2 355 264.2 .. 148.7 .. 524.0 10.7 3.74 6.1 2.53 4.1 5.36 8.7
1997 608.2 12.3 223.4 367 258.0 .. 138.7 .. 519.1 10.5 3.60 5.9 2.37 3.9 5.09 8.3
1998 602.1 12.2 225.7 375 253.1 .. 137.4 519.6 10.5 3.39 5.6 2.29 3.8 4.97 8.2
1999 589.5 11.8 226.7 385 249.5 .. 137.1 .. 519.6 10.4 3.38 5.7 2.29 3.9 4.86 8.2
2000 572.8 11.5 223.8 391 253.8p .. 134.0p .. 501.0 10.0 3.18 5.6 2.21 3.9 4.69 8.2
2001 563.8p 11.3p 223.4p 396p .. .. .. .. 497.9p 10.0p 3.06p 5.4p 2.03p 3.6p 4.51p 8.0p
2000 March 140.8 11.3 55.3 393 29.9p .. 34.5p .. 145.4 11.7 0.80 5.7 0.57 3.9 1.20 8.5
June 142.9 11.5 54.5 381 70.3p .. 34.0p 117.0 8.9 0.79 5.5 0.54 3.8 1.14 7.9
Sept 146.8 11.7 57.8 394 110.3p .. 32.7p .. 111.9 8.4 0.80 5.4 0.58 3.9 1.19 8.1
Dec 142.3 11.3 56.3 395 43.4p 32.8p .. 126.6 9.5 0.79 5.6 0.54 3.8 1.16 8.1
2001 March 137.8p 11.2p 54.3p 394p 27.4p .. 34.0p .. 138.1p 11.2p 0.78p 5.6p 0.51p 3.7p 1.11p 8.0p
June 141.1p 11.3p 54.5p 386p 66.4p .. 33.9p .. 120.5p 9.7p 0.73p 5.2p 0.49p 3.4p 1.12p 7.9p
Sept 145.1p 11.5p 58.0p 400p .. .. 33.5p .. 113.2p 9.0p 0.77p 5.4p 0.53p 3.7p 1.11p 7.7p
Dec 139.7p 11.1p 56.5p 404p .. .. .. .. 126.0p 10.0p 0.78p 5.6p 0.51p 3.7p 1.16p 8.3p
Year and All live Live births Marriages Divorces Deaths Infant Neonatal Perinatal
quarter births outside marriage mortality5 mortality6 mortality7
Number Rate1 Number Rate2 Number Rate3 Number Rate4 Number Rate1 Number Rate2 Number Rate3 Number Rate8
Constituent countries of the United Kingdom Numbers (thousands) and rates
Notes: Rates for the most recent quarters will be particularly subject to revision, even
when standard detail is given, as they are based on provisional numbers or on
estimates derived from events registered in the period.
Figures for England and Wales represent the numbers of deaths registered in each
year up to 1992, and the number of deaths occurring in each year from 1993.
Provisional figures are registrations.
From 1972 figures for England and figures for Wales each exclude events for persons usually
resident outside England and Wales. These events are however included in the totals for
England and Wales combined, and for the United Kingdom.
From 1981 births to non-resident mothers in Northern Ireland are excluded from the
figures for Northern Ireland, and for the United Kingdom.
Figures may not add exactly due to rounding.
53   Nat ional  Stat ist ics
Health Statistics Quarterly 14   Summer 2002
Table 2.1
continued
Vital statistics summary
Wales
1976 33.4 11.9 2.9 86 19.5 .. .. .. 36.3 13.0 0.46 13.7 0.32 9.6 0.64 19.0
1981 35.8 12.7 4.0 112 19.8 .. .. .. 35.0 12.4 0.45 12.6 0.29 8.1 0.51 14.1
1986 37.0 13.1 7.8 211 19.5 .. 7.9 .. 34.7 12.3 0.35 9.5 0.21 5.6 0.38 10.3
1991 38.1 13.2 12.3 323 16.6 .. 8.6 .. 34.1 11.8 0.25 6.6 0.16 4.1 0.30 7.9
1996 34.9 11.9 14.4 412 14.8 .. 8.4 .. 34.6 11.8 0.20 5.6 0.13 3.6 0.26 7.5
1997 34.5 11.8 14.8 428 14.6 .. 8.0 .. 34.6 11.8 0.20 5.9 0.13 3.9 0.27 7.9
1998 33.4 11.4 14.8 444 14.2 .. 7.8 .. 34.0 11.6 0.19 5.6 0.12 3.6 0.27 8.0
1999 32.1 10.9 14.8 461 14.0 .. 7.4 .. 35.0 11.9 0.20 6.1 0.13 4.0 0.25 7.7
2000 31.3 10.6 14.8 472 14.1p .. 7.1p .. 33.3 11.3 0.17 5.3 0.11 3.5 0.23 7.2
2001 30.6p 10.4p 14.8p 483p .. .. .. .. 33.2p 11.3p 0.17p 5.5p 0.11p 3.4p 0.23P 7.5p
2000 March 7.8 10.7 3.7 470 1.6p .. 1.9p .. 9.6 13.1 0.04 5.6 0.03 3.8 0.06 8.0
June 7.7 10.5 3.5 452 3.9p .. 1.8p .. 7.9 10.8 0.04 4.9 0.03 3.3 0.05 6.9
Sept 8.1 10.9 3.9 478 6.4p .. 1.7p .. 7.5 10.1 0.05 6.2 0.04 4.3 0.06 7.8
Dec 7.7 10.4 3.8 486 2.2p .. 1.7p 8.3 11.2 0.03 4.3 0.02 2.6 0.05 6.3
2001 March 7.7p 10.6p 3.7p 477p 1.4p .. 1.9p .. 9.3p 12.7p 0.05p 5.8p 0.03p 3.4p 0.06p 7.9p
June 7.5p 10.2p 3.6p 473p 3.7p .. 1.8p .. 8.1p 11.1p 0.04p 4.9p 0.03p 3.3p 0.06p 7.8p
Sept 7.7p 10.4p 3.7p 481p .. .. 1.8p .. 7.4p 10.0p 0.04p 5.3p 0.02p 3.0p 0.05p 6.6p
Dec 7.7p 10.4p 3.9p 501p .. .. .. .. 8.4p 11.3p 0.05p 6.0p 0.03p 4.0p 0.06p 7.8p
Scotland
1976 64.9 12.5 6.0 93 37.5 53.8 8.1 6.5 65.3 12.5 0.96 14.8 0.67 10.3 1.20 18.3
1981 69.1 13.4 8.5 122 36.2 47.5 9.9 8.0 63.8 12.3 0.78 11.3 0.47 6.9 0.81 11.6
1986 65.8 12.9 13.6 206 35.8 42.8 12.8 10.7 63.5 12.4 0.58 8.8 0.34 5.2 0.67 10.2
1991 67.0 13.1 19.5 291 33.8 38.7 12.4 10.6 61.0 12.0 0.47 7.1 0.29 4.6 0.58 8.6
1996 59.3 11.6 21.4 360 30.2 32.8 12.3 10.9 60.7 11.8 0.37 6.2 0.23 3.9 0.55 9.2
1997 59.4 11.6 22.4 377 29.6 31.7 12.2 11.0 59.5 11.6 0.32 5.3 0.19 3.2 0.47 7.8
1998 57.3 11.2 22.3 389 29.7 31.2 12.4 11.2 59.2 11.6 0.32 5.5 0.20 3.5 0.49 8.5
1999 55.1 10.8 22.7 412 29.9 31.1 11.9 10.8 60.3 11.8 0.28 5.0 0.18 3.3 0.42 7.6
2000 53.1 10.4 22.6 426 30.4 29.5 11.1p 10.3p 57.8 11.3 0.31 5.7 0.21 4.0 0.45 8.4
2001 52.5p 10.3p 22.8p 433p .. .. .. .. 57.4p 11.2p 0.29p 5.5p 0.20p 3.8p 0.45p 8.5p
2000 March 13.7 10.8 5.9 433 3.6 14.0 2.9 10.7 17.2 13.5 0.09 6.3 0.06 4.2 0.11 8.1
June 13.2 10.4 5.5 418 8.4 32.8 3.0 11.0 13.7 10.7 0.07 5.5 0.05 3.8 0.11 8.5
Sept 13.4 10.4 5.7 427 12.4 47.9 2.7 9.9 12.9 10.1 0.08 5.7 0.06 4.1 0.12 8.8
Dec 12.8 10.0 5.5 427 6.0 23.2 2.6 9.7 14.0 10.9 0.07 5.4 0.05 3.8 0.11 8.2
2001 March 13.5p 10.7p 6.0p 445p 3.4p 13.6p 2.6p 9.9p 15.8p 12.5p 0.09p 6.4p 0.06p 4.5p 0.13p 9.6p
June 12.9p 10.1p 5.4p 422p 8.2p 32.7p 2.7p 9.9p 13.8p 10.8p 0.07p 5.7p 0.06p 4.6p 0.11p 8.8p
Sept 13.2p 10.2p 5.6p 427p 11.9p 46.5p 2.6p 9.4p 13.3p 10.3p 0.07p 4.9p 0.04p 3.3p 0.10p 7.3p
Dec 12.9p 10.0p 5.7p 439p 6.1p 24.0p 2.7p 10.0p 14.6p 11.3p 0.06p 4.8p 0.03p 2.6p 0.11p 8.1p
Northern Ireland
1976 26.4 17.3 1.3 50 9.9 .. 0.6 .. 17.0 11.2 0.48 18.3 0.35 13.3 0.59 22.3
1981 27.2 17.0 1.9 69 9.6 45.4 1.4 4.2 16.3 10.6 0.36 13.2 0.23 8.3 0.42 15.3
1986 28.0 17.8 3.6 127 10.2 .. 1.5 .. 16.1 10.3 0.36 13.2 0.23 8.3 0.42 15.3
1991 26.0 16.2 5.3 203 9.2 37.7 2.3 6.8 15.1 9.4 0.19 7.4 0.12 4.6 0.22 8.4
1996 24.4 14.6 6.3 260 8.3 .. 2.3 .. 15.2 9.1 0.14 5.8 0.09 3.7 0.23 9.4
1997 24.1 14.3 6.4 266 8.1 .. 2.2 .. 15.0 9.0 0.14 5.6 0.10 4.2 0.21 8.6
1998 23.7 14.0 6.7 284 7.8 .. 2.5 .. 15.0 8.9 0.13 5.6 0.09 3.9 0.20 8.1
1999 23.0 13.6 7.0 303 7.6 .. 2.3 .. 15.7 9.3 0.15 6.4 0.11 4.8 0.23 10.0
2000 21.5 12.7 6.8 318 7.6 .. 2.4 .. 14.9 8.8 0.11 5.1 0.82 3.8 0.15 7.3
2001 22.0p 12.9p 7.1p 326p .. .. .. .. .. .. .. .. .. .. .. ..
2000 March 5.8 13.7 1.8 319 0.8 .. 0.6 .. 4.3 10.2 0.03 4.5 0.02 3.8 0.04 7.6
June 5.3 12.6 1.6 308 2.1 .. 0.7 .. 3.5 8.3 0.03 5.3 0.02 4.1 0.04 7.3
Sept 5.5 12.7 1.8 326 3.4 .. 0.5 .. 3.3 7.7 0.03 5.3 0.02 3.9 0.04 7.5
Dec 5.0 11.6 1.6 316 1.3 .. 0.5 .. 3.8 8.9 0.03 5.2 0.02 3.4 0.03 6.6
2001 March 5.8p 13.8p 1.9p 332p .. .. .. .. 4.1p 9.8p 0.05p 7.9p 0.03p 5.7p 0.06p 9.4p
June 5.3p 12.6p 1.7p 312p .. .. .. .. 3.6p 8.4p .. .. .. .. .. ..
Sept 5.6p 13.0p 1.8p 317p .. .. .. .. 3.3p 7.8p .. .. .. .. .. ..
Dec 5.3p 12.3p 1.8p 341p .. .. .. .. .. .. .. .. .. .. .. ..
Year and All live Live births Marriages Divorces Deaths Infant Neonatal Perinatal
quarter births outside marriage mortality5 mortality6 mortality7
Number Rate1 Number Rate2 Number Rate3 Number Rate4 Number Rate1 Number Rate2 Number Rate3 Number Rate8
1 Per 1,000 population of all ages.
2 Per 1,000 live births.
3 Persons marrying per 1,000 unmarried population 16 and over.
4 Persons divorcing per 1,000 married population.
5 Deaths under 1 year.
6 Deaths under 4 weeks.
7 Stillbirths and deaths under 1 week. In October 1992 the legal definition of a stillbirth
was changed, from baby born dead after 28 completed weeks of gestation or more, to
one born dead after 24 completed weeks of gestation or more.
8 Per 1,000 live births and stillbirths.
p Provisional.
.. Figures not available.
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  Dependency ratio Live births    Expectation of
 life (in years)
at birth
Population Live births Deaths Children1 Elderly2 TFR3 Outside Mean age Age- Males Females Infant
marriage as of mother standardised mortality
percentage at birth mortality rate5
of total (years) rate4
live births
United Kingdom
1976 56,216.1 675.5 680.8 42.1 29.5 1.74 9.0 26.4 10,486 69.6 75.2 14.5
1981 56,357.5 730.7 658.0 37.1 29.7 1.82 12.5 26.8 9,506 70.8 76.8 11.2
1986 56,858.5 754.8 660.7 33.5 29.6 1.78 21.4 27.0 8,897 71.9 77.7 9.5
1991 57,813.8 792.3 646.2 33.1 29.9 1.81 29.8 27.7 8,107 73.2 78.8 7.4
1996 58,807.2 733.2 636.0 33.8 29.8 1.72 35.5 28.6 7,522 74.3 79.5 6.1
1997 59,014.0 726.6 629.7 33.8 29.7 1.72 36.8 28.8 7,370 74.6 79.6 5.9
1998 59,237.0 716.9 629.2 33.6 29.6 1.71 37.6 28.9 7,290 74.8 79.8 5.7
1999 59,500.9 700.0 632.1 33.4 29.5 1.69 38.8 28.9 7,255 75.1p 80.0p 5.8
2000 59,755.7 679.0 610.6p .. .. 1.64 39.5 29.1 6,913 .. .. 5.6
2001 .. 669.3p .. .. .. .. 40.1p .. .. .. .. ..
England
1976 46,659.9 550.4 560.3 41.4 29.7 1.70 9.2 26.4 10,271 .. 14.2 ..
1981 46,820.8 598.2 541.0 36.4 29.9 1.79 12.9 26.8 9,298 71.1 77.0 10.9
1986 47,342.4 623.6 544.5 33.1 29.8 1.87 21.4 27.0 8,694 72.2 77.9 9.5
1991 48,208.1 660.8 534.0 32.8 29.9 1.81 30.1 27.7 7,941 73.4 79.0 7.3
1996 49,089.1 614.2 524.0 33.6 29.8 1.73 35.5 28.7 7,333 74.6 79.7 6.1
1997 49,284.2 608.2 519.1 33.6 29.8 1.72 36.7 28.8 7,190 74.9 79.9 5.9
1998 49,494.6 602.1 519.6 33.4 29.6 1.72 37.5 29.0 7,128 75.1 80.0 5.6
1999 49,752.9 589.5 519.6 33.3 29.5 1.69 38.5 29.0 7,062 75.4p 80.2p 5.7
2000 49,997.1 572.8 503.0p .. .. 1.65 39.1 29.2 6,738 .. .. 5.6
2001 .. 563.8 .. .. .. .. 39.6p .. 6,668 p .. .. 5.4p
Wales
1976 2,799.3 33.4 36.3 42.0 30.9 1.78 8.7 26.0 10,858 .. .. 13.7
1981 2,813.5 35.8 35.0 37.6 31.6 1.86 11.2 26.6 9,846 70.4 76.4 12.6
1986 2,819.6 37.0 34.7 34.4 32.5 1.86 21.1 26.5 9,012 71.6 77.6 9.5
1991 2,891.5 38.1 34.1 34.4 33.4 1.89 32.3 27.0 8,074 73.2 78.9 6.6
1996 2,921.1 34.9 34.6 35.1 33.6 1.82 41.2 27.8 7,664 74.0 79.2 5.6
1997 2,926.9 34.5 34.6 35.0 33.6 1.82 42.8 28.0 7,578 74.4 79.4 5.9
1998 2,933.3 33.4 34.0 34.7 33.5 1.79 44.4 28.0 7,366 74.5 79.5 5.6
1999 2,937.0 32.1 35.0 34.5 33.5 1.74 46.1 28.1 7,532 74.8p 79.7p 6.1
2000 2,946.2 31.3 33.5p .. .. 1.70 47.2 28.2 7,071 .. .. 5.3
2001 .. 30.6p .. .. .. .. 48.3p .. 7,040 p .. .. 5.5p
Scotland
1976 5,233.4 64.9 65.3 44.7 28.4 1.80 9.3 26.0 11,675 68.2 74.4 14.8
1981 5,180.2 69.1 63.8 38.2 28.4 1.84 12.2 26.3 10,849 69.1 75.3 11.3
1986 5,123.0 65.8 63.5 33.5 28.0 1.67 20.6 26.6 10,135 70.2 76.2 8.8
1991 5,107.0 67.0 61.0 32.2 28.7 1.69 29.1 27.4 9,254 71.4 77.1 7.1
1996 5,128.0 59.3 60.7 32.6 28.6 1.55 36.0 28.5 8,868 72.2 77.8 6.2
1997 5,122.5 59.4 59.5 32.5 28.7 1.58 37.7 28.6 8,623 72.4 77.9 5.3
1998 5,120.0 57.3 59.2 32.3 28.7 1.55 39.0 28.8 8,533 72.6 78.1 5.5
1999 5,119.2 55.1 60.3 32.0 28.8 1.51 41.2 28.9 8,618 72.8p 78.2p 5.0
2000 5,114.6 53.1 57.8p .. .. 1.47 42.6 29.0 8,217 .. .. 5.7
2001 .. 52.5p .. .. .. .. 43.3p .. 8,153 p .. .. 5.5p
Northern Ireland6
1976 1,523.5 26.4 17.0 56.1 25.3 2.70 5.0 27.4 11,746 67.5 73.8 18.3
1981 1,543.0 27.2 16.3 50.6 25.3 2.59 7.0 27.5 10,567 69.2 75.5 13.2
1986 1,573.5 28.0 16.1 46.5 24.7 2.44 12.8 27.5 10,071 70.9 77.1 10.2
1991 1,607.3 26.0 15.1 44.0 25.6 2.16 20.3 28.0 8,564 72.6 78.4 7.4
1996 1,669.1 24.4 15.2 42.9 25.2 1.95 26.0 28.8 8,057 73.8 79.2 5.8
1997 1,680.3 24.1 15.0 42.3 25.1 1.92 26.7 29.0 7,810 74.2 79.5 5.6
1998 1,688.6 23.7 15.0 41.6 24.9 1.89 28.5 29.0 7,438 74.3 79.5 5.6
1999 1,691.8 23.0 15.7 40.8 25.0 1.85 30.3 29.0 7,672 74.5p 79.6p 6.4
2000 1,697.8 21.5 14.9p .. .. 1.74 31.8 29.2 7,242 .. .. 5.1
2001 .. 22.0p .. .. .. .. 32.6p .. .. .. .. ..
Key demographic and health indicators
Notes: Some of these indicators are also in other tables. They are brought together to make
comparison easier.
Figures for England and Wales represent the number of deaths registered in each year
up to 1992, and the number of deaths occurring in each year from 1993.
From 1981 births to non residents mothers in Northern Ireland are excluded from
the figures for Northern Ireland, and the United Kingdom.
1 Percentage of children under 16 to working population (males 16–64 and females 16–59).
2 Percentage of males 65 and over and females 60 and over to working population (males
16–64 and females 16–59).
3 TFR (total fertility rate) is the number of children that would be born to a woman if
current patterns of fertility persisted throughout her childbearing life. It is sometimes
called the TPFR (total period fertility rate).
4 Per million population. The age-standardised mortality rate makes allowances for changes
in the age structure of the population. See Notes to tables.
5 Deaths under one year per 1,000 live births.
6 Northern Ireland data have been revised to take account of changed Northern Ireland
population estimates from 1981.
p Provisional.
. . Figures not available.
Table 2.2
Constituent countries of the United Kingdom Numbers (thousands), rates, percentages, mean age
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Live births: age of mother
  Age of mother at birth  Age of mother at birth Mean TFR1
age
Year and All Under 20–24 25–29 30–34 35–39 40 and All Under 20–24 25–29 30–34 35–39 40 and
(years)
quarter ages 20 over ages 20 over
Total live births (numbers)   Age-specific fertility rates2
1961 811.3 59.8 249.8 248.5 152.3 77.5 23.3 89.2 37.3 172.6 176.9 103.1 48.1 15.0 27.6 2.77
1964(max)1 876.0 76.7 276.1 270.7 153.5 75.4 23.6 92.9 42.5 181.6 187.3 107.7 49.8 13.7 27.2 2.93
1966 849.8 86.7 285.8 253.7 136.4 67.0 20.1 90.5 47.7 176.0 174.0 97.3 45.3 12.5 26.8 2.75
1971 783.2 82.6 285.7 247.2 109.6 45.2 12.7 83.5 50.6 152.9 153.2 77.1 32.8 8.7 26.2 2.37
1976 584.3 57.9 182.2 220.7 90.8 26.1 6.5 60.4 32.2 109.3 118.7 57.2 18.6 4.8 26.4 1.71
1977(min)1 569.3 54.5 174.5 207.9 100.8 25.5 6.0 58.1 29.4 103.7 117.5 58.6 18.2 4.4 26.5 1.66
1981 634.5 56.6 194.5 215.8 126.6 34.2 6.9 61.3 28.1 105.3 129.1 68.6 21.7 4.9 26.8 1.80
1986 661.0 57.4 192.1 229.0 129.5 45.5 7.6 60.6 30.1 92.7 124.0 78.1 24.6 4.8 27.0 1.77
1991 699.2 52.4 173.4 248.7 161.3 53.6 9.8 63.6 33.0 89.3 119.4 86.7 32.1 5.3 27.7 1.82
1992 689.7 47.9 163.3 244.8 166.8 56.7 10.2 63.5 31.7 86.2 117.3 87.2 33.4 5.8 27.9 1.80
1993 673.5 45.1 152.0 236.0 171.1 58.8 10.5 62.6 31.0 82.7 114.1 87.0 34.1 6.2 28.1 1.76
1994 664.7 42.0 140.2 229.1 179.6 63.1 10.7 61.9 29.0 79.4 112.1 88.7 35.8 6.4 28.4 1.75
1995 648.1 41.9 130.7 217.4 181.2 65.5 11.3 60.4 28.5 76.8 108.6 87.3 36.2 6.8 28.5 1.72
1996 649.5 44.7 125.7 211.1 186.4 69.5 12.1 60.5 29.8 77.5 106.9 88.6 37.2 7.2 28.6 1.73
1997 643.1 46.4 118.6 202.8 187.5 74.9 12.9 59.8 30.2 76.6 104.8 88.8 38.9 7.6 28.8 1.73
1998 635.9 48.3 113.5 193.1 188.5 78.9 13.6 59.0 30.9 75.5 102.2 89.9 39.8 7.8 28.9 1.72
1999 621.9 48.4 110.7 181.9 185.3 81.3 14.3 57.6 30.8 73.7 99.2 89.2 39.8 8.1 29.0 1.70
2000 604.4 45.8 107.7 170.7 180.1 85.0 15.1 55.7 29.2 70.6 95.4 88.0 40.5 8.3 29.1 1.66
2001p 594.9 44.2 108.9 160.0 179.0 86.5 16.3 54.6 27.5 69.1 94.3 88.8 40.8 8.3 29.2 ..
1997 March 158.1 11.5 29.8 50.4 45.7 17.7 3.1 59.6 31 77 105 88 38 7 28.7 1.70
June 163.3 11.3 29.5 51.6 48.4 19.2 3.3 60.9 30 76 107 92 40 8 28.9 1.75
Sept 164.9 11.8 30.3 52.1 48.1 19.3 3.3 60.8 30 78 107 90 40 8 28.8 1.78
Dec 156.8 11.8 29.0 48.7 45.4 18.7 3.2 57.8 30 75 101 86 38 7 28.8 1.70
1998 March 155.8 11.7 27.8 47.9 46.2 18.8 3.3 58.7 31 74 102 89 39 8 28.9 1.68
June 158.6 11.4 27.5 48.6 48.1 19.7 3.3 59.1 29 73 103 92 40 8 29.0 1.71
Sept 166.1 12.7 29.8 50.6 48.9 20.7 3.6 61.2 32 79 107 93 41 8 28.9 1.81
Dec 155.4 12.4 28.5 46.1 45.4 19.6 3.4 57.3 31 75 98 86 39 8 28.9 1.70
1999 March 152.1 12.0 27.1 45.0 45.1 19.6 3.4 57.1 31 73 99 88 39 8 28.9 1.69
June 157.3 11.8 27.2 46.2 48.0 20.5 3.6 58.4 30 73 101 92 40 8 29.1 1.72
Sept 160.1 12.5 28.7 46.8 47.5 20.9 3.7 58.8 32 75 102 91 41 8 29.0 1.74
Dec 152.4 12.0 27.8 43.9 44.8 20.3 3.6 56.0 30 72 96 86 39 8 29.0 1.66
2000 March 148.7 11.4 26.4 42.5 44.1 20.6 3.6 55.1 29 70 96 87 40 8 29.1 1.64
June 150.7 11.1 26.0 42.8 45.7 21.4 3.7 55.9 29 69 96 90 41 8 29.2 1.66
Sept 154.9 11.8 27.8 43.6 46.2 21.7 3.9 56.8 30 73 97 90 41 8 29.1 1.69
Dec 150.1 11.5 27.5 41.8 44.1 21.4 3.9 55.0 29 72 93 86 41 9 29.1 1.64
2001 Marchp 144.5 11.0 26.5 39.8 42.3 21.0 4.0 54.4 28 69 94 87 40 9 29.2 1.63
Junep 148.7 10.8 26.4 40.3 45.5 21.7 4.0 54.8 27 67 95 90 41 9 29.3 1.65
Septp 152.9 11.4 28.1 40.9 46.4 22.0 4.1 56.3 28 71 97 93 42 9 29.2 1.70
Decp 147.7 11.1 27.9 38.9 43.8 21.8 4.2 53.8 27 69 93 87 41 9 29.2 1.63
Note: The rates for women of all ages, under 20, and 40 and over are based upon the populations of women aged 15–44, 15–19, and 40–44 respectively.
1 TFR (total fertility rate) is the number of children that would be born to a woman if current patterns of fertility persisted throughout her childbearing life. It is sometimes called the TPFR
(total period fertility rate). During the post Second World War period the TFR reached a maximum in 1964 and a minimum in 1977.
2 Births per 1,000 women in the age-group; all quarterly age-specific fertility rates are adjusted for days in the quarter. They are not adjusted for seasonality, and therefore have been revised
from those previously published.
p Provisional.
Table 3.1
England and Wales Numbers (thousands), rates, mean age and TFRs
National  Stat ist ics    56
Health Statistics Quarterly 14   Summer 2002
  Age of mother at birth Age of mother at birth Registration1
Year and All Under 20–24 25–29 30–34 35–39 40 and Mean All Under 20–24 25–29 30–34 35–39 40 and Joint Sole
quarter ages 20 over age ages 20 over
(years) Same Different
address2 address2
Live births outside marriage (numbers) Percentage of total live births   As a percentage of all
in age-group births outside marriage
1971 65.7 21.6 22.0 11.5 6.2 3.2 1.1 23.7 8.4 26.1 7.7 4.7 5.7 7.0 9.0 45.5 54.5
1976 53.8 19.8 16.6 9.7 4.7 2.3 0.7 23.3 9.2 34.2 9.1 4.4 5.2 8.6 10.1 51.0 49.0
1981 81.0 26.4 28.8 14.3 7.9 1.3 0.9 23.4 12.8 46.7 14.8 6.6 6.2 3.9 12.5 58.2 41.8
1986 141.3 39.6 54.1 27.7 13.1 5.7 1.1 23.8 21.4 69.0 28.2 12.1 10.1 12.6 14.7 46.6 19.6 33.8
1991 211.3 43.4 77.8 52.4 25.7 9.8 2.1 24.8 30.2 82.9 44.9 21.1 16.0 18.3 21.3 54.6 19.8 25.6
1992 215.2 40.1 77.1 55.9 28.9 10.9 2.3 25.2 31.2 83.7 47.2 22.8 17.3 19.3 22.9 55.4 20.7 23.9
1993 216.5 38.2 75.0 57.5 31.4 11.9 2.5 25.4 32.2 84.8 49.4 24.4 18.4 20.2 23.5 54.8 22.0 23.2
1994 215.5 35.9 71.0 58.5 34.0 13.4 2.7 25.8 32.4 85.5 50.6 25.5 18.9 21.2 25.2 57.5 19.8 22.7
1995 219.9 36.3 69.7 59.6 37.0 14.4 3.0 26.0 33.9 86.6 53.3 27.4 20.4 22.0 26.2 58.1 20.1 21.8
1996 232.7 39.3 71.1 62.3 40.5 16.2 3.2 26.1 35.8 88.0 56.5 29.5 21.7 23.4 26.7 58.1 19.9 21.9
1997 238.2 41.1 69.5 63.4 42.2 18.2 3.7 26.2 37.0 88.7 58.6 31.3 22.5 25.0 28.6 59.5 19.3 21.2
1998 240.6 43.0 67.8 62.4 43.9 19.6 3.9 26.3 37.8 89.1 59.7 32.3 23.3 24.8 29.0 60.9 18.3 20.8
1999 241.9 43.0 67.5 61.2 45.0 20.8 4.3 26.4 38.9 89.0 61.0 33.6 24.3 25.6 30.2 61.8 18.2 19.9
2000 238.6 41.1 67.5 59.1 43.9 22.3 4.7 26.5 39.5 89.7 62.6 34.6 24.4 26.2 31.0 62.7 18.2 19.2
2001 238.2 39.6 68.1 56.8 45.3 23.3 5.1 26.7 40.0 89.5 62.6 35.5 25.3 26.9 31.6 63.2 18.4 18.4
1997 March 58.5 10.2 17.4 15.7 10.2 4.2 0.9 26.1 37.0 88.7 58.4 31.0 22.4 23.9 28.7 58.4 19.5 22.1
 June  58.9 10.1 17.1 15.5 10.6 4.7 0.9 26.3 36.1 89.1 58.0 30.1 22.0 24.3 28.4 59.6 19.4 21.0
 Sept 61.4 10.5 17.9 16.5 10.9 4.7 0.9 26.2 37.3 88.8 58.9 31.8 22.7 24.4 27.8 59.9 18.9 21.2
 Dec 59.3 10.4 17.2 15.7 10.4 4.6 0.9 26.2 37.8 88.3 59.2 32.2 23.0 24.8 29.3 60.0 19.2 20.7
1998 March 58.5 10.4 16.5 15.3 10.7 4.6 1.0 26.3 37.5 89.0 59.5 31.9 23.1 24.4 29.6 60.5 18.4 21.1
 June 58.4 10.3 16.2 15.4 10.8 4.7 0.9 26.4 36.8 89.6 59.1 31.8 22.5 24.0 28.3 61.0 18.2 20.8
 Sept 63.2 11.3 17.9 16.3 11.5 5.2 1.0 26.3 38.1 89.2 60.0 32.3 23.6 25.2 28.5 60.9 18.4 20.7
 Dec 60.5 11.0 17.2 15.4 10.9 5.0 1.0 26.3 38.9 88.5 60.4 33.3 24.0 25.6 29.6 61.2 18.4 20.4
1999 March 59.0 10.8 16.4 15.0 10.9 5.0 1.0 26.3 38.8 89.7 60.5 33.4 24.1 25.4 29.5 61.4 18.2 20.4
June 59.8 10.5 16.5 15.3 11.2 5.2 1.1 26.5 38.0 89.2 60.6 33.0 23.4 25.3 31.3 61.6 18.2 20.1
Sept 62.9 11.1 17.7 16.0 11.7 5.4 1.1 26.4 39.3 88.7 61.7 34.1 24.7 25.6 29.3 62.2 18.1 19.6
Dec 60.2 10.6 17.0 14.9 11.1 5.3 1.1 26.4 39.5 88.4 61.2 34.0 24.8 26.2 30.8 62.0 18.4 19.5
2000 March 59.0 10.2 16.5 14.8 10.9 5.4 1.2 26.5 39.7 89.7 62.6 34.8 24.7 26.1 31.7 62.5 18.1 19.5
June 57.9 10.0 16.1 14.4 10.9 5.5 1.1 26.6 38.5 89.7 61.9 33.5 23.8 25.7 30.6 62.9 17.8 19.2
Sept 61.7 10.6 17.6 15.3 11.3 5.7 1.2 26.5 39.8 89.7 63.3 35.0 24.5 26.5 30.4 62.7 18.1 19.2
Dec 60.1 10.3 17.3 14.7 10.9 5.7 1.2 26.5 40.0 89.5 62.8 35.2 24.7 26.6 31.4 62.6 18.6 18.8
2001 Marchp 58.0 9.9 16.7 13.9 10.7 5.7 1.1 26.5 39.8 90.3 63.0 34.9 24.8 26.9 28.0 62.5 18.7 18.8
Junep 58.1 9.6 16.3 14.1 11.2 5.7 1.3 26.7 39.1 89.0 61.5 34.9 24.5 26.4 32.2 63.3 18.5 18.5
Septp 61.8 10.2 17.6 14.7 12.0 6.0 1.3 25.0 40.4 89.5 62.6 35.9 25.8 27.2 32.2 63.5 18.4 18.1
Decp 60.4 9.9 17.6 14.2 11.4 5.9 1.4 26.7 40.9 89.1 63.1 36.4 26.0 27.2 33.9 63.3 18.6 18.1
1 Births outside marriage can be registered by both the mother and father (joint) or by the mother alone (sole).
2 Usual address(es) of parents.
p Provisional.
Table 3.2 Live births outside marriage: age of mother and type of registration
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England and Wales (residents)Table 4.1 Conceptions: age of woman at conception
Age of woman at conception
Year and quarter All ages Under 16 Under 18 Under 20 20–24 25–29 30–34 35–39 40 and over
(a) numbers (thousands)
1991 853.7 7.5 40.1 101.6 233.3 281.5 167.5 57.6 12.1
1993 819.0 7.3 35.8 87.2 203.6 271.7 181.0 63.0 12.6
1994 801.6 7.8 36.1 85.4 190.4 261.8 185.0 66.2 12.9
1995 790.3 8.1 37.9 86.6 181.1 250.3 190.3 68.7 13.2
1996 816.9 8.9 43.5 94.9 179.8 252.6 200.0 75.5 14.1
1997 800.4 8.3 43.4 96.0 167.3 242.6 200.9 78.9 14.7
1998 797.0 8.5 44.1 101.6 163.3 232.4 201.4 82.9 15.4
1999 774.0 7.9 42.0 98.8 157.6 218.5 197.1 86.0 16.0
2000p 766.4 8.1 41.3 97.6 158.8 209.2 195.2 88.6 17.0
1999 March 191.5 1.9 10.4 24.9 39.6 54.3 48.4 20.6 3.8
June 190.4 2.0 10.5 24.4 39.1 53.8 47.9 21.2 4.1
Sept 194.0 2.0 10.4 24.1 38.4 54.7 50.7 22.1 4.1
Dec 198.0 2.1 10.8 25.4 40.5 55.6 50.2 22.2 4.1
2000 Marchp 193.1 2.0 10.5 25.1 40.4 53.2 48.3 21.9 4.2
Junep 188.7 2.1 10.4 24.3 39.3 51.5 47.5 21.8 4.3
Septp 190.0 2.1 10.0 23.5 38.4 52.0 49.7 22.2 4.2
Decp 194.7 2.0 10.4 24.7 40.8 52.6 49.7 22.7 4.3
2001 Marchp 189.0 1.9 10.2 24.3 40.4 49.9 47.7 22.3 4.4
(b) rates (conceptions per thousand women in age-group)
1991 77.7 8.9 44.6 64.1 120.2 135.1 90.1 34.4 6.6
1993 76.1 8.1 42.5 59.9 110.8 131.4 92.0 36.5 7.4
1994 74.7 8.3 42.0 58.9 107.8 128.1 91.3 37.5 7.6
1995 73.7 8.6 42.0 58.9 106.3 125.0 91.7 37.9 7.9
1996 76.1 9.5 46.4 63.3 110.9 127.9 95.1 40.4 8.4
1997 74.4 8.9 45.9 62.6 108.0 125.4 95.2 41.0 8.7
1998 74.0 9.0 47.0 64.9 108.5 123.0 96.0 41.8 8.9
1999 71.7 8.3 45.0 62.9 104.9 119.2 94.9 42.1 9.1
2000p 70.6 8.3 43.8 62.2 104.1 116.9 95.3 42.2 9.3
1999 March 72.0 8.0 45.2 64.3 106.8 118.8 94.1 41.3 8.8
June 70.8 8.6 44.9 62.3 104.3 117.3 92.4 41.7 9.2
Sept 71.2 8.1 44.1 60.9 101.1 118.8 96.9 42.7 9.1
Dec 72.6 8.5 45.6 64.1 106.4 121.3 96.3 42.7 9.1
2000 Marchp 71.7 8.5 45.1 64.4 107.0 118.4 94.4 42.5 9.3
Junep 70.0 8.5 44.5 62.3 103.9 115.3 93.1 42.0 9.5
Septp 69.6 8.3 42.0 59.6 99.8 116.2 96.7 41.9 9.2
Decp 71.3 7.9 43.5 62.2 105.6 118.7 97.0 42.8 9.3
2001 Marchp 70.5 7.7 43.2 62.3 105.9 116.1 95.2 42.7 9.6
(c) percentage terminated by abortion
1991 19.4 51.1 39.9 34.5 22.2 13.4 13.7 22.0 41.6
1993 19.2 49.9 39.2 34.3 22.8 13.9 13.5 21.5 40.2
1994 19.5 50.3 39.8 34.7 23.4 14.3 13.6 21.1 40.9
1995 19.7 47.6 38.7 34.6 24.2 14.8 13.6 20.7 38.0
1996 20.8 49.2 40.0 36.2 25.7 15.6 14.1 21.2 37.6
1997 21.3 49.7 40.6 36.8 26.7 16.4 14.2 21.0 38.0
1998 22.3 52.4 42.0 37.8 27.8 17.1 14.9 21.5 37.9
1999 22.6 52.6 43.0 38.6 28.5 17.5 14.7 21.2 37.0
2000p 22.7 54.0 44.2 39.4 29.2 17.7 14.5 20.5 35.4
1999 March 22.3 51.4 41.9 38.0 27.9 17.2 14.7 21.6 36.2
June 23.0 52.9 43.5 38.6 28.6 18.0 15.5 21.5 37.8
Sept 22.1 52.7 43.1 38.7 28.5 17.2 14.1 20.6 37.3
Dec 22.8 53.5 43.6 39.1 29.2 17.7 14.7 21.2 36.6
2000 Marchp 22.9 53.8 44.3 39.6 29.6 17.7 14.5 20.4 35.3
Junep 23.2 55.1 44.4 39.2 29.7 18.1 15.1 20.9 35.1
Septp 22.0 53.2 43.8 38.7 28.2 17.4 14.0 19.8 35.4
Decp 22.8 53.9 44.1 39.8 29.3 17.5 14.5 20.8 35.9
2001 Marchp 23.4 54.3 44.9 40.1 29.8 18.6 14.8 20.6 34.9
Notes: Conceptions are estimates derived from birth registrations and abortion notifications.
Rates for women of all ages, under 16, under 18, under 20 and 40 and over are based on the population of women aged 15–44, 13–15, 15–17, 15–19 and 40–44 respectively.
For a quarterly analysis of conceptions under 18 for local authority areas see the National Statistics website, www.statistics.gov.uk.
p  Provisional.
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England and WalesAbortions: residents and non-residents; age and gestation (residents only)Table 4.2
All women (residents)
All ages Age group Gestation weeks (percentages)
Year and quarter All1  Residents1 Non-1 Under 16–19 20–24 25–29 30–34 35–44 45 and Under 9–12 13–19 20 and
women residents 16 over 9 over
Numbers (thousands) Percentages
1971 126.8 94.6 32.2 2.3 18.2 24.5 17.3 14.2 15.9 0.5 16.6 57.9 21.8 1.0
1976 129.7 101.9 27.8 3.4 24.0 23.6 19.3 14.6 14.7 0.5 24.8 55.8 15.0 1.1
1981 162.5 128.6 33.9 3.5 31.4 34.3 21.9 18.7 17.6 0.6 31.0 53.4 13.5 1.3
1986 172.3 147.6 24.7 3.9 33.8 45.3 28.7 18.0 17.5 0.4 33.4 53.8 11.5 1.4
1991 179.5 167.4 12.1 3.2 31.1 52.7 38.6 23.4 17.9 0.4 35.2 52.9 10.6 1.2
1992 172.1 160.5 11.6 3.0 27.6 49.0 38.4 23.9 18.1 0.5 36.8 51.8 10.3 1.2
1993 168.7 157.8 10.9 3.1 25.8 46.8 38.1 24.7 18.8 0.5 39.2 49.7 9.9 1.2
1994 166.9 156.5 10.3 3.2 25.2 44.9 38.1 25.5 19.2 0.4 40.5 48.4 9.9 1.2
1995 163.6 154.3 9.3 3.3 24.9 43.4 37.3 25.8 19.2 0.5 41.9 47.3 9.6 1.2
1996 177.5 167.9 9.6 3.6 28.8 46.4 39.3 28.2 21.1 0.4 40.0 48.7 10.1 1.3
1997 179.7 170.1 9.6 3.4 29.9 45.0 40.2 28.9 22.3 0.5 41.2 47.9 9.6 1.2
1998 187.4 177.9 9.5 3.8 33.2 45.8 40.4 30.4 23.8 0.5 41.4 47.6 9.7 1.3
1999 183.2 173.7 9.5 3.6 32.8 45.0 38.5 29.1 24.1 0.5 42.5 46.5 9.5 1.4
2000 185.4 175.5 9.8 3.7 33.2 47.1 37.9 28.7 24.4 0.5 43.3 45.0 10.3 1.5
2001p 186.22 176.32 9.9 3.6 33.4 48.2 36.5 28.7 25.2 0.5 42.8 45.0 10.6 1.6
1997 March 46.2 43.6 2.5 0.9 7.7 11.8 10.3 7.3 5.5 0.1 37.4 50.2 11.1 1.3
June 45.2 42.8 2.4 0.8 7.4 11.4 10.2 7.2 5.6 0.1 41.3 48.0 9.4 1.2
Sept 45.1 42.7 2.4 0.9 7.5 11.1 10.0 7.3 5.8 0.1 42.0 47.2 9.6 1.2
Dec 43.3 41.0 2.3 0.8 7.4 10.7 9.6 7.0 5.4 0.1 44.5 46.0 8.3 1.2
1998 March 48.4 45.9 2.5 1.0 8.7 12.0 10.5 7.7 5.8 0.1 37.5 50.4 10.8 1.3
June 46.4 44.0 2.4 0.9 8.1 11.4 10.1 7.6 5.8 0.1 40.8 48.3 9.5 1.4
Sept 46.9 44.5 2.4 1.0 8.3 11.3 10.0 7.6 6.2 0.1 42.5 46.7 9.5 1.2
Dec 45.7 43.5 2.2 0.9 8.1 11.0 9.8 7.5 5.9 0.1 44.9 45.0 8.9 1.2
1999 March 47.5 45.2 2.4 0.9 8.7 11.8 10.0 7.5 6.1 0.1 40.1 48.2 10.3 1.5
June 45.3 42.9 2.4 0.9 8.0 11.1 9.6 7.2 5.9 0.1 42.3 46.9 9.3 1.4
Sept 45.8 43.4 2.4 0.9 8.2 11.2 9.5 7.3 6.1 0.1 43.1 46.1 9.3 1.4
Dec 44.6 42.3 2.4 0.9 7.9 10.9 9.4 7.0 6.0 0.1 44.7 44.7 9.2 1.4
2000 March 49.5 46.9 2.6 1.0 9.1 12.5 10.2 7.5 6.4 0.1 38.9 47.9 11.6 1.6
June 45.8 43.4 2.5 0.9 8.2 11.8 9.2 7.1 6.0 0.1 42.2 46.0 10.3 1.4
Sept 46.1 43.6 2.5 1.0 8.1 11.5 9.5 7.3 6.1 0.1 44.5 44.0 10.1 1.4
Dec 43.9 41.7 2.2 0.9 7.8 11.2 8.9 6.8 5.9 0.1 47.8 41.7 9.0 1.4
2001 Marchp 47.9 45.3 2.5 0.9 8.7 12.4 9.4 7.3 6.4 0.1 40.6 46.3 11.6 1.6
Junep 46.7 44.1 2.5 0.9 8.3 12.1 9.2 7.2 6.3 0.1 42.0 45.7 10.6 1.6
Septp 46.2 43.7 2.4 1.0 8.2 11.8 9.1 7.3 6.3 0.1 43.2 44.7 10.6 1.6
Decp 45.3 42.9 2.4 0.9 8.2 11.8 8.9 6.9 6.2 0.1 45.7 43.1 9.6 1.5
Rates (per thousand women residents)
ASR3 Crude rate2
(women 15–44) (women 15–44)
1971 9.9 10.1 : 2.3 13.9 13.1 10.7 10.0 5.6 0.3
1976 10.2 10.5 : 2.9 16.9 14.2 10.4 9.2 5.3 0.3
1981 11.9 12.4 : 3.0 19.4 18.6 13.1 10.1 5.9 0.4
1986 13.0 13.5 : 3.7 22.0 21.9 15.5 10.8 5.1 0.3
1991 15.0 15.2 : 3.8 24.0 27.1 18.5 12.6 5.1 0.3
1992 14.6 14.8 : 3.5 22.4 25.9 18.4 12.5 5.2 0.3
1993 14.5 14.7 : 3.4 22.0 25.5 18.4 12.6 5.5 0.3
1994 14.6 14.6 : 3.5 22.0 25.4 18.6 12.6 5.6 0.2
1995 14.5 14.4 : 3.5 21.7 25.5 18.6 12.4 5.5 0.2
1996 16.0 15.6 : 3.9 24.3 28.6 19.9 13.4 6.0 0.2
1997 16.3 15.8 : 3.7 24.5 29.0 20.8 13.7 6.1 0.3
1998 17.1 16.5 : 4.0 26.5 30.4 21.4 14.5 6.4 0.3
1999 16.8 16.1 : 3.8 26.0 29.9 21.0 14.0 6.3 0.3
2000 17.0 16.2 : 3.8 26.7 30.9 21.1 14.0 6.2 0.3
2001p 17.0 16.2 : 3.7 26.1 30.6 21.5 14.2 6.3 0.3
1997 March 16.7 16.2 : 3.8 25.4 29.8 21.2 13.9 6.2 0.2
June 16.4 15.9 : 3.6 24.1 29.3 21.0 13.7 6.2 0.3
Sept 16.3 15.9 : 3.8 24.4 28.7 20.8 13.9 6.3 0.3
Dec 15.8 15.3 : 3.5 24.0 28.0 20.1 13.2 5.9 0.3
1998 March 17.7 17.1 : 4.2 28.0 31.6 21.9 14.7 6.4 0.3
June 16.9 16.3 : 3.8 26.0 30.2 21.3 14.4 6.3 0.3
Sept 17.1 16.5 : 4.1 26.4 30.1 21.3 14.5 6.6 0.3
Dec 16.7 16.1 : 3.9 25.8 29.3 20.9 14.4 6.3 0.3
1999 March 17.5 16.7 : 3.9 27.7 31.4 21.5 14.5 6.5 0.3
June 16.6 15.9 : 3.6 25.5 29.6 20.9 13.9 6.2 0.3
Sept 16.8 16.1 : 3.7 26.1 29.7 20.9 14.1 6.4 0.3
Dec 16.3 15.6 : 3.8 25.1 28.8 20.7 13.6 6.2 0.3
2000 March 18.2 17.3 : 4.2 29.1 33.1 22.6 14.6 6.6 0.3
June 16.8 16.0 : 3.6 26.1 30.9 20.6 13.9 6.2 0.3
Sept 16.9 16.1 : 4.0 26.0 30.1 21.3 14.2 6.2 0.3
Dec 16.1 15.3 : 3.6 24.9 29.1 20.4 13.4 5.9 0.2
2001 March4p 17.6 16.7 : 3.6 27.5 32.0 21.7 14.5 6.5 0.3
June4p 17.1 16.2 : 3.7 26.1 30.9 21.5 14.2 6.3 0.3
Sept4p 16.9 16.1 : 3.8 25.5 29.9 21.5 14.6 6.3 0.3
Dec4p 16.6 15.7 : 3.5 25.4 29.7 21.2 13.8 6.1 0.2
1 Includes cases with not stated age and/or gestation week.
2 Includes incomplete forms that have been returned to practitoners.
3 Rates for all women residents age-standardised to the European population for ages 15–44.
4 The denominators used to calculate rates are population projections (1998-based). Rates for Under 16 and 45 and over are based on female populations aged 13–15 and 45–49 respectively.
p Provisional; figures for March, June and September quarters revised.
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Table 5.1 Expectation of life at birth and selected age
Males Females
Year At   At age Year At     At age
birth birth
5 20 30 50 60 70 80 5 20 30 50 60 70 80
United Kingdom1
1971 68.8 65.3 50.9 41.3 23.0 15.3   9.5 5.5 1971 75.0 71.4 56.7 47.0 28.3 19.8 12.5 6.9
1976 69.6 66.0 51.4 41.9 23.4 15.7   9.6 5.6 1976 75.2 72.0 57.3 47.5 28.7 20.3 12.9 7.2
1981 70.8 66.9 52.3 42.7 24.1 16.3 10.1 5.8 1981 76.8 72.7 57.9 48.1 29.2 20.8 13.3 7.5
1986 71.9 67.8 53.2 43.6 24.9 16.8 10.5 6.0 1986 77.7 73.5 58.7 48.9 29.8 21.2 13.8 7.9
1991 73.2 68.9 54.3 44.7 26.0 17.7 11.1 6.4 1991 78.8 74.4 59.6 49.7 30.7 21.9 14.4 8.4
1994 73.9 69.5 54.8 45.2 26.5 18.1 11.3 6.5 1994 79.2 74.7 59.9 50.1 31.0 22.2 14.5 8.4
1995 74.1 69.7 55.0 45.5 26.8 18.4 11.5 6.6 1995 79.4 74.9 60.1 50.3 31.2 22.4 14.6 8.5
1996 74.3 69.9 55.2 45.7 26.9 18.5 11.6 6.7 1996 79.5 75.0 60.1 50.3 31.2 22.4 14.6 8.5
1997 74.6 70.2 55.5 45.9 27.2 18.8 11.8 6.7 1997 79.6 75.1 60.3 50.5 31.4 22.6 14.7 8.5
1998 74.8 70.4 55.7 46.1 27.4 19.0 11.9 6.8 1998 79.8 75.3 60.4 50.6 31.5 22.6 14.8 8.6
1999p 75.1 70.7 55.9 46.4 27.7 19.2 12.1 6.9 1999p 80.0 75.5 60.6 50.8 31.7 22.8 14.9 8.6
England and Wales
1971 69.0 65.6 51.1 41.5 23.1 15.4   9.5 5.5 1971 75.2 71.6 56.9 47.1 28.4 20.0 12.6 7.0
1976 69.9 66.2 51.6 42.1 23.5 15.8   9.7 5.7 1976 76.0 72.2 57.4 47.7 28.8 20.4 13.0 7.2
1981 71.0 67.1 52.5 42.9 24.3 16.4 10.1 5.8 1981 77.0 72.9 58.1 48.3 29.4 20.9 13.4 7.5
1986 72.1 68.0 53.4 43.8 25.0 16.9 10.6 6.1 1986 77.9 73.6 58.9 49.0 30.0 21.4 13.9 7.9
1991 73.4 69.1 54.5 44.9 26.2 17.9 11.2 6.4 1991 79.0 74.6 59.8 49.9 30.8 22.1 14.5 8.4
1994 74.1 69.7 55.0 45.4 26.7 18.3 11.4 6.5 1994 79.4 74.9 60.1 50.3 31.2 22.3 14.6 8.5
1995 74.4 70.0 55.2 45.7 26.9 18.5 11.6 6.6 1995 79.6 75.1 60.3 50.4 31.3 22.5 14.7 8.6
1996 74.6 70.2 55.4 45.9 27.1 18.7 11.7 6.7 1996 79.7 75.2 60.3 50.5 31.4 22.6 14.7 8.6
1997 74.8 70.4 55.7 46.1 27.4 18.9 11.9 6.8 1997 79.8 75.3 60.5 50.7 31.6 22.7 14.8 8.6
1998 75.1 70.7 55.9 46.4 27.6 19.1 12.0 6.9 1998 80.0 75.5 60.6 50.8 31.7 22.8 14.9 8.6
1999p 75.4 70.9 56.2 46.6 27.9 19.3 12.2 7.0 1999p 80.2 75.7 60.8 51.0 31.9 23.0 15.0 8.7
England
1981 71.1 67.1 52.5 42.9 24.3 16.4 10.1 5.8 1981 77.0 72.9 58.2 48.4 29.4 20.9 13.4 7.5
1986 72.2 68.1 53.4 43.8 25.1 17.0 10.6 6.1 1986 77.9 73.7 58.9 49.1 30.0 21.4 13.9 7.9
1991 73.4 69.1 54.5 44.9 26.2 17.9 11.2 6.4 1991 79.0 74.6 59.8 49.9 30.9 22.1 14.5 8.4
1994 74.1 69.7 55.0 45.5 26.7 18.3 11.4 6.6 1994 79.4 74.9 60.1 50.3 31.2 22.4 14.6 8.5
1995 74.4 70.0 55.3 45.7 27.0 18.5 11.6 6.6 1995 79.6 75.1 60.3 50.5 31.4 22.5 14.7 8.6
1996 74.6 70.2 55.5 45.9 27.2 18.7 11.7 6.7 1996 79.7 75.2 60.4 50.6 31.4 22.6 14.7 8.6
1997 74.9 70.5 55.7 46.2 27.4 18.9 11.9 6.8 1997 79.9 75.4 60.5 50.7 31.6 22.7 14.8 8.6
1998 75.1 70.7 56.0 46.4 27.6 19.1 12.0 6.9 1998 80.0 75.5 60.6 50.8 31.7 22.8 14.9 8.6
1999p 75.4 71.0 56.2 46.7 27.9 19.4 12.2 7.0 1999p 80.2 75.7 60.8 51.0 31.9 23.0 15.0 8.7
Wales
1981 70.4 66.5 51.9 42.2 23.6 15.8   9.7 5.5 1981 76.4 72.3 57.5 47.7 28.9 20.4 13.1 7.4
1986 71.6 67.5 52.9 43.3 24.6 16.6 10.4 6.0 1986 77.6 73.3 58.5 48.7 29.7 21.1 13.8 7.8
1991 73.2 68.9 54.2 44.6 25.9 17.6 11.0 6.4 1991 78.9 74.4 59.6 49.8 30.7 21.9 14.4 8.4
1994 73.5 69.1 54.4 44.9 26.2 17.9 11.1 6.5 1994 79.0 74.5 59.7 49.8 30.8 22.0 14.4 8.4
1995 73.8 69.4 54.7 45.2 26.5 18.1 11.3 6.6 1995 79.2 74.7 59.8 50.0 30.9 22.2 14.5 8.5
1996 74.0 69.5 54.8 45.4 26.6 18.3 11.4 6.5 1996 79.2 74.7 59.8 50.0 31.0 22.2 14.5 8.5
1997 74.4 69.9 55.2 45.7 27.0 18.6 11.6 6.8 1997 79.4 74.9 60.0 50.2 31.1 22.4 14.6 8.5
1998 74.5 70.1 55.4 45.9 27.1 18.7 11.7 6.8 1998 79.5 75.0 60.1 50.3 31.2 22.4 14.6 8.5
1999p 74.8 70.4 55.7 46.2 27.4 19.0 12.0 6.9 1999p 79.7 75.1 60.3 50.5 31.4 22.6 14.7 8.6
Scotland
1971 67.3 64.0 49.5 40.1 22.0 14.6   9.1 5.4 1971 73.7 70.1 55.4 45.6 27.2 19.0 11.9 6.7
1976 68.2 64.4 49.9 40.4 22.3 14.9   9.2 5.3 1976 74.4 70.6 55.9 46.1 27.6 19.4 12.4 6.9
1981 69.1 65.2 50.6 41.1 22.9 15.4   9.5 5.5 1981 75.3 71.2 56.4 46.7 27.9 19.7 12.7 7.2
1986 70.2 66.0 51.4 41.9 23.5 15.8   9.9 5.7 1986 76.2 71.9 57.1 47.3 28.4 20.1 13.0 7.5
1991 71.4 67.1 52.5 43.0 24.6 16.6 10.4 6.1 1991 77.1 72.6 57.8 48.1 29.1 20.6 13.4 7.8
1994 71.9 67.5 52.8 43.4 24.9 16.9 10.6 6.1 1994 77.4 72.9 58.1 48.3 29.4 20.8 13.5 7.8
1995 72.1 67.7 53.1 43.6 25.2 17.2 10.8 6.2 1995 77.6 73.2 58.3 48.6 29.6 21.0 13.7 7.9
1996 72.2 67.8 53.1 43.7 25.3 17.3 10.9 6.3 1996 77.8 73.2 58.4 48.7 29.7 21.1 13.7 7.9
1997 72.4 67.9 53.3 43.9 25.5 17.5 11.0 6.4 1997 77.9 73.4 58.6 48.8 29.9 21.3 13.8 7.9
1998 72.6 68.1 53.5 44.1 25.7 17.7 11.1 6.4 1998 78.1 73.5 58.7 48.9 29.9 21.3 13.8 7.9
1999p 72.8 68.4 53.7 44.3 25.9 17.9 11.3 6.5 1999p 78.2 73.7 58.8 49.1 30.1 21.4 13.9 7.9
Northern Ireland1
1981 69.2 65.4 50.9 41.5 23.2 15.6 9.7 5.8 1981 75.5 71.6 56.8 47.1 28.3 20.0 12.8 7.3
1986 70.9 66.8 52.2 42.7 24.2 16.4 10.4 6.2 1986 77.1 72.9 58.1 48.3 29.3 20.8 13.4 7.8
1991 72.6 68.2 53.6 44.1 25.5 17.3 11.0 6.4 1991 78.4 74.0 59.2 49.4 30.3 21.6 14.2 8.3
1994 73.1 68.8 54.2 44.7 26.0 17.8 11.2 6.6 1994 78.6 74.2 59.4 49.6 30.6 21.9 14.3 8.4
1995 73.5 69.1 54.5 45.0 26.3 18.0 11.3 6.6 1995 78.9 74.5 59.6 49.8 30.8 22.0 14.4 8.4
1996 73.8 69.4 54.7 45.2 26.5 18.2 11.3 6.6 1996 79.2 74.7 59.9 50.0 30.9 22.1 14.4 8.4
1997 74.2 69.7 55.0 45.5 26.8 18.3 11.5 6.6 1997 79.5 75.0 60.2 50.3 31.2 22.4 14.6 8.4
1998 74.3 69.8 55.1 45.6 26.9 18.5 11.6 6.6 1998 79.5 75.0 60.2 50.4 31.3 22.4 14.5 8.3
1999p 74.5 70.0 55.4 45.9 27.2 18.7 11.7 6.6 1999p 79.6 75.1 60.3 50.5 31.4 22.5 14.6 8.3
Note: Figures from 1981 are calculated from the population estimates revised in the light of the 1991 Census.  All figures are based on a three-year period; see Notes to tables for further
information.
1 United Kingdom and Northern Ireland data has been revised to take account of changed Northern Ireland population estimates from 1981.
p Provisional.
 Constituent countries of the United Kingdom Years
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  Age group
Year and quarter All ages   Under 11 1–4 5–9 10–14 15–19 20–24 25–34 35–44 45–54 55–64 65–74 75–84 85 and over
Numbers (thousands)
Males
1976 300.1 4.88 0.88 0.68 0.64 1.66 1.66 3.24 5.93 20.4 52.0 98.7 80.3 29.0
1981 289.0 4.12 0.65 0.45 0.57 1.73 1.58 3.18 5.54 16.9 46.9 92.2 86.8 28.5
1986 287.9 3.72 0.57 0.32 0.38 1.43 1.75 3.10 5.77 14.4 43.6 84.4 96.2 32.2
1991 277.6 2.97 0.55 0.34 0.35 1.21 1.76 3.69 6.16 13.3 34.9 77.2 95.8 39.3
1996 268.7 2.27 0.44 0.24 0.29 0.93 1.41 4.06 5.84 13.6 30.1 71.0 90.7 47.8
1997 264.9 2.14 0.41 0.27 0.33 0.95 1.44 3.94 5.71 13.5 28.9 68.0 90.2 49.1
1998 264.7 2.07 0.41 0.24 0.29 0.88 1.29 4.01 5.90 13.6 29.1 66.1 90.5 50.4
1999 264.3 2.08 0.41 0.22 0.28 0.90 1.27 3.85 5.93 13.6 28.7 64.3 90.4 52.3
2000 255.5 1.89 0.34 0.22 0.28 0.87 1.22 3.76 6.05 13.4 27.9 60.6 87.2 51.9
2001p 253.6 1.82 0.33 0.19 0.32 0.93 1.28 3.83 6.18 13.4 27.6 57.6 87.2 52.8
Females
1976 298.5 3.46 0.59 0.45 0.42 0.62 0.67 1.94 4.04 12.8 29.6 67.1 104.7 72.1
1981 288.9 2.90 0.53 0.30 0.37 0.65 0.64 1.82 3.74 10.5 27.2 62.8 103.6 73.9
1986 293.3 2.59 0.49 0.25 0.27 0.56 0.67 1.65 3.83 8.8 25.8 58.4 106.5 83.6
1991 292.5 2.19 0.44 0.25 0.22 0.46 0.64 1.73 3.70 8.4 21.3 54.2 103.3 95.7
1996 291.5 1.69 0.32 0.18 0.20 0.43 0.51 1.85 3.66 8.9 18.2 50.2 96.7 108.7
1997 290.4 1.66 0.30 0.18 0.21 0.43 0.49 1.72 3.74 9.0 18.0 48.3 95.5 110.9
1998 290.3 1.56 0.31 0.18 0.19 0.41 0.48 1.72 3.68 9.1 17.9 46.9 94.7 113.2
1999 291.8 1.55 0.30 0.17 0.22 0.39 0.47 1.67 3.79 9.0 18.0 45.1 93.9 117.2
2000 280.1 1.49 0.25 0.16 0.18 0.38 0.47 1.69 3.87 9.1 17.6 42.2 89.3 113.4
2001p 278.9 1.45 0.27 0.20 0.17 0.39 0.47 1.67 3.86 9.0 17.6 40.6 89.0 114.2
Rates (deaths per 1,000 population in each age group)
Males
1976 12.5 16.2 0.65 0.34 0.31 0.88 0.96 0.92 2.09 6.97 19.6 50.3 116.4 243.2
1981 12.0 12.6 0.53 0.27 0.29 0.82 0.83 0.89 1.83 6.11 17.7 45.6 105.2 226.5
1986 11.8 11.0 0.44 0.21 0.23 0.71 0.82 0.87 1.67 5.27 16.6 42.9 101.1 214.8
1991 11.2 8.3 0.40 0.21 0.23 0.69 0.86 0.94 1.76 4.62 13.8 38.5 93.6 197.1
1996 10.5 7.0 0.32 0.13 0.18 0.58 0.83 095 1.62 4.02 12.0 34.5 85.1 192.1
1997 10.3 6.5 0.31 0.15 0.19 0.58 0.89 0.93 1.54 3.94 11.5 33.2 82.5 190.3
1998 10.3 6.4 0.31 0.14 0.17 0.53 0.82 0.96 1.55 3.94 11.3 32.4 81.2 187.2
1999 10.2 6.5 0.31 0.12 0.16 0.54 0.80 0.93 1.51 3.93 10.9 31.6 80.1 187.9
2000 9.8 6.1 0.26 0.12 0.16 0.52 0.76 0.93 1.49 3.84 10.4 29.8 76.1 181.3
2001p 9.7 6.0 0.25 0.11 0.18 0.56 0.79 0.94 1.53 3.86 10.3 28.3 76.2 184.4
2000 March 11.6 6.3 0.33 0.12 0.19 0.56 0.78 1.00 1.59 4.25 12.0 34.7 92.2 228.4
June 9.3 6.3 0.25 0.11 0.17 0.50 0.73 0.88 1.48 3.80 10.1 28.8 71.9 167.4
Sept 8.6 5.8 0.20 0.12 0.15 0.46 0.73 0.88 1.41 3.51 9.3 26.8 66.7 153.1
Dec 9.5 6.0 0.24 0.15 0.14 0.57 0.80 0.94 1.50 3.81 10.1 28.8 73.9 177.3
2001 Marchp 10.8 6.3 0.28 0.10 0.21 0.58 0.77 0.97 1.57 4.08 11.1 31.3 85.1 211.9
Junep 9.5 5.7 0.28 0.09 0.17 0.56 0.74 0.91 1.48 3.82 10.1 27.6 74.9 177.2
Septp 8.9 5.7 0.21 0.13 0.14 0.48 0.80 0.90 1.48 3.66 9.7 26.2 68.7 162.2
Decp 9.7 6.2 0.23 0.12 0.21 0.60 0.86 0.99 1.59 3.88 10.2 28.2 76.1 187.0
Females
1976 11.8 12.2 0.46 0.24 0.21 0.35 0.40 0.56 1.46 4.30 10.1 26.0 74.6 196.6
1981 11.3   9.4 0.46 0.19 0.19 0.32 0.35 0.52 1.26 3.80 9.5 24.1 66.2 178.2
1986 11.4   8.0 0.40 0.17 0.17 0.29 0.33 0.47 1.12 3.23 9.2 23.4 62.5 171.0
1991 11.3 6.4 0.33 0.16 0.15 0.28 0.33 0.45 1.06 2.91 8.1 22.0 58.6 163.8
1996 11.0 5.4 0.24 0.10 0.12 0.29 0.31 0.45 1.03 2.62 7.1 20.7 55.8 150.8
1997 10.9 5.3 0.23 0.10 0.13 0.28 0.32 0.42 1.03 2.63 6.9 20.2 54.6 151.8
1998 10.9 5.0 0.24 0.11 0.12 0.26 0.32 0.43 0.99 2.62 6.8 19.9 53.9 151.5
1999 10.9 5.1 0.24 0.10 0.13 0.25 0.31 0.43 0.99 2.60 6.7 19.3 53.5 154.8
2000 10.5 5.1 0.20 0.09 0.11 0.24 0.31 0.44 0.99 2.61 6.4 18.2 50.9 147.6
2001p 10.4 5.0 0.22 0.12 0.10 0.25 0.31 0.43 0.98 2.58 6.4 17.5 50.8 148.6
2000 March 12.8 5.4 0.21 0.09 0.12 0.27 0.30 0.46 1.07 2.82 7.2 21.3 62.3 190.5
June 9.7 4.8 0.23 0.09 0.09 0.22 0.26 0.45 0.96 2.56 6.2 17.4 47.7 132.6
Sept 9.1 5.1 0.16 0.08 0.10 0.25 0.34 0.45 0.95 2.50 5.9 16.5 44.1 123.7
Dec 10.2 4.9 0.19 0.12 0.12 0.25 0.33 0.40 0.98 2.56 6.3 17.6 49.9 144.5
2001 Marchp 11.9 5.0 0.27 0.14 0.11 0.27 0.32 0.46 1.03 2.67 6.7 19.6 57.8 174.8
Junep 10.1 4.6 0.22 0.10 0.08 0.26 0.31 0.43 0.96 2.58 6.4 17.1 49.4 141.4
Septp 9.3 5.1 0.17 0.10 0.10 0.20 0.26 0.41 0.97 2.47 6.0 15.8 45.3 129.5
Decp 10.4 5.3 0.23 0.13 0.11 0.26 0.36 0.44 0.97 2.60 6.5 17.6 50.9 149.1
Note: Figures represent the numbers of deaths registered in each year up to 1992 and the numbers of deaths occurring in each year from 1993.
1 Rates per 1,000 live births.
p Provisional registrations.
Table 6.1 Deaths: age and sex
England and Wales Numbers (thousands) and rates
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Table 6.2 Deaths: subnational
Year and Northern and Trent Eastern London South South West North
quarter Yorkshire East West Midlands West
Total deaths (deaths per 1,000 population of all ages)
1994 11.2 10.8 10.1 9.4 10.4 11.4 10.5 11.5
1995 11.3 11.0 10.4 9.6 10.7 11.9 10.9 11.6
1996 11.2 10.9 10.2 9.2 10.6 11.5 10.6 11.5
1997 11.0 10.8 10.1 8.9 10.4 11.5 10.5 11.4
1998 11.3 11.0 10.1 8.6 10.2 11.3 10.5 11.5
1999 11.0 10.8 10.1 8.6 10.3 11.5 10.6 11.3
2000 10.6 10.4 9.8 8.0 9.9 11.2 10.2 10.8
2001p 10.6 10.4 9.8 7.9 9.7 10.9 10.1 10.8
2000 March 12.8 12.5 11.8 9.8 12.1 13.7 12.3 12.8
June 9.9 9.8 9.2 7.5 9.2 10.7 9.7 10.1
Sept 9.2 9.0 8.6 7.1 8.6 9.7 9.1 9.5
Dec 10.4 10.3 9.6 7.9 9.6 10.7 9.8 10.6
2001 Marchp 11.9 11.8 10.9 9.0 10.9 12.1 11.6 12.2
Junep 10.1 10.2 9.5 7.7 9.5 10.6 9.8 10.6
Septp 9.5 9.3 8.8 7.2 8.9 9.9 9.2 9.7
Decp 10.7 10.3 9.9 7.9 9.7 11.0 10.0 11.0
Infant mortality (deaths under 1 year per 1,000 live births)
1994 6.8 7.2 5.3 6.3 4.9 5.3 7.2 6.2
1995 6.6 6.4 5.2 6.4 5.2 5.3 7.1 6.6
1996 6.3 6.3 5.3 6.3 5.4 5.5 6.8 6.4
1997 6.2 5.9 4.8 5.8 5.0 5.8 7.0 6.7
1998 6.1 6.0 5.0 6.0 4.5 4.8 6.5 6.3
1999 6.0 6.1 4.6 6.0 5.0 4.7 6.9 6.5
2000 6.9 6.0 4.4 5.4 4.4 4.7 6.8 6.3
2001p 5.6 5.4 4.5 6.1 4.1 5.4 6.4 6.0
2000 March 7.5 5.3 4.3 5.6 4.9 5.2 6.7 6.2
June 7.6 5.4 4.4 5.0 4.3 4.3 6.9 6.7
Sept 6.0 6.4 4.5 5.5 4.1 3.5 7.6 6.3
Dec 6.3 6.8 4.4 5.6 4.5 5.7 5.8 6.0
2001 Marchp 6.2 5.6 4.1 6.4 4.5 6.1 6.8 5.7
Junep 5.6 5.8 4.5 4.7 3.8 4.6 6.8 6.4
Septp 5.0 5.2 4.6 6.5 4.2 5.0 5.9 6.0
Decp 5.7 5.3 5.1 6.7 4.1 5.9 6.2 5.9
Neonatal mortality (deaths under 4 weeks per 1,000 live births)
1994 4.5 5.0 3.4 4.2 3.3 3.4 5.4 3.9
1995 4.5 4.5 3.4 4.3 3.5 3.7 5.3 4.2
1996 4.1 4.2 3.5 4.4 3.6 3.8 4.9 4.1
1997 4.1 3.9 3.3 3.6 3.4 3.9 5.0 4.3
1998 3.8 4.2 3.4 4.1 2.9 3.3 4.8 4.1
1999 4.0 4.4 3.0 4.1 3.2 3.2 4.8 4.3
2000 4.6 4.4 3.0 3.7 3.1 3.0 5.0 4.3
2001p 3.4 3.6 2.9 4.1 2.8 3.7 4.4 3.8
2000 March 5.1 4.0 2.9 4.1 3.2 3.1 4.6 4.5
June 5.0 3.9 3.2 3.3 3.2 2.8 5.1 4.3
Sept 4.5 4.8 3.1 3.8 2.8 2.3 5.9 4.6
Dec 4.0 4.8 2.8 3.6 3.3 3.8 4.4 3.9
2001 Marchp 3.5 3.4 2.6 4.3 3.1 4.3 4.8 3.3
Junep 3.4 4.1 2.9 3.2 2.8 2.9 4.5 4.0
Septp 2.9 3.4 3.0 4.7 3.3 3.4 4.1 3.7
Decp 3.7 3.4 3.3 4.3 2.1 4.0 4.3 4.3
Perinatal mortality (stillbirths and deaths under 1 week per 1,000 total births)2
1994 9.2 9.1 7.8 9.5 7.6 7.9 10.6 9.2
1995 9.5 9.3 7.7 9.7 7.5 7.4 10.1 8.6
1996 8.5 8.7 7.5 9.6 7.8 7.5 10.2 8.7
1997 8.2 7.9 7.3 8.9 7.3 8.7 9.6 8.8
1998 8.6 8.7 7.4 9.0 6.8 7.3 9.3 8.8
1999 8.3 8.1 7.0 9.0 6.9 7.8 9.9 8.6
2000 9.0 8.5 7.1 9.0 6.7 6.6 9.6 8.6
2001p 7.5 8.1 7.0 8.9 6.7 7.2 9.0 8.9
2000 March 9.9 6.5 7.1 10.0 7.6 6.6 9.8 8.8
June 9.5 9.1 6.0 7.9 6.6 6.7 9.6 8.5
Sept 8.2 8.9 7.5 9.5 6.4 6.0 9.5 8.3
Dec 8.5 9.5 7.7 8.6 6.0 7.2 9.4 8.7
2001 Marchp 8.1 8.8 7.0 9.4 6.0 7.5 9.9 7.7
Junep 7.3 8.4 7.2 8.9 6.5 7.0 8.5 9.3
Septp 6.6 7.3 7.2 8.3 7.4 5.6 8.9 8.9
Decp 7.9 8.0 6.6 9.1 7.0 8.7 8.9 9.6
Note:  Figures represent the numbers of deaths registered in each year up to 1992 and the number of deaths occurring in each year from 1993.
1 The Regional Office boundaries were revised from 1 April 1999. See Health Statistics Quarterly 03 In Brief for details of the changes. Earlier years’ figures have been revised to reflect the new
boundaries.
2 In October 1992 the legal definition of a stillbirth was changed, from a baby born dead after 28 completed weeks of gestation or more, to one born dead after 24 completed weeks of
gestation or more.
p   Provisional registrations.
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Deaths: selected causes (International Classification)1 and sexTable 6.3
Malignant neoplasms
Year and                     All deaths All causes Oesophagus Stomach Colon Rectosigmoid Trachea, Melanoma Other Breast3 Cervix Ovary
quarter (age - junction, bronchus of skin malignant uteri
standardised rectum, and and lung neoplasms
per anus of skin
Number Crude million
   (thousands) rate per population2)
100,000
population
A00-R99 (C15) (C16) (C18) (C19-C21) (C33-C34) (C43) (C44) (C50) (C53) (C56)
V01-Y89
England and Wales Number(thousands) and rate for all deaths and age-standardised rates2 per million population for selected causes
Males
1971 288.4 1,207 13,466 76 317 187 144 1,066 10 12 4 : :
1981 289.0 1,196 12,189 90 251 181 135 1,028 17 9 3 : :
1991 277.6 1,111 10,232 117 185 193 117 842 23 10 3 : :
1993 279.6 1,109 10,027 123 162 188 106 766 25 8 3 : :
1994 267.6 1,058 9,503 128 162 182 101 743 24 9 3 : :
1995 274.4 1,079 9,582 126 148 181 99 712 26 9 3 : :
1996 268.7 1,051 9,268 126 145 174 99 681 25 8 2 : :
1997 264.9 1,031 9,020 125 136 174 93 649 25 7 2 : :
1998 264.7 1,025 8,894 128 131 168 94 641 26 8 3 : :
1999 264.3 1,017 8,779 127 126 160 90 609 27 7 2 : :
2000 255.5 978 8,353 127 117 157 89 590 28 6 2 : :
2001p 253.6 970 8,283 131 113 157 89 579 26 7 3 : :
2000 March 73.0 1,123 9,562 133 114 155 90 591 28 6 2 : :
June 60.5 931 7,975 124 110 155 91 584 27 7 2 : :
Sept 57.7 879 7,527 121 120 161 89 577 28 7 3 : :
Dec 64.3 979 8,357 131 123 158 85 610 29 6 2 : :
2001 Marchp 69.4 1,076 9,170 136 115 166 88 593 24 8 3 : :
Junep 61.7 947 8,080 130 111 155 87 567 28 7 3 : :
Septp 58.4 885 7,579 125 114 156 88 562 25 6 2 : :
Decp 64.2 974 8,320 132 112 152 93 592 28 7 3 : :
Females
1971 278.9 1,104 8,189 40 149 176 79 183 14 6 379 83 126
1981 288.9 1,134 7,425 42 111 157 74 252 16 5 405 69 121
1991 292.5 1,120 6,397 49 74 146 61 300 18 4 401 54 118
1993 299.2 1,140 6,347 51 66 137 53 294 22 3 376 47 115
1994 285.6 1,086 6,040 50 66 135 51 296 22 4 370 42 114
1995 295.2 1,119 6,128 52 61 130 49 294 20 4 359 42 115
1996 291.5 1,102 5,993 51 55 125 49 292 20 3 343 41 121
1997 290.4 1,095 5,926 51 57 121 48 285 20 3 336 37 115
1998 290.3 1,091 5,874 49 54 116 47 291 21 3 327 35 116
1999 291.8 1,093 5,859 52 50 115 46 289 20 3 318 33 111
2000 280.1 1,045 5,589 51 47 107 44 285 21 3 310 33 109
2001p 278.9 1,041 5,532 49 47 103 44 285 20 3 309 31 113
2000 March 82.3 1,235 6,460 53 44 108 43 287 22 2 311 33 111
June 64.7 971 5,254 48 48 105 45 278 21 2 319 30 108
Sept 62.1 922 5,027 51 50 106 44 279 20 3 303 35 111
Dec 71.0 1,054 5,620 51 47 107 45 296 22 4 306 35 107
2001 Marchp 78.4 1,186 6,205 48 54 104 45 294 21 3 306 31 118
Junep 67.2 1,006 5,380 48 47 106 42 281 20 3 309 30 112
Septp 62.7 928 4,992 49 43 102 45 270 19 3 306 31 108
Decp 70.6 1,045 5,564 49 42 101 45 295 20 3 316 32 112
1. The Ninth Revision of the International Classification of Diseases, 1975, came into operation in England and Wales on 1 January 1979. The Tenth Revision of the International Classification of Diseases, 1992,
came into operation in England and Wales on 1 January 2001. The cause descriptions and codes relate to ICD-10.
2. Directly age-standardised to the European Standard Population. See Notes to Tables.
3. For changes to this table compared with that in the previous three editions see ‘in brief ’.
p Provisional registrations.
Notes: Between 1 January 1984 and 31 December 1992, ONS applied its own interpretation of the International Classification of Diseases Section Rule 3 in the coding of deaths where terminal events and other
‘modes of dying’ such as cardiac arrest, cardiac failure, certain thrombembolic disorders, and unspecified pneumonia and bronchopneumonia, were stated by the certifier to be the underlying cause of death
and other major pathology appeared on the certificate. In these cases ONS Rule 3 allowed the terminal event to be considered a direct sequel to the major pathology and that primary condition was
selected as the underlying cause of death. Prior to 1984 and between 1 January 1993 and 31 December 2000, such certificates were coded to the terminal event. National Statistics also introduced
automated coding of cause of death in 1993, which may also affect comparisons of deaths by cause from 1993. Further details can be found in the annual volumes Mortality statistics: Cause 1984, Series
DH2 no. 11, and Mortality statistics: Cause 1993 (revised) and 1994, Series DH2 no. 21.
From 1 January 2001, under ICD-10, Rule 3 has again been changed - for details see the article in Health Statistics Quarterly no. 13. This has resulted in a fall in the death rates from respiratory diseases,
notably pneumonia, and consequently slight rises in the rates for other causes eg. strokes. For details of the major changes between ICD-9 and ICD-10, see the articles in Health Statistics Quarterly 08, 13
and 14.
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       Malignant neoplasms
Prostate Bladder Leukaemia3 Diabetes Ischaemic Cerebro Pneumonia Bronchitis, Asthma Gastric Diseases3 Land Intentional Year and
mellitus heart vascular emphysema and of the liver transport self harm and quarter
disease diseases and other duodenal accidents3 events of
chronic ulcer undetermined
obstructive intent
pulmonary
disease
(C61) (C67) (C91-C95) (E10-E14) (120-125) (160-169) (J12-J18) (J40-J44) (J45-J46) (K25-K27) (K70-K76) (V01-V89) (X60-X84,
Y10-Y34,
excl. Y33.9)
Deaths: selected causes (International Classification)1 and sexTable 6.3
continued
England and Wales Age-standardised rates2 per million population for selected causes
Males
198 124 74 82 3,801 1,541 920 944 21 107 41 209 124 1971
214 121 74 82 3,664 1,141 1,053 683 28 90 58 119 151 1981
302 121 76 130 2,981 939 390 605 31 73 76 123 158 1991
296 114 70 100 2,829 794 759 566 24 67 76 95 149 1993
295 109 69 97 2,595 755 679 494 23 67 83 91 148 1994
296 111 71 100 2,535 754 753 524 20 63 92 87 146 1995
287 104 65 96 2,410 743 725 480 19 63 97 92 137 1996
277 100 66 94 2,261 714 741 475 19 61 102 92 140 1997
274 98 66 93 2,200 699 708 460 18 59 114 83 147 1998
270 93 67 93 2,082 666 759 471 17 64 117 84 145 1999
257 92 66 87 1,946 615 724 414 17 59 117 84 135 2000
277 94 70 95 1,876 699 391 408 16 56 139 85 137 2001p
259 91 65 104 2,192 703 1,104 602 19 69 119 91 145 2000 March
251 90 63 80 1,905 583 604 348 15 54 108 85 138 June
254 91 70 75 1,717 555 514 305 17 54 115 84 132 Sept
265 94 66 90 1,971 619 677 400 16 58 125 74 122 Dec
297 93 71 103 2,165 793 504 533 16 72 144 81 133 2001 Marchp
271 93 63 96 1,887 667 381 397 16 52 128 86 127 Junep
260 91 73 89 1,680 628 288 320 14 51 132 80 135 Septp
282 99 74 94 1,859 708 393 385 17 50 150 92 154 Decp
Females
: 32 47 89 1,668 1,352 624 193 25 44 31 82 84 1971
: 35 47 66 1,601 1,012 740 155 30 57 43 41 81 1981
: 34 44 95 1,404 809 324 211 30 46 49 45 51 1991
: 34 43 73 1,330 711 569 223 27 45 48 35 48 1993
: 34 42 69 1,222 677 499 202 24 43 50 34 44 1994
: 32 41 72 1,179 677 553 227 24 42 55 30 46 1995
: 31 41 67 1,126 667 534 220 21 43 57 30 44 1996
: 31 43 65 1,060 639 559 225 23 41 61 29 45 1997
: 31 40 64 1,042 634 533 225 22 40 64 28 43 1998
: 30 45 64 975 618 578 240 22 39 66 28 45 1999
: 31 39 62 897 566 533 216 20 41 68 24 44 2000
: 29 41 62 874 615 301 219 20 39 78 25 43 2001p
: 30 40 73 1,017 646 853 331 26 51 69 27 48 2000 March
: 30 36 58 862 538 423 177 16 36 63 22 48 June
: 32 42 55 801 502 358 153 17 36 65 23 42 Sept
: 31 38 62 909 579 502 202 22 40 74 25 39 Dec
: 29 41 68 1,010 701 418 290 25 46 83 24 40 2001 Marchp
: 31 41 61 863 582 271 206 19 39 75 28 43 Junep
: 28 43 55 766 554 215 163 16 34 77 25 42 Septp
: 29 40 64 861 1025 304 220 19 37 77 24 45 Decp
See notes opposite.
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Report:
Legal abortions in
England and Wales, 2001
This report provides provisional figures on terminations performed
during 2001 under the Abortion Act 1967, on women normally resident
in England and Wales.  Provisional abortion rates for 2001 are shown in
Table 4.2.
KEY OBSERVATIONS:
 In 2001 there were 175,952 abortions performed on residents of
England and Wales, a rise of 410 (0.2 per cent) compared to 2000.
 The age-standardised abortion rate in 2001 was 17.0 abortions per
1,000 women aged 15–44, the same as the previous year. (Table 4.2).
 Compared to 2000 the rates for women aged under 25 have fallen
slightly while those for ages 25 and over have risen. (Table 4.2)
 The NHS funded 76 per cent (134,213) of terminations compared to
74 per cent in 2000.  The percentage of terminations paid for by the
NHS varied by the area of the woman’s usual residence from over
85 per cent for residents of Wales, Trent and Northern & Yorkshire
regional office areas to 65 per cent of abortions for London
residents.
 Just under 88 per cent of terminations were performed before 13
weeks of gestation and 11 per cent between 13 and 19 weeks’
gestation, both similar to the previous year.
EXPLANATORY NOTES:
The figures relate to abortion notifications received by 26 March 2002.
Numbers of abortions by area are based on the woman’s usual address
of residence.  Some women, however,  may have stated a temporary
address as their place of usual residence giving a potential to inflate the
counts for areas where the abortions were performed.  These figures
therefore should be treated with caution.
The data in Table 1 relate to the areas for the Regional Offices and
Health Authorities of England and Wales in existence on 1 April 2001.
Incomplete forms are returned to practitioners for clarification.  Forms
relating to 314 abortions in 2001 are still awaiting a reply and have not
been fully processed.  These abortions are only included in the all ages
figures for all women, residents and the crude abortion rate in Table
4.2.  They are not included in Table 1 of this report.  It is assumed that
all of these 314 abortions have been performed on residents of England
and Wales.
Longer term trends are shown in Table 4.2, and the graph on page 4
shows quarterly abortion rates from 1984 to 2001.
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Age group Gestation weeks Purchaser
 Place of usual residence Total* Under 16–19 20–24 25–29 30–34 35–44 45 and Under 9–12 13–19 20 and NHS NHS Non–
16 over 9 over contract NHS
Table 1 Legal abortions: Regional Office and health authority of residence by age group,
gestation weeks and purchaser, 2001
England and Wales
* Includes cases with age not stated.
England and Wales 175,952 3,643 33,366 48,152 36,451 28,708 25,175 455 75,363 79,173 18,651 2,765 75,783 58,430 41,739
England 168,446 3,426 31,671 46,018 35,047 27,627 24,225 430 72,283 75,590 17,925 2,648 71,621 56,126 40,699
Wales 7,506 217 1,695 2,134 1,404 1,081 950 25 3,080 3,583 726 117 4,162 2,304 1,040
Regional Offices and Health Authorities
Northern and Yorkshire 15,922 437 3,523 4,613 2,979 2,273 2,058 39 7,163 6,979 1,577 203 12,454 1,260 2,208
Bradford 1,332 27 270 427 243 201 160 4 382 768 160 22 920 131 281
Calderdale and Kirklees 1,448 40 318 390 251 241 204 4 621 648 159 20 413 767 268
County Durham & Darlington 1,247 37 300 335 224 168 178 5 572 527 135 13 1,114 10 123
East Riding & Hull 1,404 32 296 437 290 197 149 3 577 693 115 19 1,235 67 102
Gateshead and South Tyneside 778 26 196 217 141 81 115 2 299 382 90 7 700 4 74
Leeds 2,240 45 429 696 429 338 294 9 1,022 969 220 29 1,626 88 526
Newcastle and North Tyneside 1,419 38 308 486 248 180 159 0 640 574 199 6 1,351 6 62
North Cumbria 753 29 187 186 142 104 105 0 442 255 48 8 720 0 33
Northumberland 687 20 167 176 140 93 87 4 372 239 66 10 637 4 46
North Yorkshire 1,632 38 354 418 290 272 257 3 683 808 117 24 1,173 87 372
Sunderland 840 40 196 252 143 106 100 3 300 422 97 21 753 18 69
Tees 1,390 49 333 409 268 180 149 2 814 447 114 15 1,323 5 62
Wakefield 752 16 169 184 170 112 101 0 439 247 57 9 489 73 190
Trent 13,204 354 2,852 3,734 2,416 2,001 1,805 42 5,364 6,512 1,166 162 9,363 2,133 1,708
Barnsley 452 17 97 118 86 76 57 1 178 213 51 10 312 50 90
Doncaster 875 27 233 224 155 117 118 1 386 397 81 11 37 731 107
Leicestershire 2,633 40 524 781 518 378 382 10 993 1,422 187 31 1,913 321 399
Lincolnshire 1,327 38 307 343 226 224 178 11 668 545 99 15 1,179 14 134
North Derbyshire 786 23 166 205 151 124 114 3 473 267 41 5 611 99 76
North Nottinghamshire 848 29 178 213 171 136 119 2 308 443 86 11 700 33 115
Nottingham 1,855 49 365 569 342 286 239 5 603 1,032 196 24 862 745 248
Rotherham 661 25 159 198 83 104 91 1 181 389 87 4 543 26 92
Sheffield 1,590 45 315 492 292 247 198 1 662 747 164 17 1,395 14 181
Southern Derbyshire 1,320 30 275 372 245 202 190 6 426 770 96 28 1,026 93 201
South Humber 857 31 233 219 147 107 119 1 486 287 78 6 785 7 65
Eastern 14,623 302 2,830 3,878 2,902 2,460 2,204 47 6,743 6,582 1,093 205 8,961 2,441 3,221
Bedfordshire 1,855 34 365 566 346 311 227 6 935 698 183 39 1,196 340 319
Cambridgeshire 1,749 32 347 450 351 306 256 7 664 953 109 23 1,428 71 250
Hertfordshire 3,151 76 534 817 629 551 534 10 1,731 1,157 226 37 1,219 953 979
Norfolk 1,783 41 386 470 359 278 245 4 729 897 133 24 1,574 74 135
North Essex 2,384 46 454 606 454 425 389 10 1,042 1,148 173 21 997 594 793
South Essex 2,273 43 478 596 475 344 332 5 1,105 973 158 37 1,297 392 584
Suffolk 1,428 30 266 373 288 245 221 5 537 756 111 24 1,250 17 161
London 50,988 636 7,172 13,948 12,481 9,183 7,445 121 22,917 21,086 6,051 934 14,157 18,982 17,849
Barking and Havering 1,938 41 368 534 411 292 291 1 1,172 601 133 32 36 1,392 510
Barnet, Enfield & Haringey 5,516 66 776 1,483 1,261 1,023 896 10 2,519 2,267 623 107 1,607 1,573 2,336
Bexley, Bromley & Greenwich 3,394 65 638 903 704 581 496 7 1,457 1,579 303 55 1,641 818 935
Brent and Harrow 3,677 38 452 1,002 900 713 556 16 2,114 1,198 308 57 115 2,743 819
Camden and Islington 3,251 29 420 889 869 586 448 10 1,560 1,288 356 47 1,332 785 1,134
Croydon 2,112 35 350 556 437 365 362 7 980 857 242 33 37 1,546 529
Ealing, Hammersmith and
Hounslow 4,603 43 625 1,305 1,156 807 659 8 2,027 1,801 686 89 816 1,915 1,872
East London and The City 6,192 85 857 1,870 1,592 1,058 718 12 2,011 3,120 923 138 3,586 363 2,243
Hillingdon 1,274 20 222 345 266 231 186 4 673 470 115 16 219 674 381
Kensington, Chelsea and
Westminster 2,845 20 279 775 811 535 416 9 1,696 902 210 37 1,353 390 1,102
Kingston and Richmond 1,241 10 162 309 296 236 226 2 631 485 97 28 430 189 622
Lambeth, Southwark and
Lewisham 8,405 105 1,137 2,316 2,117 1,527 1,184 18 3,260 3,667 1,296 182 1,611 4,133 2,661
Merton, Sutton and Wandsworth 3,557 52 444 887 959 662 545 8 1,603 1,486 412 56 1,278 868 1,411
Redbridge and Waltham Forest 2,983 27 442 774 702 567 462 9 1,214 1,365 347 57 96 1,593 1,294
South East 25,469 517 4,843 6,630 5,144 4,095 4,154 86 11,778 10,780 2,496 415 7,060 11,992 6,417
Berkshire 2,920 42 517 749 660 478 468 6 1,402 1,089 362 67 541 1,337 1,042
Buckinghamshire 2,104 29 391 552 403 370 350 9 1,022 842 208 32 397 1,246 461
East Kent 1,704 45 363 445 371 222 252 6 900 612 163 29 24 1,373 307
East Surrey 1,176 31 189 281 248 187 230 10 656 414 91 15 148 718 310
East Sussex, Brighton and Hove 2,357 37 419 637 513 391 351 9 894 1,163 271 29 393 1,143 821
Isle of Wight, Portsmouth and
South East Hampshire 1,814 46 412 498 339 282 232 5 568 1,026 197 23 1,374 190 250
North and Mid Hampshire 1,365 27 257 366 258 214 240 3 719 499 129 18 147 798 420
Health Statistics Quarterly 14 S ummer 2002
National  Stat ist ics    66
Table 1
continued
Legal abortions: Regional Office and health authority of residence by age group,
gestation weeks and purchaser, 2001
England and Wales
Age group Gestation weeks Purchaser
 Place of usual residence Total* Under 16–19 20–24 25–29 30–34 35–44 45 and Under 9–12 13–19 20 and NHS NHS Non–
16 over 9 over contract NHS
South East continued
Northamptonshire 1,837 39 357 502 359 293 284 3 683 948 176 30 857 478 502
Oxfordshire 1,767 34 339 437 365 279 309 4 801 775 161 30 1,452 58 257
Southampton and South West
Hampshire 1,460 48 323 398 284 202 203 2 461 854 130 15 658 570 232
West Kent 3,056 71 594 768 577 525 513 8 1,714 1,019 264 59 85 2,360 611
West Surrey 1,937 26 335 507 394 315 351 9 1,132 618 147 40 209 1,221 507
West Sussex 1,972 42 347 490 373 337 371 12 826 921 197 28 775 500 697
South West 11,841 283 2,562 3,017 2,164 1,924 1,860 31 4,471 5,968 1,228 174 7,708 1,749 2,384
Avon 2,705 58 531 685 514 477 432 8 933 1,332 397 43 1,658 290 757
Cornwall and Isles of Scilly 1,067 31 241 259 190 184 160 2 176 789 82 20 899 60 108
Dorset 1,654 27 360 459 298 238 270 2 573 886 180 15 729 274 651
Gloucestershire 1,415 36 331 361 234 241 210 2 654 613 124 24 1,140 97 178
North and East Devon 971 32 215 253 172 159 137 3 432 459 69 11 910 19 42
Somerset 1,060 26 247 257 195 160 172 3 444 481 108 27 837 75 148
South and West Devon 1,431 41 330 369 257 205 222 7 490 793 136 12 1,168 187 76
Wiltshire 1,538 32 307 374 304 260 257 4 769 615 132 22 367 747 424
West Midlands 17,053 411 3,565 4,653 3,304 2,775 2,316 29 6,452 7,934 2,360 307 2,051 11,763 3,239
Birmingham 4,459 82 874 1,297 894 742 562 8 1,610 2,020 752 77 95 3,330 1,034
Coventry 1,515 35 346 469 307 204 153 1 657 685 149 24 10 1,448 57
Dudley 903 25 219 228 170 137 122 2 309 413 162 19 8 672 223
Herefordshire 382 11 77 98 64 65 66 1 216 129 31 6 323 16 43
North Staffordshire 1,039 24 227 294 199 173 121 1 304 575 143 17 110 670 259
Sandwell 1,120 34 216 293 255 175 143 4 407 493 194 26 13 929 178
Shropshire 1,045 17 227 253 183 196 167 2 440 478 99 28 210 646 189
Solihull 499 11 112 132 87 67 89 1 213 204 74 8 27 293 179
South Staffordshire 1,520 41 361 388 272 244 213 1 586 730 174 30 701 552 267
Walsall 726 27 159 181 150 114 95 0 162 418 134 12 430 113 183
Warwickshire 1,573 39 309 415 302 257 246 5 704 709 141 19 43 1,374 156
Wolverhampton 976 32 194 274 185 167 124 0 287 499 168 22 52 705 219
Worcestershire 1,296 33 244 331 236 234 215 3 557 581 139 19 29 1,015 252
North West 19,346 486 4,324 5,545 3,657 2,916 2,383 35 7,395 9,749 1,954 248 9,867 5,806 3,673
Bury and Rochdale 1,073 30 244 265 209 191 133 1 474 465 114 20 500 261 312
East Lancashire 1,333 52 327 359 250 185 156 4 558 612 149 14 1,167 21 145
Liverpool 1,775 23 406 594 319 250 180 3 384 1,139 226 26 1,109 265 401
Manchester 2,106 47 384 737 454 287 194 3 1,018 865 188 35 1,009 836 261
Morecambe Bay 682 20 165 210 113 91 82 1 192 431 57 2 496 90 96
North Cheshire 980 26 220 255 212 146 120 1 437 437 97 9 17 807 156
North West Lancashire 1,226 32 276 338 200 203 174 3 495 574 135 22 149 779 298
St. Helen’s and Knowsley 985 26 217 286 199 139 115 3 225 626 115 19 642 138 205
Salford and Trafford 1,455 38 305 429 280 219 183 1 576 749 116 14 916 216 323
Sefton 731 15 184 210 134 87 100 1 260 378 78 15 502 88 141
South Cheshire 1,601 35 353 412 270 257 268 6 532 851 195 23 607 708 286
South Lancashire 705 23 148 194 116 125 98 1 304 341 52 8 413 98 194
Stockport 815 21 180 192 139 150 131 2 326 416 68 5 258 401 156
West Pennine 1,449 43 336 388 299 219 163 1 655 636 146 12 497 714 238
Wigan and Bolton 1,510 33 353 408 307 241 166 2 702 677 115 16 988 171 351
Wirral 920 22 226 268 156 126 120 2 257 552 103 8 597 213 110
Wales 7,506 217 1,695 2,134 1,404 1,081 950 25 3,080 3,583 726 117 4,162 2,304 1,040
Bro Taf 2,127 62 442 678 408 291 242 4 801 1,118 174 34 1,522 130 475
Dyfed Powys 1,066 24 229 296 196 160 157 4 478 486 87 15 920 43 103
Gwent 1,415 50 324 385 248 214 187 7 656 592 144 23 390 884 141
Morgannwg 1,205 42 298 341 238 152 134 0 469 585 135 16 1,100 9 96
North Wales 1,693 39 402 434 314 264 230 10 676 802 186 29 230 1,238 225
* Includes cases with age not stated.
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Report:
Death registrations in
England and Wales, 2001:
causes
This report gives numbers of deaths registered in England and Wales in
2001 by age and sex, and for selected underlying causes of death. It
also compares death rates by sex and age with those for deaths that
occurred in 1999 and 2000.  The year 2001 is the first in which cause
of death has been coded according to the Tenth Revision of the
International Classification of Diseases (ICD-10).
Deaths by sex and age of deceased
 A total of 532,498 deaths were registered in 2001, compared with
537,877 registered in 2000, a decline of 1.0 per cent.
 The number of male deaths fell by 1.2 per cent and female deaths
by 0.8 per cent between 2000 and 2001.
Table 1 shows death rates by age and sex, for the years 1999 to 2001,
together with percentage changes.
 In 2001 the provisional crude death rates (based on mid-2000
population estimates) were 9.7 per thousand population for males,
and 10.4 per thousand for females.  These have fallen from 9.8
and 10.5 respectively in 2000, continuing the overall long-term
decline.
 The largest absolute percentage changes in age-specific death
rates occurred in the same age group for both sexes: the rate for
boys aged 5 to 9 fell by 11.5 per cent between 2000 and 2001,
while that for girls aged 5 to 9 rose by 26.5 per cent. However,
these are based on small numbers of deaths.
England and Wales
Age group 1999* 2000* 2001† Percentage change 1999–2000 Percentage change 2000–01
Males Females Males Females Males Females Males Females Males Females
Death rates per 1,000 population, by sex and age: 1999–2001*Table 1
All ages 10.2 10.9 9.8 10.5 9.7 10.4 -3.9 -4.4 -0.7 -0.4
Under 1** 6.5 5.1 6.1 5.1 6.0 5.0 -6.3 -1.0 -2.0 -1.2
 1–4 0.3 0.2 0.3 0.2 0.3 0.2 -16.5 -17.3 -1.8 10.6
 5–9 0.1 0.1 0.1 0.1 0.1 0.1 0.6 -6.0 -11.5 26.9
 10–14 0.2 0.1 0.2 0.1 0.2 0.1 2.4 -17.4 12.7 -4.5
 15–19 0.5 0.2 0.5 0.2 0.6 0.2 -3.5 -0.1 6.3 0.5
 20–24 0.8 0.3 0.8 0.3 0.8 0.3 -5.1 -2.3 4.2 1.3
 25–29 0.9 0.4 0.9 0.4 0.8 0.4 0.0 0.4 -2.8 -1.9
 30–34 1.0 0.5 1.0 0.5 1.0 0.5 -1.6 4.8 5.8 -1.1
 35–39 1.2 0.8 1.2 0.8 1.2 0.8 0.9 0.4 0.3 2.5
 40–44 1.9 1.3 1.8 1.3 1.9 1.2 -3.1 -1.2 3.9 -2.4
 45–49 3.0 2.0 3.0 2.0 3.0 2.0 -0.3 -2.0 1.2 -1.0
 50–54 4.8 3.1 4.6 3.2 4.6 3.1 -3.8 1.3 0.0 -1.3
 55–59 8.3 5.1 7.8 5.0 8.0 5.1 -5.7 -1.7 2.8 1.4
 60–64 13.8 8.5 13.3 8.0 12.9 7.9 -3.5 -5.5 -3.7 -1.3
 65–69 23.9 14.1 22.4 13.5 21.3 12.8 -6.3 -4.4 -5.1 -4.8
 70–74 40.6 24.9 38.3 23.1 36.5 22.5 -5.7 -7.0 -4.7 -2.9
 75–79 66.3 41.8 63.3 40.1 61.1 38.1 -4.6 -4.2 -3.5 -4.8
 80–84 108.1 72.3 99.4 66.9 103.7 69.4 -8.0 -7.4 4.3 3.7
 85 and over 187.9 154.8 181.3 147.6 184.4 148.6 -3.5 -4.6 1.7 0.6
* 1999 and 2000 rates are based on death occurrences;  2001 rates on death registrations.
** Deaths per 1,000 live births.
† Provisional rates based on mid-2000 population estimates.
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Figure 1 Male age-specific death rates as a percentage
of rates in 1991, England and Wales,
1991–2001
Figure 2 Female age-specific death rates as a
percentage of rates in 1991, England and
Wales, 1991–2001
 There were considerable percentage falls in the age-specific rates
for both males and females in the age groups 65 to 79 and for
males aged 60 to 64.
 The infant mortality rate in 2001 fell to 5.5 deaths per thousand
live births from 5.6 in 2000. Again, this continues the long-term
decline.
Figures 1 and 2 show the relative change between 1991 and 2001in age-
specific death rates for males and females respectively. The long-term
decline in death rates continued for most sex/age groups. The relative
fall between 1991 and 2001 was most pronounced at ages 1 to 14 for
both sexes. There was comparatively little decline in mortality rates at
ages 15 to 44 and 85 and over during the ten-year period. Male death
rates declined more than female rates in every age group shown.
However, absolute mortality rates remain higher in males for every age
group.
Deaths by underlying cause
Table 2 gives deaths by sex and age for selected underlying causes of
death.
In 2001 the main causes of death were cancer, accounting for 26 per
cent of all deaths, ischaemic heart disease (IHD), 20 per cent,
respiratory diseases, 13 per cent, and cerebrovascular diseases (stroke
and related conditions), 11 per cent.
Within these overall percentages, there are some differences between
the figures for males and females.  Higher proportions of men than
women died of cancer (28 and 24 per cent respectively) and of IHD (23
and 17 per cent respectively), while more women than men died of
cerebrovascular diseases (13 and 9 per cent).  However, the proportions
dying of respiratory diseases were similar (12 per cent of males and 13
per cent of females).
EXPLANATORY NOTES
Coding of underlying cause of death
Since January 2001 cause of death has been coded to the Tenth
Revision of the International Classification of Diseases (ICD-10).1,2,3
This was introduced on the recommendation of the World Health
Organization (WHO) and replaced the Ninth Revision (ICD 9)4,5 which
had been in use since 1979.  ICD-10 represents the largest change in the
ICD in over 50 years.  The major changes have been described in detail
in Health Statistics Quarterly 086 and 13.7 In order to help quantify the
changes, ONS has carried out a bridge coding study.  All deaths
registered in 1999 were independently coded to both ICD-9 and ICD-10
and the causes in each revision compared using internationally agreed
groups of equivalent codes. The results can be found in the Report
‘Results of the ICD bridge coding study, England and Wales, 1999’ in
this publication.8
Cause of death is assigned by an automated coding system with the
exception of deaths due to external causes (ICD-10 codes V01-Y89).
These are coded clerically using information from coroners’ certificates
(including inquest verdicts) to produce consistent figures on suicides,
homicides, and other deaths not from natural causes.
Occurrences and registrations
The year in which a death is registered may not equate to the year of
occurrence of that death. Up to 1992 ONS (formerly OPCS)
publications gave numbers of deaths registered in the data year.
However, since 1993 most of our published figures represent the
number of deaths which occurred in the data year.  This change has
little effect on annual totals but makes it easier to analyse seasonal
variations in mortality.  We, therefore, take two annual extracts:9
 The first annual extract from our deaths database, produced in April
following the data year, comprises registrations in that year.  Outputs
produced using this extract include this Report and an area-based
Report in Population Trends, as well as the annual VS tables and the
Compendium of Clinical and Health Indicators.
 The second extract is produced in the September following the year
to which it relates, and comprises occurrences in the data year. This
extract forms the basis for the annual mortality reference volumes in
the DH series.
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Table 2 Deaths by age, sex and underlying cause, 2001 registrations
 * The figures for individual cause categories exclude deaths at ages under 28 days.
Age group
ICD10 code Causes of death * All  Under 1  1–4  5–14  15–24  25–34  35–44  45–54  55–64  65–74  75–84  85 and
ages over
A00-R99, All causes, all ages M 253,608 1,818 329 512 2,203 3,830 6,184 13,424 27,599 57,638 87,238 52,833
V01-Y89 F 278,890 1,449 272 369 858 1,665 3,858 8,984 17,608 40,639 89,036 114,152
All causes, ages under M 1,205 1,205 - - - - - - - - - -
28 days F 943 943 - - - - - - - - - -
A00-R99, All causes, ages 28 days M 252,403 613 329 512 2,203 3,830 6,184 13,424 27,599 57,638 87,238 52,833
V01-Y89 and over F 277,947 506 272 369 858 1,665 3,858 8,984 17,608 40,639 89,036 114,152
A00-B99 Certain infectious and M 2,026 62 34 20 33 85 153 159 174 346 590 370
parasitic diseases F 2,253 37 19 19 34 63 69 92 142 328 685 765
A00-A09 Intestinal infectious M 260 - 2 - - - 2 2 3 35 105 111
diseases F 514 1 - - - 1 - 5 9 32 185 281
A15-A16 Respiratory tuberculosis M 167 - - - 2 5 13 12 14 42 66 13
F 112 - - - 1 2 2 6 13 40 33 15
A17-A19 Other tuberculosis M 48 - - - 1 6 2 5 3 11 16 4
F 46 - - 1 1 6 - 1 6 11 9 11
A39 Meningococcal infection M 100 20 19 8 16 6 12 6 8 3 1 1
F 96 16 14 6 12 5 5 8 11 7 8 4
A40-A41 Septicaemia M 811 25 8 8 5 15 18 30 71 151 294 186
F 987 9 2 5 7 18 18 31 59 152 339 347
B15-B19 Viral hepatitis M 135 - - - 2 2 29 51 25 15 10 1
F 62 - - - 2 1 8 6 7 22 13 3
B20-B24 Human immunodeficiency M 129 3 - - 1 35 51 23 9 6 1 0
virus [HIV] disease F 48 1 1 2 1 15 16 4 6 - - 2
B90 Sequelae of tuberculosis M 30 - - - 1 - - - - 9 14 6
F 41 - - - - - - 2 - 10 23 6
C00-D48 Neoplasms M 72,259 8 44 103 180 400 1,113 4,264 10,978 20,973 24,517 9,679
F 67,279 8 36 101 123 479 1,616 4,730 9,133 16,106 21,673 13,274
C00-C97 Malignant neoplasms M 70,661 5 39 94 176 382 1,074 4,208 10,839 20,607 23,913 9,324
F 65,573 5 33 95 119 463 1,588 4,671 9,007 15,838 21,046 12,708
C00-C14 Malignant neoplasms of lip, M 1,097 - - 1 2 10 22 186 291 282 218 85
oral cavity and pharynx F 597 - - - 1 6 17 59 104 143 163 104
C15 Malignant neoplasm of M 3,915 - - - 2 11 51 338 752 1,173 1,221 367
oesophagus F 2,222 - - - - 1 19 95 210 502 842 553
C16 Malignant neoplasm of stomach M 3,494 - - 1 - 13 47 154 461 1,082 1,244 492
F 2,160 - - - - 10 35 95 164 476 792 588
C18 Malignant neoplasm of colon M 4,801 - - - 3 10 50 284 692 1,469 1,611 682
F 4,665 - - - 4 8 49 202 506 996 1,629 1,271
C19-C21 Malignant neoplasm of rectosigmoid M 2,683 - - - - 5 48 184 480 798 858 310
junction, rectum and anus F 2,014 - - - 1 11 34 95 209 406 685 573
C22 Malignant neoplasm of liver and M 1,175 - 1 - 6 16 25 90 227 344 344 122
intrahepatic bile ducts F 880 - 1 3 1 5 7 42 104 222 341 154
C23-C24 Malignant neoplasm of gallbladder M 184 - - - - - 1 6 26 61 61 29
and biliary tract F 343 - - - - 1 6 16 51 88 100 81
C25 Malignant neoplasm of pancreas M 2,869 - - - - 7 57 212 553 870 864 306
F 3,158 - - - 1 - 34 131 394 798 1,155 645
C32 Malignant neoplasm of larynx M 611 - - - - 1 7 54 145 167 178 59
F 143 - - - - 2 1 13 24 40 33 30
C33-C34 Malignant neoplasm of trachea, M 17,667 - - - - 16 113 940 2,962 5,920 6,109 1,607
bronchus and lung F 11,183 - - - - 11 100 705 1,692 3,514 3,949 1,212
England and Wales Numbers
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Table 2
continued
Deaths by age, sex and underlying cause, 2001 registrations
* The figures for individual cause categories exclude deaths at ages under 28 days.
Age group
ICD10 code Causes of death * All  Under 1  1–4  5–14  15–24  25–34  35–44  45–54  55–64  65–74  75–84  85 and
ages over
C43 Malignant melanoma of skin M 757 - - - 4 27 52 112 151 176 177 58
F 718 - - - 6 19 48 92 118 152 172 111
C44 Other malignant neoplasms of skin M 218 - - - 1 - 2 9 17 46 70 73
F 184 - - - 1 - 1 5 6 16 41 114
C45 Mesothelioma M 1,340 - - - 1 - 10 88 346 458 364 73
F 247 - - - - 1 3 16 47 68 87 25
C46 Kaposi’s sarcoma M 4 - - - - - 1 1 - - - 2
F 1 - - - - - - - - - - 1
C50 Malignant neoplasm of breast M 80 - - - - - - 5 13 19 33 10
F 11,574 - - - 3 111 620 1,412 1,974 2,367 2,855 2,232
C53 Malignant neoplasm of cervix F 1,046 - - - 6 66 119 169 158 184 255 89
uteri
C54-C55 Malignant neoplasm of other and F 1,400 - - - - 3 12 76 216 380 440 273
unspecified parts of uterus
C56 Malignant neoplasm of ovary F 4,078 - - - - 25 82 433 815 1,143 1,112 468
C61 Malignant neoplasm of prostate M 8,936 1 - - - - 4 83 559 2,048 3,900 2,341
C62 Malignant neoplasm of testis M 58 - - - 4 10 15 6 6 10 4 3
C64 Malignant neoplasm of kidney, M 1,636 - 1 3 - 14 31 168 328 493 453 145
except renal pelvis F 1,022 - 1 4 2 2 18 65 165 277 333 155
C67 Malignant neoplasm of bladder M 2,955 - - 1 - 2 14 68 298 761 1,159 652
F 1,480 - - - - 2 11 35 84 280 588 480
C71 Malignant neoplasm of brain M 1,726 1 15 17 23 69 142 288 439 432 261 39
F 1,236 - 8 27 22 40 83 156 244 361 223 72
C81 Hodgkin’s disease M 133 - - 2 15 11 18 16 16 24 24 7
F 98 - - - 6 9 9 7 14 19 25 9
C82-C85 Non-Hodgkin’s lymphoma M 2,136 - 3 8 18 31 81 181 392 586 625 211
F 1,938 - 1 3 7 24 34 109 276 488 658 338
C90 Multiple myeloma and malignant M 1,141 - - - - 2 16 64 200 336 378 145
plasma cell neoplasms F 1,088 - - - - 1 7 31 131 278 422 218
C91-C95 Leukaemia M 2,114 2 8 40 45 52 80 139 265 513 657 313
F 1,679 2 12 36 21 42 53 100 191 321 512 389
C97 Malignant neoplasms of independent M 532 - 1 1 2 - 3 21 60 139 205 100
(primary) multiple sites F 420 - - 1 - 4 9 25 58 109 131 83
D00-D48 In situ and benign neoplasms, and M 1,598 3 5 9 4 18 39 56 139 366 604 355
neoplasms of uncertain or unknown F 1,706 3 3 6 4 16 28 59 126 268 627 566
behaviour
D50-D89 Diseases of the blood and M 416 3 5 11 13 16 30 28 39 56 113 102
blood-forming organs and certain F 580 4 5 6 9 12 11 27 35 78 140 253
disorders involving the immune
mechanism
D50-D64 Anaemias M 166 1 1 4 7 5 7 5 7 13 45 71
F 355 1 2 3 2 2 3 8 9 35 80 210
E00-E90 Endocrine, nutritional and M 3,545 12 13 27 44 60 121 206 397 880 1,153 632
metabolic diseases F 4,197 14 24 17 44 41 79 114 261 669 1,378 1,556
E10-E14 Diabetes mellitus M 2,954 - - - 4 31 73 151 318 769 1,039 569
F 3,200 - 2 1 9 15 41 54 182 548 1,140 1,208
F00-F99 Mental and behavioural disorders M 4,840 - - 4 159 386 266 179 135 381 1,518 1,812
F 9,434 - 2 3 40 69 67 73 80 296 2,564 6,240
England and Wales Numbers
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Table 2
continued
Deaths by age, sex and underlying cause, 2001 registrations
* The figures for individual cause categories exclude deaths at ages under 28 days. 
Age group
ICD10 code Causes of death * All  Under 1  1–4  5–14  15–24  25–34  35–44  45–54  55–64  65–74  75–84  85 and
ages over
F01,F03 Vascular and unspecified dementia M 3,634 - - - - - 1 10 39 325 1,473 1,786
F 8,929 - - - - - - 5 33 262 2,485 6,144
F10-F19 Mental and behavioural disorders M 1,119 - - 4 159 385 259 165 91 39 13 4
due to psychoactive substance use F 296 - - 2 38 66 58 60 40 21 5 6
G00-G99 Diseases of the nervous system M 6,532 42 56 70 132 164 251 354 525 1,133 2,379 1,426
F 7,844 32 39 49 79 114 178 325 507 1,033 2,554 2,934
G00-G03 Meningitis M 109 8 8 3 5 11 9 12 18 13 15 7
(excluding meningococcal) F 79 3 7 3 4 4 2 7 10 8 22 9
G12.2 Motor neuron disease M 773 1 - - - 6 17 72 156 258 220 43
F 661 - - - - 1 6 34 122 219 222 57
G20 Parkinson’s disease M 2,156 - - - 1 - - 4 39 332 1,115 665
F 1,705 - - - - - - 3 27 180 749 746
G30 Alzheimer’s disease M 1,389 - - - - - - 9 35 192 619 534
F 3,194 - - - - - - 9 49 266 1,124 1,746
G35 Multiple sclerosis M 296 - - - 1 14 30 57 70 72 43 9
F 591 - - - 1 8 48 138 135 147 98 16
H00-H59 Diseases of the eye and adnexa M 6 1 - - - - 1 1 1 - 1 1
F 13 - - - - 1 - - - - - 12
H60-H95 Diseases of the ear and M 10 1 - - 1 - 2 2 1 1 1 1
mastoid process F 10 1 - - - 1 - - 2 - 2 4
I00-I99 Diseases of the circulatory system M 101,506 25 11 28 99 337 1,317 4,454 10,358 24,055 38,452 22,370
F 110,849 16 18 23 60 154 590 1,558 4,162 14,134 39,347 50,787
I05-I09 Chronic rheumatic heart diseases M 350 - - - 3 4 6 17 37 96 129 58
F 960 1 - - 1 2 5 16 84 247 362 242
I10-I15 Hypertensive diseases M 1,388 - - - 1 7 19 102 177 314 523 245
F 1,928 - - - 2 3 16 35 109 268 661 834
I20-I25 Ischaemic heart diseases M 58,695 2 2 1 5 103 771 3,101 7,282 15,401 21,525 10,502
F 47,482 - - 1 4 19 170 642 2,160 7,363 17,797 19,326
I21-I22 Acute myocardial infarction M 26,117 2 1 - 3 56 377 1,440 3,339 7,134 9,696 4,069
F 20,495 - - - 3 10 97 296 1,072 3,697 8,198 7,122
I26-I51 Other heart diseases M 9,853 16 6 18 61 120 225 401 722 1,695 3,499 3,090
F 14,952 14 17 17 38 39 127 202 456 1,339 4,602 8,101
I60-I69 Cerebrovascular diseases M 22,242 3 1 8 23 68 211 594 1,379 4,141 9,120 6,694
F 36,427 - 1 5 9 61 206 493 988 3,535 12,451 18,678
I60-I62 Intracranial haemorrhage M 3,324 - - 7 20 57 164 401 599 799 912 365
F 4,311 - - 5 7 51 170 368 527 959 1,363 861
I63 Cerebral infarction M 2,755 - 1 - 2 6 19 58 188 548 1,130 803
F 3,719 - 1 - 1 4 11 39 94 367 1,362 1,840
I64 Stroke, not specified as M 12,159 - - - 1 3 20 111 488 2,249 5,339 3,948
haemorrhage or infarction F 21,759 - - - - 3 16 71 312 1,836 7,601 11,920
I70 Atherosclerosis M 440 - - - - - 2 3 11 72 179 173
F 750 - - - - - - 2 9 40 210 489
I71 Aortic aneurysm and dissection M 5,474 - 2 - 3 8 28 77 426 1,589 2,355 986
F 3,627 - - - - 5 12 23 106 640 1,647 1,194
J00-J99 Diseases of the respiratory system M 31,092 52 27 16 39 93 250 630 1,927 5,871 12,064 10,123
F 36,376 30 29 29 38 58 162 474 1,355 4,474 11,473 18,254
J10-J11 Influenza M 18 2 2 - - - 1 - 1 1 5 6
F 22 - 1 1 1 1 1 2 - 1 7 7
England and Wales
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Table 2
continued
Deaths by age, sex and underlying cause, 2001 registrations
* The figures for individual cause categories exclude deaths at ages under 28 days. 
Age group
ICD10 code Causes of death * All  Under 1  1–4  5–14  15–24  25–34  35–44  45–54  55–64  65–74  75–84  85 and
ages over
J12-J18 Pneumonia M 12,242 16 8 3 15 39 110 252 501 1,407 4,243 5,648
F 19,436 16 8 6 8 24 80 155 304 1,129 4,948 12,758
J40-J44 Bronchitis, emphysema and other M 13,114 - - - 1 2 32 195 957 3,309 5,707 2,911
chronic obstructive pulmonary F 10,581 - 1 - 2 3 10 168 711 2,578 4,524 2,584
diseases
J45-J46 Asthma M 458 - 4 5 9 18 35 51 73 96 92 75
F 815 - 2 13 13 13 32 54 84 153 227 224
K00-K93 Diseases of the digestive system M 10,647 16 12 7 28 169 684 1,404 1,570 2,081 2,966 1,710
F 12,789 17 10 11 19 116 361 815 995 1,901 4,068 4,476
K25-K27 Gastric and duodenal ulcer M 1,746 - - 1 2 6 31 86 177 396 646 401
F 2,070 - - - 2 5 12 46 103 307 780 815
K40-K46 Hernia M 296 1 - - - 2 5 5 14 43 123 103
F 487 1 - - 1 - 1 7 22 52 178 225
K57 Diverticular disease of intestine M 475 - - - - 2 6 17 37 107 193 113
F 1,326 - - - 1 - 3 10 47 187 512 566
K70-K76 Diseases of the liver M 3,735 2 2 1 11 112 548 1,068 921 617 362 91
F 2,377 3 3 1 5 63 273 583 507 446 376 117
L00-L99 Diseases of the skin and M 359 - - - - - 3 15 24 67 124 126
subcutaneous tissue F 926 - - - 4 7 8 18 24 93 309 463
M00-M99 Diseases of the musculoskeletal M 1,291 - 1 5 7 13 15 56 100 256 427 411
system and connective tissue F 3,313 1 4 4 5 10 26 60 143 366 1,058 1,636
M05-M06, Rheumatoid arthritis and M 239 - - - - 1 1 7 23 84 90 33
M08 juvenile arthritis F 735 - - 1 - - 5 6 53 138 328 204
M80-M81 Osteoporosis M 316 - - - - - 1 3 10 21 102 179
F 1,238 - - - - - - 3 12 41 313 869
N00-N99 Diseases of the genitourinary M 3,268 1 1 2 9 12 23 74 162 490 1,263 1,231
system F 4,423 4 1 2 9 13 35 69 170 445 1,404 2,271
N00-N15 Glomerular and renal M 374 - - - 4 3 3 17 21 91 147 88
tubulo-interstitial diseases F 438 2 1 - 2 3 8 15 25 69 158 155
N17-N19 Renal failure M 1,372 - 1 2 3 7 11 41 81 206 528 492
F 1,461 2 - - 3 5 18 19 68 159 446 741
N40 Hyperplasia of prostate M 162 - - - - - - - 3 22 72 65
O00-O99 Pregnancy, childbirth and F 45 - - - 8 25 12 - - - - -
the puerperium
P00-P96 Certain conditions originating M 105 97 6 1 1 - - - - - - -
in the perinatal period F 79 71 4 2 2 - - - - - - -
Q00-Q99 Congenital malformations, M 634 99 46 38 60 50 68 53 102 59 47 12
deformations and chromosomal F 651 126 28 34 30 50 50 69 90 72 64 38
abnormalities
Q20-Q28 Congenital malformations of M 313 49 21 22 35 30 39 27 35 31 19 5
the circulatory system F 278 64 10 20 14 18 26 22 23 36 33 12
R00-R99 Symptoms, signs and abnormal M 3,048 154 15 5 33 76 91 123 94 100 442 1,915
clinical and laboratory findings, F 10,357 111 9 3 14 23 36 46 66 73 975 9,001
not elsewhere classified
R54 Senility without mention of M 2,234 - - - - - - - - 10 363 1,861
psychosis F 9,699 - - - - - - - - 22 899 8,778
R95 Sudden infant death syndrome M 114 113 1 - - - - - - - - -
F 76 75 1 - - - - - - - - -
England and Wales Numbers
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Table 2
continued
Deaths by age, sex and underlying cause, 2001 registrations
Age group
ICD10 code Causes of death * All  Under 1  1–4  5–14  15–24  25–34  35–44  45–54  55–64  65–74  75–84  85 and
ages over
R99 Other ill-defined and unspecified M 570 41 8 4 25 64 82 114 92 77 49 14
causes of mortality F 325 36 6 2 11 19 33 44 58 40 43 33
V01-Y89 External causes of morbidity M 10,819 40 58 175 1,365 1,969 1,796 1,422 1,012 889 1,181 912
and mortality F 6,529 34 44 66 340 429 558 514 443 571 1,342 2,188
V01-X59 Accidents M 6,210 22 38 139 798 942 845 632 533 555 906 800
F 4,811 15 34 46 195 182 246 245 221 404 1,160 2,063
V01-V99, Transport accidents ** M 2,340 3 15 96 555 488 363 234 191 165 159 71
Y85 F 783 1 14 32 130 98 79 64 72 93 128 72
V01-V89 Land transport accidents M 2,272 3 14 95 544 473 352 219 185 160 156 71
F 769 1 14 31 126 96 77 63 70 93 127 71
W00-W19 Falls M 1,329 - 1 5 29 50 101 148 154 211 371 259
F 1,367 - 2 1 5 11 43 66 68 142 439 590
W65-W74 Accidental drowning and M 158 1 5 7 27 27 25 26 17 9 11 3
submersion F 47 1 8 3 2 5 9 9 3 1 4 2
X00-X09 Exposure to smoke, M 185 2 7 7 13 27 25 23 16 24 28 13
fire and flames F 146 - 3 4 8 6 14 15 8 16 29 43
X40-X49 Accidental poisoning by and M 806 - 1 1 118 263 220 109 45 21 18 10
exposure to noxious substances F 315 - 1 1 39 50 79 58 29 23 27 8
X41 Accidental poisoning by and M 73 - - - 10 25 18 13 3 2 2 -
exposure to antiepileptic, F 74 - - 1 8 12 18 16 8 5 5 1
sedative-hypnotic, antiparkinsonism
and psychotropic drugs,
not elsewhere classified
X42 Accidental poisoning by and M 380 - 1 - 59 158 116 39 4 1 1 1
exposure to narcotics and F 73 - - - 15 18 19 11 3 2 4 1
psychodysleptics [hallucinogens],
not elsewhere classified
X44 Accidental poisoning by and M 159 - - - 30 55 37 13 9 8 5 2
exposure to other and unspecified F 85 - - - 9 10 25 13 8 6 10 4
drugs, medicaments and
biological substances
X59 Accidental exposure to unspecified M 867 1 2 2 7 15 29 30 43 88 258 392
factor F 1,871 1 - 1 1 3 9 16 18 95 472 1,255
X60-X84 Intentional self-harm M 2,639 - - 3 261 598 575 509 304 178 148 63
F 739 - - 2 50 100 156 133 132 68 66 32
X85-Y09 Assault M 294 9 8 9 74 85 55 18 20 9 5 2
F 131 7 4 8 22 22 30 15 3 7 11 2
Y10-Y34 Event of undetermined intent M 1,432 9 10 19 224 337 302 237 130 98 48 18
F 608 10 5 9 71 122 117 103 56 51 43 21
X60-X84, Intentional self-harm and event M 3,695 1 2 10 410 837 802 699 410 260 185 79
Y10-Y34 of undetermined intent*** F 1,209 4 - 7 99 193 244 217 179 115 102 49
excl. Y33.9
X85-Y09, Assault; and other specified M 670 17 16 21 149 183 130 65 44 25 16 4
Y33.9 events of undetermined intent F 269 13 9 12 44 51 59 34 12 11 18 6
* The figures for individual cause categories exclude deaths at ages under 28 days.
** Including sequelae of transport accidents.
*** Code Y33.9 is excluded as it is used to identify deaths registered after an adjourned inquest. Most of these are later re-coded to homicide. See sections 2.9 and 3.5 in the notes to the
annual reference volume Mortality Statistics: Injury and Poisoning 1999, series DH4 no 24.
England and Wales Numbers
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Report:
Results of the ICD-10
bridge coding study,
England and Wales, 1999
INTRODUCTION
In England and Wales, cause of death data for 2001 are the first to be
coded to the International Classification of Diseases Tenth Revision
(ICD-10). The previous revision, ICD-9, was in use since 1979. The
change to ICD-10 represents the largest change to cause of death
statistics in over 50 years.
The major changes were described in detail in Health Statistics
Quarterly 081 and 13.2 The first character of the ICD code is now a
letter. This has enabled expansion of the number of codes to provide for
recently recognised conditions and more detail about common disease.
Some diseases and groups of conditions have moved between ICD
Chapters to reflect current ideas of aetiology and pathology.
The changes that have the largest effect on mortality statistics, however,
are in the rules used to select the underlying cause of death from the
diseases and injuries listed on the death certificate. A table summarising
the changes to all of the mortality rules is given in the report of the
United States comparability study.3 Most notably, the change in Rule 3
has a particularly large effect. This Rule is described fully in Box 1 in
Health Statistics Quarterly 13.2 Briefly, it allows a condition which is
reported in either Part I or II of the death certificate to take precedence
over the condition selected using the other coding rules if the latter is
obviously a direct consequence of the former. In ICD-10 the list of
conditions affected by Rule 3 is more clearly defined than in ICD-9 and
is also broader in scope. The impact of this is to reduce the number of
deaths assigned to conditions such as pneumonia and to increase the
number of deaths assigned to chronic debilitating diseases. In England
and Wales, about 20 per cent of deaths mention pneumonia so that the
effect of this rule change is large.
In order to help quantify the changes described above, ONS has carried
out a bridge coding study. All deaths registered in 1999 were
independently coded to both ICD-9 and ICD-10 and the causes in each
revision compared, using internationally agreed groups of equivalent
codes. In carrying out the bridge coding study minor errors in coding in
both ICD-9 and ICD-10 were identified. The policy on correction was
to change any mistakes found in ICD-10 coding, but not to change the
ICD-9 codes, as mortality statistics using the latter had already been
published. This has only a very small impact on the results.
TRANSFERS OF DEATHS BETWEEN ICD CHAPTERS
Table 1 shows a crosstabulation of deaths registered in 1999 grouped by
Chapter in both ICD-10 and ICD-9. The table shows that the vast
majority of deaths (around 95 per cent) remained in comparable
Chapters in ICD-10. However, there were substantial movements in and
out of some Chapters, reflecting both changes in classification of
specific causes, and changes in selection of underlying cause from the
combination of codes on a given certificate. These changes are
discussed in the section on comparability ratios below.
COMPARABILITY RATIOS
Comparability ratios indicate the net effect of the change in
classification on a particular cause. These ratios are calculated by
dividing the number of deaths coded to a particular cause in ICD-10 by
the number coded to that cause in ICD-9. A ratio of 1 means that the
number of deaths coded to that cause is the same in both revisions. If
the comparability ratio is 0.5 it means that half as many deaths have
been coded to that cause in ICD-10 as in ICD-9. A ratio of exactly 1
does not necessarily mean that assignment of deaths to that category is
unchanged. It may mean that the same numbers of deaths have moved
into and out of the category.
We have calculated comparability ratios for 108 causes of death. These
were selected by including all of the causes of death on the ICD-10
ONS Standard Short List, the majority of the causes listed on the
European Union Short List, and causes requested during consultation
with users. Advice on the use of these ratios to adjust ICD-9-coded data
for earlier years is also provided in this report.
Comparability ratios are shown in Table 2 of this report. The main
changes are presented below, by ICD-10 Chapter.
I Certain infectious and parasitic diseases
Overall, the number of deaths assigned to this Chapter has increased by
11 per cent (a ratio of 1.11) for females and six per cent (a ratio of 1.06)
for males. Significant changes within the Chapter are seen for intestinal
infectious diseases, with a 34 per cent increase for females and a 22 per
Health Statistics Quarterly 14 Summer 2002
National  Stat ist ics    76
ICD-10 Chapter
I Certain infectious and parasitic diseases 3,051 27 5 15 5 17 70 402
II Neoplasms 67 135,443 1,002 108 26 9 153 3,295
III Diseases of the blood and blood-forming organs
and certain disorders involving the immune
mechanism 113 13 786 64 7 0 15 49
IV Endocrine, nutritional and metabolic diseases 10 14 6 7,074 48 52 258 286
V Mental and behavioural disorders 3 3 0 18 8,449 19 135 4,675
VI-VIII Diseases of the nervous system and sense organs 11 20 5 8 919 9,772 259 3,658
IX Diseases of the circulatory system 47 73 22 92 1,338 91 215,886 8,217
X Diseases of the respiratory system 61 70 10 45 111 103 349 73,775
XI Diseases of the digestive system 100 57 2 25 109 7 171 528
XII Diseases of the skin and subcutaneous tissue 22 2 0 8 4 7 37 21
XIII Diseases of the musculoskeletal system and
connective tissue 46 14 5 21 14 19 270 1,102
XIV Diseases of the genitourinary system 19 28 1 24 18 12 80 79
XV Pregnancy, childbirth and the puerperium 0 0 0 0 0 0 2 1
XVI Certain conditions originating in the
perinatal period 21 0 0 1 0 6 4 13
XVII Congenital malformations, deformations and
chromosomal abnormalities 3 12 2 7 0 15 42 152
XVIII Symptoms, signs and abnormal clinical and
laboratory findings, not elsewhere classified 1 1 0 14 17 3 111 12
XX External causes of morbidity and mortality 36 14 9 13 80 32 220 188
Total 3,611 135,791 1,855 7,537 11,145 10,164 218,062 96,453
ICD-9 Chapter I II IV III V VI VII VIII
Infectiious Neoplasms Diseases of Endocrine, Mental Diseases Diseases Diseases
and parasitic the blood and nutritional and disorders of the of the of the
diseases blood-forming metabolic nervous circulatory respiratory
organs diseases, and system system system
immunity and sense
disorders organs
Table 1 Underlying cause of death by Chapter in ICD-10 and ICD-9
cent increase for males, and for septicaemia, with a 13 per cent increase
for females and a 10 per cent increase for males.
For both of these causes, a proportion of the increase is due to the
application of Rule 3 to deaths involving pneumonia. Intestinal
infectious diseases have also increased due to the fact that various types
of non-specific gastroenteritis are now indexed to diarrhoea of
presumed infectious origin. Septicaemia has also increased because a
variety of infections previously coded to non-specific Chapter codes
have now been coded to septicaemia.
Two factors have affected the number of deaths allocated to non-
respiratory tuberculosis. Firstly the application of Rule 3 means that
more deaths have been allocated to this cause. Two assumptions used in
ICD-9 are no longer used in ICD-10. These relate to some forms of
abscess and lupus. In ICD-9 they were assumed to be tuberculous even
if this was not stated on the death certificate. This assumption is not
made in ICD-10, so the number of deaths allocated to non-respiratory
tuberculosis has declined as a result. This has counter-acted the effect
of Rule 3. The decline is significant for males but not for females.
II Neoplasms
The Neoplasms Chapter as a whole has been widened to include some
‘disorders of blood’ from Chapter III, causing an increase of three per
cent for females and four per cent for males in the number of deaths
allocated to this Chapter. Malignant neoplasms as a whole have
increased by about two per cent for females and three per cent for
males.
A number of specific cancers showed no change in the number of
deaths allocated to them in ICD-10 compared to ICD-9 for both males
and females. These include pancreas, cervix, testis, kidney, eye, brain
and other parts of the central nervous system, and non-Hodgkin’s
lymphoma.
A number of cancers have shown small increases or decreases in one or
both sexes which are statistically significant because of the relatively
large number of deaths coded to them.
The following codes are newly introduced in ICD-10 – C45
Mesothelioma, C46 Kaposi’s sarcoma, and C97 Independent primary
multiple sites.
The number of deaths assigned to Malignant melanoma (C43) has
decreased and the number of deaths assigned to Other malignant
neoplasm of skin (C44) has increased. Both causes have gained deaths
as a result of the application of Rule 3. However, other malignant
neoplasm of skin has gained some deaths coded to malignant melanoma
in ICD-9, but malignant melanoma has not gained any deaths from
other malignant neoplasm of skin. In addition, both have lost deaths to
the new C97 code.
Larger changes of note are an increase in deaths allocated to malignant
neoplasms of lymphoid, haematopoitic and related tissue, especially
multiple myeloma and leukaemia. The exact definitions of these cancers
have changed slightly in ICD-10. However, the increases are still
apparent if the exact ICD-9 equivalents to the new groups in ICD-10 are
used rather than the ICD-9 codes formerly in use.
These and other changes to deaths from cancer as a result of the
introduction of ICD-10 will be explored in more detail in a later article.
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III Diseases of the blood and blood-forming organs
and certain disorders involving the immune
mechanism
The number of deaths assigned to this Chapter has decreased overall.
This is because myelodysplastic syndromes and chronic myeloprolific
diseases have been reclassified to In situ and benign neoplasms and
neoplasms of uncertain behaviour in Chapter II. Although this Chapter
has gained ‘certain disorders involving the immune mechanism’ from
Chapter IV, the numbers involved are small.
IV Endocrine, nutritional and metabolic diseases
There has been an increase of five per cent in females and four per cent
in males in the number of deaths allocated to this Chapter. Diabetes has
shown an increase of around four per cent for both males and females,
due to the application of Rule 3. This increase in diabetes is not as great
as the decrease seen following the introduction of automatic cause
coding in 1993, which was around 20 to 25 per cent.4
V Mental and behavioural disorders
The number of deaths allocated to mental and behavioural disorders has
increased by around 20 per cent. This is as a result of the application of
Rule 3. Within the Chapter, large increases are seen in the number of
deaths allocated to dementia (an increase of over 50 per cent in females
and over 60 per cent in males). There has been no increase in the
number of deaths allocated to drug use (excluding alcohol and tobacco).
There has been no change in the number of deaths allocated to mental
and behavioural disorders due to the use of alcohol for males, but a
decline of 11 per cent was seen for females. There appears to have been
some reassignment of deaths from this group to Alcoholic liver disease
(K70). The changes in alcohol-related deaths will be examined in more
detail in a later paper.
VI Diseases of the nervous system
Diseases of the nervous system have also shown an increase in ICD-10,
due to the application of Rule 3. Within the Chapter, meningitis showed
no change and increases were seen for motor neuron disease,
Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, with
very substantial increases for Parkinson’s disease (49 per cent for both
sexes) and Alzheimer’s disease (89 per cent for females, 110 per cent
for males). The relationship between the changes to dementia and
Alzheimer’s disease is complex and will be examined in more detail in
a later paper.
VII Diseases of the eye and adnexa and VIII Diseases
of the ear and mastoid process
These are new Chapters in ICD-10, having previously been part of
Chapter VI, Diseases of the nervous system and sense organs, in ICD-9.
The number of deaths classified to these Chapters is extremely small
and has not shown a significant change for females or males.
IX Diseases of the circulatory system
Diseases of the circulatory system showed a four per cent increase
between ICD-9 and ICD-10 for females and a three per cent increase
for males. Within the Chapter, ischaemic heart disease (IHD) showed
little change, whereas cerebrovascular diseases (CVD) showed
increases of nine per cent for females and 13 per cent for males. This
latter change is due to the application of Rule 3 to deaths involving
pneumonia. Within the CVD group, there has been a small increase in
stroke (not specified as haemorrhage or infarction) and a larger increase
in cerebral infarction. However, the numbers for the latter are much
smaller, and they have less of an impact on the overall comparability
ratio for CVD.
ICD-10
177 37 15 52 0 5 3 12 9 3,902 291 8.1 I
95 0 8 33 0 0 6 3 33 140,281 4,490 3.3 II
7 1 6 4 0 1 3 1 6 1,076 -779 -42.0 lll
22 2 1 16 0 0 11 1 15 7,816 279 3.7 lV
34 0 1 9 0 0 1 6 108 13,461 2,316 20.8 V
11 2 50 11 0 4 14 13 42 14,799 4,635 45.6 Vl-Vlll
165 47 43 95 0 1 44 48 229 226,438 8,376 3.8 lX
70 15 22 41 0 14 3 32 110 74,831 -21,622 -22.4 X
20,881 3 5 30 0 2 9 4 65 21,998 392 1.8 XI
6 1,011 15 7 0 0 0 1 1 1,142 -4 -0.3 XII
25 8 3,365 14 0 0 5 4 57 4,969 1,402 39.3 Xlll
29 8 7 6,919 0 0 4 0 27 7,255 -24 -0.3 XIV
0 0 0 0 31 0 0 0 0 34 3 9.7 XV
0 0 0 2 0 84 5 1 1 138 23 20.0 XVI
9 1 4 3 0 3 1,066 0 4 1,323 148 12.6 XVII
0 1 2 5 0 0 0 14,518 7 14,692 41 0.3 XVIII
75 10 23 38 0 1 1 7 16,191 16,938 33 0.2 XX
21,606 1,146 3,567 7,279 31 115 1,175 14,651 16,905 551,093
IX XII XIII X XI XV XIV XVI E
Diseases Diseases Diseases Diseases Complications Certain Congenital Symptoms, External Total Net gain/ Percentage
of the of the of the of the of pregnancy, conditions anomalies signs and ill- causes of loss in net gain/loss
digestive skin and musculoskeletal genitourinary childbirth and originating in defined injury and
system subcutaneous system and system the puerperium the perinatal conditions poisoning
tissue connective period
tissue
Table 1
continued
Underlying cause of death by Chapter in ICD-10 and ICD-9
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Figure 1
Among deaths from IHD there has been movement between codes,
resulting in a decrease in the number of deaths assigned to acute
myocardial infarction. This is because in ICD-9, acute ischaemic heart
disease or ischaemic heart disease with a stated duration of less than
four weeks were coded to Acute myocardial infarction (410). In ICD-10
these deaths are coded to Acute ischaemic heart disease (I24.9), which
is a new code. This accounted for about 260 deaths. A further 3,600
deaths coded to 410 in ICD-9 have been coded to Chronic ischaemic
heart disease (I25) in ICD-10. These are deaths which had acute
myocardial infarction or other acute ischaemic heart disease on the
death certificate, but with a stated duration of more than four weeks.
X Diseases of the respiratory system
This Chapter has shown a decrease of around 25 per cent between ICD-
9 and ICD-10. This is largely as a result of the application of Rule 3 to
deaths involving pneumonia, which has itself declined by over 35 per
cent for females and over 40 per cent for males.
The number of deaths assigned to influenza did not change
significantly.
Chronic lower respiratory diseases increased by three per cent overall,
but within this group chronic bronchitis and emphysema showed a
decrease, whereas other chronic obstructive pulmonary disease showed
an increase. This is because if both chronic bronchitis and emphysema
are mentioned on the death certificate then the death is coded to Other
chronic obstructive pulmonary disease (J44.8).
Asthma showed an increase for females, but not for males.
XI Diseases of the digestive system
Diseases of the digestive system showed a small increase between ICD-
9 and ICD-10 (one per cent for females, two per cent for males). Within
the Chapter, increases of less than 10 per cent for both males and
females were seen for hernia, diseases of the liver, and alcoholic liver
disease. The changes to alcoholic liver disease are likely to be as a
result of the reassignment of other alcohol-related deaths. These
changes will be explored in a later paper.
XII Diseases of the skin and subcutaneous tissue
The number of deaths assigned to this Chapter did not show a
significant change between ICD-9 and ICD-10.
XIII Diseases of the musculoskeletal system and
connective tissue
This Chapter showed an increase of around 40 per cent in the number
of deaths allocated to it in ICD-10 compared to ICD-9. This is largely
due to the application of Rule 3. Arthritis showed an increase of 67 per
cent for males and 57 per cent for females. Osteoporosis showed an
increase of around 30 per cent. This may also reflect a reassignment of
deaths previously coded as falls (see Chapter XX). This will be
examined in more detail in a later paper.
XIV Diseases of the genitourinary system
Diseases of the genitourinary system showed no overall change
between ICD-9 and ICD-10. Within the Chapter increases were seen for
diseases of the kidney and ureter for males and renal failure for both
males and females. This is largely due to changes in the classification
of diseases within the Chapter, with exact equivalence of codes being
difficult to obtain.
XV Pregnancy, childbirth and the puerperium
The number of deaths assigned to this Chapter did not show a
significant change between ICD-9 and ICD-10.
XVI Certain conditions originating in the perinatal
period and XVII Congenital malformations,
deformations and chromosomal abnormalities
These Chapters have not been examined in this report. A substantial
number of the deaths from these causes are neonatal. The WHO-
recommended perinatal certificate for stillbirths and neonatal deaths is
used in England and Wales. No single underlying cause can be selected.
This means that these deaths cannot be coded by the software used for
automatic coding of cause of death. The text for each of the conditions
mentioned is coded to ICD-10 using a modified version of the special
ONS software that was used to code cause of death for neonates in
ICD-9. An updated version of the ONS Hierarchical classification of
causes of stillbirths and neonatal deaths5,6 is being developed. The
changes due to the introduction of ICD-10 will be examined in a future
paper.
XVIII Symptoms, signs and abnormal clinical and
laboratory findings, not elsewhere classified
This Chapter showed no change between ICD-9 and ICD-10. Sudden
Infant Death Syndrome (SIDS) headline figures are based on all
mentions of SIDS, not just underlying cause, and so will not be affected
by the move to ICD-10. Most deaths in this chapter are certified as due
to ‘old age’ or ‘senility’, without mention of dementia and with no
disease or injury mentioned.
XX External causes of injury and poisoning
Overall the number of deaths allocated to external causes has not
changed between ICD-9 and ICD-10. However, this masks changes
within the Chapter.
The number of deaths assigned to accidents as a whole has remained
largely unchanged. In addition, no significant changes were seen for
transport accidents, or land transport accidents. However, it should be
noted that it is no longer possible to obtain an exact equivalent of the
old ‘Motor Vehicle Traffic Accidents’ group from ICD-9. This is
because of a change in the axis of classification. In ICD-9, the focus
was on the nature of the accident and type of vehicle. With ICD-10, the
focus is on the person involved in the accident. In order for a death to
be coded as a motor vehicle accident, ICD-10 coding rules require the
word ‘motor’ or the type of vehicle, such as car, pick-up truck, or van,
to be listed on the death certificate. For example, if the death certificate
lists ‘one-vehicle accident’ or ‘head-on collision’, but the type of
vehicle is not stated, the cause of death is coded as Other land transport
accident (V80-V89). A later article will discuss changes within the land
transport accidents group.
The number of deaths allocated to falls has seen a decrease of over 50
per cent for females and around 30 per cent for males. This is largely
due to the fact that fractures with cause unspecified (E887 in ICD-9) are
no longer assumed to be due to a fall and are therefore not included
with them as they were in ICD-9. There may also be some reassignment
of deaths to causes such as osteoporosis. These patterns will be
explored in more detail in a later paper.
Some deaths due to injury have very little information provided about
them. In these situations in ICD-10 the code X59 Accidental exposure
to unspecified factor is assigned to the death, whereas in ICD-9 the
limited detail provided may have been sufficient to assign a more
specific code. Over 1,700 female deaths were assigned to this code,
compared to over 700 male deaths. This is likely to be as a result of the
fact that more of these deaths occur at older ages, and more deaths at
older ages are to females. Most of these deaths (1,600) were coded as
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Fracture of unspecified cause (E887) in ICD-9. A further 400 were
assigned to the nearest equivalent to the X59 code in ICD-9 (E928.9).
The rest have come from a variety of ICD-9 codes. These changes will
be examined in later papers on falls and on accidents as a whole.
Accidental poisonings showed no significant changes. However, at the
4-digit level there is not an exact equivalence between ICD-9 and ICD-
10. The details of the changes for drugs and medicaments will be
explored in the next report from the ONS database of drug-related
poisoning deaths, due to be published in Health Statistics Quarterly 17.
Some deaths have been reclassified from accidental poisoning due to
alcohol to mental and behavioural disorders due to alcohol. This will be
explored in a paper on alcohol-related deaths.
Suicide and homicide are based on verdict, and so have not changed
significantly between ICD revisions. In ICD-10, the code Y33.9 is used
to identify adjourned inquests in the same way as E988.8 was used in
ICD-9.
HOW TO APPLY COMPARABILITY RATIOS TO EXAMINE
TRENDS OVER TIME
The comparability ratios in Table 2 should be applied to England and
Wales data coded in ICD-9 in order to examine trends over time. For a
particular cause, the number of deaths coded to the equivalent cause in
ICD-9 (shown in the table) in the years being compared should be
multiplied by the comparability ratio in order to give an ‘expected’
number of deaths which would have been coded to this cause in ICD-
10. The ratio can also be applied directly to rates, to give an ‘expected’
rate.7
These ratios are only applicable to England and Wales mortality data
from 1993 onwards, when ONS introduced automatic cause coding.
Data for years prior to 1993 are not comparable with data for 1993 to
2000.4 The ratios can only be applied to causes defined by the exact
ICD codes in both revisions that were used to calculate them.
When are comparability ratios not needed?
Where a comparability ratio is given in the table but its confidence
interval includes 1, this means that the difference between the number
of deaths allocated to the cause in ICD-9 and ICD-10 is not statistically
significant. Adjustment will add little to comparisons over time.
When are comparability ratios needed?
Where a comparability ratio is given in the table and its confidence
interval does NOT include 1, this ratio should be applied to data for
1993 to 2000 to adjust for the change to ICD-10 when making
comparisons with data for 2001 and subsequent years. For causes with
very large numbers of deaths, such as IHD, ratios close to 1 can still
appear significant. In this case adjustment may have little effect on
rates.
How should ratios be applied to specific age groups?
The comparability ratios in Table 2 can be applied to age-specific data
as well as to data for all ages combined. Earlier analyses have shown
that there is little difference in the age-standardised rates obtained if
age-specific ratios are applied to data instead of an all-age ratio.2
However, if the data being examined are to be used to examine trends in
specific age groups, it may be sensible to apply age-specific
comparability ratios. This is because there may be systematic
differences by age in factors affecting the selection of the underlying
cause of death. For example, the level of detail provided on a death
certificate can differ by age. In addition, the likelihood of a person
having chronic conditions varies by age. These conditions may be
selected as the underlying cause of death instead of causes such as
pneumonia.
Where there is a statistically significant pattern in comparability ratios
by age, age-specific comparability ratios for the broad age groups under
75, 75 to 84, and 85 and over will be published on the National
Statistics website.
How can trends be examined for causes of death
which have ICD-10 codes but no equivalent in ICD-9?
Some causes listed in the table have no equivalent codes in ICD-9. For
these causes of death, it is not possible to analyse trends before the
introduction of ICD-10. However, by using the bridge-coded data it is
possible to identify the ICD-9 codes which were used to code deaths
assigned to these causes in ICD-10. We plan to investigate the coding of
mesothelioma in a later paper.
How can trends be examined for causes of death not
covered in Table 2?
This report contains comparability ratios for 108 major causes of death.
Diseases not covered by these groups can be examined using the
bridge-coded data for 1999. This data set contains counts of numbers of
deaths by ICD-10 code, ICD-9 code, age and sex. We plan to make
these data available via the National Statistics website.
FUTURE WORK
As described above, more detailed work is being carried out on a wider
range of causes, for example falls, motor vehicle accidents and injuries,
and on cancers by site. These more detailed analyses will be published
on the National Statistics website.
ONS plan to examine the effects on comparability ratios of changes in
death certification practice and disease mix over time, by bridge coding
a sample of an earlier year’s data. This study may provide ratios which
can be applied to earlier years to gain a more accurate picture of trends
over time.
It is unlikely that one year will exactly reflect the long-term disease mix
in England and Wales. The number of deaths attributed to pneumonia
can vary quite markedly year by year. Between 1993 and 2000 it was
generally around 55,000, but 1999 had a particularly high number of
deaths, around 59,000. In 1994, there were just under 49,000 deaths
from pneumonia. We also plan to examine the impact of this variation
on comparability ratios.
The results of both these analyses will be published on the National
Statistics website and in Health Statistics Quarterly when they are
available.
WEBSITE
We have set up an area of the National Statistics website dedicated to
ICD-10 for mortality. This can be found at http://www.statistics.gov.uk/
icd10mortality. This site contains detailed information on the
background to the bridge coding study, the main changes between ICD-
9 and ICD-10, advice on the use of comparability ratios, and detailed
analyses of specific causes of death. In addition there are downloadable
tables of comparability ratios for use in analysis and a downloadable
database of bridge-coded data to allow customers to analyse specific
causes not covered in this report, as described above.
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ICD-10 code ICD-9 code Name 10/9 ratio 95% Confidence Interval
A00-B99 001-139 Certain infectious and parasitic diseases 1.107 (1.075, 1.139)
A00-A09 001-009 Intestinal infectious diseases 1.340 (1.226, 1.464)
A15-A19,  B90 010-018,  137 All tuberculosis (including sequelae) 1.080 (0.994, 1.174)
A15-A16 010-012 Respiratory tuberculosis 1.021 (0.897, 1.162)
A17-A19 013-018 Non-respiratory tuberculosis 0.909 (0.716, 1.154)
A39 036 Meningococcal infection 0.991 (0.952, 1.031)
A40-A41 038 Septicaemia 1.130 (1.085, 1.177)
B15-B19 070 Viral hepatitis 1.108 (0.999, 1.228)
B20-B24 042-044 Human immunodeficiency virus (HIV) disease 1.038 (0.854, 1.263)
C00-D48 140-239 Neoplasms 1.031 (1.030, 1.033)
C00-C97 140-208 Malignant neoplasms 1.022 (1.020, 1.023)
C00-C14 140-149 Malignant neoplasm of lip,  oral cavity and pharynx 0.960 (0.931, 0.989)
C15 150 Malignant neoplasm of oesophagus 1.003 (0.997, 1.010)
C16 151 Malignant neoplasm of stomach 1.001 (0.993, 1.010)
C17 152 Malignant neoplasm of small intestine 0.917 (0.840, 1.000)
C18 153 Malignant neoplasm of colon 1.015 (1.009, 1.021)
C19-C21 154 Malignant neoplasm of rectosigmoid junction,  rectum,  anus and anal canal 1.017 (1.008, 1.027)
C22 155 Malignant neoplasm of liver and intrahepatic bile ducts 0.977 (0.958, 0.996)
C23-C24 156 Malignant neoplasm of gallbladder and biliary tract 0.988 (0.958, 1.019)
C25 157 Malignant neoplasm of pancreas 0.999 (0.994, 1.004)
C32 161 Malignant neoplasm of larynx 1.051 (0.995, 1.110)
C33-C34 162 Malignant neoplasm of trachea,  bronchus and lung 0.996 (0.993, 0.998)
C43 172 Malignant melanoma of skin 0.955 (0.934, 0.977)
C44 173 Other malignant neoplasm of skin 1.140 (1.041, 1.248)
C45 No equivalent codes Mesothelioma
C46 No equivalent codes Kaposi’s sarcoma
C50 174-175 Malignant neoplasm of breast 1.027 (1.022, 1.031)
C53 180 Malignant neoplasm of cervix uteri 0.997 (0.982, 1.013)
C54-C55 179,  182 Malignant neoplasm of other and unspecified parts of uterus 1.021 (1.003, 1.039)
C56 183 Malignant neoplasm of ovary 0.992 (0.986, 0.998)
C64 189.0 Malignant neoplasm of kidney,  except renal pelvis 1.015 (1.000, 1.030)
C67 188 Malignant neoplasm of bladder 1.016 (1.002, 1.030)
C69-C72 190-192 Malignant neoplasm of eye,  brain and other parts of central nervous system 1.003 (0.986, 1.021)
C71 191 Malignant neoplasm of brain 1.009 (0.992, 1.027)
C81-C96 200-208 Malignant neoplasm of lymphoid,  haematopoietic and related tissue 1.047 (1.039, 1.056)
C81 201 Hodgkin’s disease 1.079 (1.012, 1.151)
C82-C85 200,  202 Non-Hodgkin’s lymphoma 1.001 (0.989, 1.013)
C90 203 Multiple myeloma and malignant plasma cell neoplasms 1.058 (1.039, 1.077)
C91-C95 204-208 Leukaemia 1.049 (1.035, 1.064)
C97 No equivalent codes Malignant neoplasm of independent (primary) multiple sites
D00-D48 210-239 In situ, benign neoplasms and neoplasms of uncertain and unknown behaviour 1.582 (1.516, 1.651)
D50-D89 280-289 Diseases of the blood and blood-forming organs and certain disorders involving the
immune mechanism 0.647 (0.607, 0.689)
D50-D64 280-285 Anaemias 0.958 (0.917, 1.000)
E00-E90 240-279 Endocrine,  nutritional and metabolic diseases 1.045 (1.032, 1.058)
E10-E14 250 Diabetes mellitus 1.042 (1.030, 1.054)
F00-F99 290-319 Mental and behavioural disorders 1.219 (1.198, 1.239)
F01-F03 290 Vascular and unspecified dementia 1.526 (1.493, 1.561)
F10-F19 291-292,  303-305 Mental and behavioural disorders due to psychoactive substance use 0.965 (0.903, 1.031)
F10 291,  303,  305.0 Mental and behavioural disorders due to use of alcohol 0.887 (0.798, 0.986)
F11-F16,  F18-F19 292,  304,  305.2-305.9 Mental and behavioural disorders due to drug use (excluding alcohol and tobacco) 1.027 (0.960, 1.100)
G00-G99 320-359 Diseases of the nervous system 1.497 (1.472, 1.522)
G00-G03 320,  322 Meningitis (excluding meningococcal) 1.012 (0.938, 1.091)
G12.2 335.2 Motor neuron disease 1.129 (1.097, 1.163)
G20 332.0 Parkinson’s disease 1.489 (1.440, 1.540)
G30 331.0 Alzheimer’s disease 1.889 (1.828, 1.953)
G35 340 Multiple sclerosis 1.257 (1.205, 1.312)
H00-H59 360-379 Diseases of the eye and adnexa 1.000 (0.662, 1.512)
H60-H95 380-389 Diseases of the ear and mastoid process 0.714 (0.447, 1.141)
I00-I99 390-459 Diseases of the circulatory system 1.043 (1.041, 1.044)
I05-I09 393-398 Chronic rheumatic heart diseases 0.917 (0.889, 0.945)
I10-I15 401-405 Hypertensive diseases 1.014 (1.002, 1.025)
I20-I25 410-414 Ischaemic heart diseases 1.007 (1.006, 1.008)
I21-I22 410 Acute myocardial infarction 0.926 (0.922, 0.929)
I26-I51 415-429 Other heart diseases 0.997 (0.989, 1.005)
I60-I69 430-438 Cerebrovascular diseases 1.090 (1.086, 1.094)
I60-I62 430-432 Intracranial haemorrhage 1.000 (0.993, 1.008)
I63 433-434 Cerebral infarction 1.405 (1.374, 1.437)
I64 436 Stroke,  not specified as haemorrhage or infarction 1.031 (1.027, 1.036)
I70 440 Atherosclerosis 1.147 (1.114, 1.181)
I71 441 Aortic aneurysm and dissection 0.999 (0.994, 1.003)
J00-J99 460-519 Diseases of the respiratory system 0.765 (0.761, 0.769)
J10-J11 487 Influenza 1.000 (0.987, 1.013)
Table 2 Comparability ratios for major causes of death, by sex, England and Wales
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J12-J18 480-486 Pneumonia 0.644 (0.639, 0.649)
J40-J47 490-494,  496 Chronic lower respiratory diseases 1.034 (1.029, 1.039)
J40-J44 490-492,  496 Bronchitis,  emphysema and other chronic obstructive pulmonary disease 1.035 (1.030, 1.041)
J40-J43 490-492 Bronchitis (chronic) and emphysema 0.787 (0.759, 0.817)
J44 496 Other chronic obstructive pulmonary disease 1.065 (1.058, 1.072)
J45-J46 493 Asthma 1.056 (1.026, 1.087)
K00-K93 520-579 Diseases of the digestive system 1.013 (1.008, 1.019)
K25-K28 531-534 Gastric,  duodenal and jejunal ulcer 0.994 (0.985, 1.003)
K25-K27 531-533 Gastric and duodenal ulcer 0.992 (0.983, 1.001)
K40-K46 550-553 Hernia 1.057 (1.024, 1.092)
K57 562 Diverticular disease of intestine 0.997 (0.986, 1.009)
K70-K76 570-573 Diseases of the liver 1.078 (1.061, 1.094)
K70,  K73-K74 571 Chronic liver disease 1.030 (1.011, 1.049)
K70 571.0-571.3 Alcoholic liver disease 1.052 (1.032, 1.073)
L00-L99 680-709 Diseases of the skin and subcutaneous tissue 0.994 (0.963, 1.026)
M00-M99 710-739 Diseases of the musculoskeletal system and connective tissue 1.391 (1.360, 1.423)
M05-M08 714 Rheumatoid arthritis and juvenile arthritis 1.574 (1.495, 1.657)
M80-M81 733.0 Osteoporosis 1.357 (1.311, 1.406)
N00-N99 580-629 Diseases of the genitourinary system 1.001 (0.992, 1.010)
N00-N28 580-594 Diseases of kidney and ureter 1.003 (0.987, 1.019)
N00-N15 No equivalent codes Glomerular and renal tubulo-interstitial diseases
N17-N19 584-586 Renal failure (without stated cause) 1.079 (1.056, 1.103)
O00-O99 630-676 Pregnancy,  childbirth and the puerperium 1.097 (0.988, 1.218)
P00-P96 760-779 Certain conditions originating in the perinatal period
Q00-Q99 740-759 Congenital malformations,  deformations and chromosomal abnormalities
Q00-Q07 740-742 Congenital malformations of the nervous system
Q20-Q28 745-747 Congenital malformations of the circulatory system
R00-R99 780-799 Symptoms,  signs and abnormal clinical and laboratory findings,  not elsewhere
classified 1.003 (1.001, 1.005)
R54 797 Senility (without mention of dementia) 0.993 (0.990, 0.996)
R95 798.0 Sudden infant death syndrome
V01-Y89 E800-E999 External causes of morbidity and mortality 1.008 (0.999, 1.017)
V01-X59 E800-E928,
excluding E870-E879 Accidents 1.011 (1.000, 1.023)
V01-V99 E800-E848 Transport accidents 1.007 (0.997, 1.017)
V01-V89 E800-E829 Land transport accidents 1.005 (0.995, 1.014)
W00-W19 E880-E888 Falls 0.456 (0.437, 0.476)
W65-W74 E910 Accidental drowning and submersion 0.977 (0.904, 1.057)
X00-X09 E890-E899 Exposure to smoke,  fire and flames 0.971 (0.929, 1.016)
X40-X49 E850-E869 Accidental poisoning by and exposure to noxious substances 1.003 (0.966, 1.042)
X40-X44 E850-E858 Accidental poisoning by drugs and medicaments 1.000 (0.964, 1.037)
X41 No equivalent codes Accidental poisoning by and exposure to antiepileptic,  sedative-hypnotic,
antiparkinsonism and psychotropic drugs,  not elsewhere classified
X42 No equivalent codes Accidental poisoning by and exposure to narcotics and psychodysleptics
(hallucinogens),  not elsewhere classified
X44 No equivalent codes Accidental poisoning by and exposure to other and unspecified drugs,  medicaments
and biological substances
X59 No equivalent codes Accidental exposure to unspecified factor
X60-X84 E950-E959 Intentional self-harm 0.999 (0.996, 1.001)
X85-Y09 E960-E969 Assault 0.990 (0.972, 1.009)
Y10-Y34 E980-E989 Injury and poisoning of undetermined intent 1.014 (0.999, 1.029)
Table 2
continued
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Table 2
continued
Comparability ratios for major causes of death, by sex, England and Wales
Males
ICD-10 code ICD-9 code Name 10/9 ratio 95% Confidence Interval
A00-B99 001-139 Certain infectious and parasitic diseases 1.056 (1.028, 1.084)
A00-A09 001-009 Intestinal infectious diseases 1.217 (1.074, 1.379)
A15-A19,  B90 010-018,  137 All tuberculosis (including sequelae) 1.007 (0.953, 1.064)
A15-A16 010-012 Respiratory tuberculosis 1.048 (0.983, 1.117)
A17-A19 013-018 Non-respiratory tuberculosis 0.725 (0.544, 0.967)
A39 036 Meningococcal infection 1.029 (0.980, 1.080)
A40-A41 038 Septicaemia 1.098 (1.053, 1.146)
B15-B19 070 Viral hepatitis 1.072 (0.976, 1.177)
B20-B24 042-044 Human immunodeficiency virus (HIV) disease 1.188 (1.091, 1.292)
C00-D48 140-239 Neoplasms 1.035 (1.033, 1.036)
C00-C97 140-208 Malignant neoplasms 1.025 (1.023, 1.026)
C00-C14 140-149 Malignant neoplasm of lip,  oral cavity and pharynx 0.986 (0.965, 1.007)
C15 150 Malignant neoplasm of oesophagus 1.010 (1.004, 1.016)
C16 151 Malignant neoplasm of stomach 1.019 (1.012, 1.026)
C17 152 Malignant neoplasm of small intestine 0.952 (0.877, 1.033)
C18 153 Malignant neoplasm of colon 1.017 (1.011, 1.024)
C19-C21 154 Malignant neoplasm of rectosigmoid junction,  rectum,  anus and anal canal 1.008 (0.999, 1.016)
C22 155 Malignant neoplasm of liver and intrahepatic bile ducts 0.983 (0.967, 1.000)
C23-C24 156 Malignant neoplasm of gallbladder and biliary tract 0.964 (0.912, 1.020)
C25 157 Malignant neoplasm of pancreas 1.002 (0.997, 1.008)
C32 161 Malignant neoplasm of larynx 1.062 (1.029, 1.096)
C33-C34 162 Malignant neoplasm of trachea,  bronchus and lung 0.996 (0.994, 0.998)
C43 172 Malignant melanoma of skin 0.966 (0.946, 0.986)
C44 173 Other malignant neoplasm of skin 1.066 (0.987, 1.151)
C45 No equivalent codes Mesothelioma
C46 No equivalent codes Kaposi’s sarcoma
C50 174-175 Malignant neoplasm of breast 1.108 (1.027, 1.195)
C61 185 Malignant neoplasm of prostate 1.038 (1.032, 1.044)
C62 186 Malignant neoplasm of testis 0.986 (0.907, 1.072)
C64 189.0 Malignant neoplasm of kidney,  except renal pelvis 1.010 (0.999, 1.021)
C67 188 Malignant neoplasm of bladder 1.008 (0.997, 1.020)
C69-C72 190-192 Malignant neoplasm of eye,  brain and other parts of central nervous system 1.001 (0.987, 1.014)
C71 191 Malignant neoplasm of brain 0.999 (0.987, 1.012)
C81-C96 200-208 Malignant neoplasm of lymphoid,  haematopoietic and related tissue 1.053 (1.045, 1.062)
C81 201 Hodgkin’s disease 1.043 (0.987, 1.102)
C82-C85 200,  202 Non-Hodgkin’s lymphoma 1.002 (0.989, 1.016)
C90 203 Multiple myeloma and malignant plasma cell neoplasms 1.053 (1.036, 1.071)
C91-C95 204-208 Leukaemia 1.061 (1.046, 1.076)
C97 No equivalent codes Malignant neoplasm of independent (primary) multiple sites
D00-D48 210-239 In situ, benign neoplasms and neoplasms of uncertain and unknown behaviour 1.787 (1.703, 1.876)
D50-D89 280-289 Diseases of the blood and blood-forming organs and certain disorders involving the
immune mechanism 0.502 (0.461, 0.546)
D50-D64 280-285 Anaemias 1.005 (0.938, 1.078)
E00-E90 240-279 Endocrine,  nutritional and metabolic diseases 1.027 (1.014, 1.041)
E10-E14 250 Diabetes mellitus 1.044 (1.032, 1.055)
F00-F99 290-319 Mental and behavioural disorders 1.188 (1.159, 1.217)
F01-F03 290 Vascular and unspecified dementia 1.663 (1.597, 1.733)
F10-F19 291-292,  303-305 Mental and behavioural disorders due to psychoactive substance use 0.977 (0.949, 1.006)
F10 291,  303,  305.0 Mental and behavioural disorders due to use of alcohol 0.932 (0.860, 1.010)
F11-F16,  F18-F19 292,  304,  305.2-305.9 Mental and behavioural disorders due to drug use (excluding alcohol and tobacco) 0.994 (0.974, 1.014)
G00-G99 320-359 Diseases of the nervous system 1.415 (1.392, 1.439)
G00-G03 320,  322 Meningitis (excluding meningococcal) 0.980 (0.913, 1.051)
G12.2 335.2 Motor neuron disease 1.120 (1.090, 1.150)
G20 332.0 Parkinson’s disease 1.494 (1.449, 1.540)
G30 331.0 Alzheimer’s disease 2.104 (1.994, 2.221)
G35 340 Multiple sclerosis 1.219 (1.152, 1.289)
H00-H59 360-379 Diseases of the eye and adnexa 1.667 (0.606, 4.586)
H60-H95 380-389 Diseases of the ear and mastoid process 0.833 (0.583, 1.192)
I00-I99 390-459 Diseases of the circulatory system 1.034 (1.032, 1.035)
I05-I09 393-398 Chronic rheumatic heart diseases 0.868 (0.819, 0.920)
I10-I15 401-405 Hypertensive diseases 1.010 (0.996, 1.025)
I20-I25 410-414 Ischaemic heart diseases 1.005 (1.004, 1.005)
I21-I22 410 Acute myocardial infarction 0.937 (0.934, 0.941)
I26-I51 415-429 Other heart diseases 0.991 (0.982, 1.000)
I60-I69 430-438 Cerebrovascular diseases 1.131 (1.125, 1.136)
I60-I62 430-432 Intracranial haemorrhage 1.002 (0.993, 1.012)
I63 433-434 Cerebral infarction 1.540 (1.495, 1.587)
I64 436 Stroke,  not specified as haemorrhage or infarction 1.057 (1.050, 1.064)
I70 440 Atherosclerosis 1.160 (1.108, 1.215)
I71 441 Aortic aneurysm and dissection 1.003 (0.999, 1.007)
J00-J99 460-519 Diseases of the respiratory system 0.789 (0.785, 0.793)
J10-J11 487 Influenza 0.960 (0.919, 1.002)
J12-J18 480-486 Pneumonia 0.583 (0.577, 0.590)
J40-J47 490-494,  496 Chronic lower respiratory diseases 1.031 (1.027, 1.035)
J40-J44 490-492,  496 Bronchitis,  emphysema and other chronic obstructive pulmonary disease 1.035 (1.031, 1.040)
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ENQUIRIES
For further information on any aspect of ICD-10 email:
icd10.mortality@ons.gov.uk.
For more general ICD enquiries email: who@ons.gov.uk.
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Comparability ratios for major causes of death, by sex, England and Wales
Males
ICD-10 code ICD-9 code Name 10/9 ratio 95% Confidence Interval
J40-J43 490-492 Bronchitis (chronic) and emphysema 0.660 (0.637, 0.683)
J44 496 Other chronic obstructive pulmonary disease 1.101 (1.094, 1.108)
J45-J46 493 Asthma 0.964 (0.928, 1.001)
K00-K93 520-579 Diseases of the digestive system 1.024 (1.018, 1.030)
K25-K28 531-534 Gastric,  duodenal and jejunal ulcer 0.999 (0.991, 1.008)
K25-K27 531-533 Gastric and duodenal ulcer 1.000 (0.992, 1.008)
K40-K46 550-553 Hernia 1.037 (1.003, 1.072)
K57 562 Diverticular disease of intestine 1.000 (0.974, 1.026)
K70-K76 570-573 Diseases of the liver 1.063 (1.050, 1.075)
K70,  K73-K74 571 Chronic liver disease 1.002 (0.988, 1.016)
K70 571.0-571.3 Alcoholic liver disease 1.052 (1.036, 1.068)
L00-L99 680-709 Diseases of the skin and subcutaneous tissue 1.003 (0.947, 1.062)
M00-M99 710-739 Diseases of the musculoskeletal system and connective tissue 1.399 (1.344, 1.457)
M05-M08 714 Rheumatoid arthritis and juvenile arthritis 1.674 (1.497, 1.871)
M80-M81 733.0 Osteoporosis 1.304 (1.222, 1.392)
N00-N99 580-629 Diseases of the genitourinary system 0.991 (0.979, 1.002)
N00-N28 580-594 Diseases of kidney and ureter 1.034 (1.013, 1.054)
N00-N15 No equivalent codes Glomerular and renal tubulo-interstitial diseases
N17-N19 584-586 Renal failure (without stated cause) 1.081 (1.054, 1.108)
N40 600 Hyperplasia of prostate 0.926 (0.876, 0.979)
P00-P96 760-779 Certain conditions originating in the perinatal period
Q00-Q99 740-759 Congenital malformations,  deformations and chromosomal abnormalities
Q00-Q07 740-742 Congenital malformations of the nervous system
Q20-Q28 745-747 Congenital malformations of the circulatory system
R00-R99 780-799 Symptoms,  signs and abnormal clinical and laboratory findings,  not elsewhere
classified 1.002 (0.996, 1.009)
R54 797 Senility (without mention of dementia) 0.996 (0.990, 1.002)
R95 798.0 Sudden infant death syndrome
V01-Y89 E800-E999 External causes of morbidity and mortality 0.999 (0.994, 1.003)
V01-X59 E800-E928,
excluding E870-E879 Accidents 0.996 (0.989, 1.003)
V01-V99 E800-E848 Transport accidents 0.998 (0.991, 1.005)
V01-V89 E800-E829 Land transport accidents 1.000 (0.994, 1.007)
W00-W19 E880-E888 Falls 0.718 (0.694, 0.744)
W65-W74 E910 Accidental drowning and submersion 0.994 (0.942, 1.049)
X00-X09 E890-E899 Exposure to smoke,  fire and flames 0.968 (0.934, 1.003)
X40-X49 E850-E869 Accidental poisoning by and exposure to noxious substances 1.009 (0.987, 1.031)
X40-X44 E850-E858 Accidental poisoning by drugs and medicaments 1.002 (0.983, 1.020)
X41 No equivalent codes Accidental poisoning by and exposure to antiepileptic,  sedative-hypnotic,
antiparkinsonism and psychotropic drugs,  not elsewhere classified
X42 No equivalent codes Accidental poisoning by and exposure to narcotics and psychodysleptics
(hallucinogens),  not elsewhere classified
X44 No equivalent codes Accidental poisoning by and exposure to other and unspecified drugs,  medicaments
and biological substances
X59 No equivalent codes Accidental exposure to unspecified factor
X60-X84 E950-E959 Intentional self-harm 1.000 (0.998, 1.001)
X85-Y09 E960-E969 Assault 1.011 (0.981, 1.041)
Y10-Y34 E980-E989 Injury and poisoning of undetermined intent 1.010 (1.000, 1.020)
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Other population and health articles, publications and data
Vital Statistics data – annual data for each Health
and Local Authority in England and Wales
VS1  Births and deaths summary data:
Population, births and deaths, fertility and mortality rates, comparisons with
the region, and with England and Wales.
VS2  Births:
Births by age of mother, number of previous children, place of confinement
and birthweight.
VS3  Deaths by cause:
Deaths by cause, sex and age.
VS4  Vital Statistics for wards:
Live births, stillbirths and deaths (by age).
VS4D  Deaths for wards:
Deaths for wards in local authorities by 12 selected causes.
VS5  Infant mortality:
Live births, stillbirths and infant deaths.  Numbers and rates.
Live births and stillbirths by birthweight.
Stillbirths by gestation period.
How to order:
Most Vital Statistics data are available on paper and CD-ROM for each year
1993–99. Prices range from £15. To order contact:
Vital Statistics Outputs Branch
Room 1300
Office for National Statistics
Segensworth Road
Titchfield
Hampshire PO15 5RR
Tel: 01329 813758
Forthcoming Annual Reference Volumes
Title Planned publication
Mortality statistics, injury and poisoning, 2000, DH4 no. 25* June 2002
Marriage, divorce and adoption statistics 2000 FM2 no. 28* July 2002
* Available through the National Statistics website only www.statistics.gov.uk
Population Trends 108
Publication 27 June 2002
Health Statistics Quarterly 15
Publication 22 August 2002
Planned  Inequalities in life expectancy by social
articles: class, 1972–1999
 Trends in neonatal deaths and stillbirths
by cause
 Epilepsy prevalence and prescribing
patterns in England and Wales
Reports:  Sudden infant deaths, 2001
 Healthy life expectancy in Great Britain,
1999
 Death registrations in England and Wales,
2001: local and health authority areas
 Infant and perinatal mortality 2001: health
areas, England and Wales
Annual  2000 Mortality Statistics: injury and
Update: poisoning (England and Wales)
Planned  New estimates of trends in births by
articles: birth order in England and Wales
 Attitudes towards ideal family size of
different ethnic/nationality groups in
Great Britain, France and Germany
 Geography for the 2001 Census in
England and Wales
 The Census Coverage Survey – the key
element of a One Number Census
Reports:  Live births in England and Wales 2001 by
local and health authority areas
 Death registrations in England and Wales
2001 by area of residence
 2000-based short-term subnational
population projections for health authority
areas in England
